PMID: 41366616 Title: Cardiovascular Prevention in Children, Adolescents, and Young Adults. A Call-to-Action of the Italian Societies of Pediatrics (SIP), Hypertension (SIIA), Study of Atherosclerosis (SISA), and Cardiovascular Prevention (SIPREC). Date: 2025 Dec 9 Abstract: Cardiovascular and cerebrovascular diseases (CVDs), primarily driven by
PMID: 41366613 Title: Dapagliflozin Reduces Ambulatory Arterial Stiffness Index in CKD Patients with and Without Diabetes Independently of Blood Pressure Control: Results from the GLUcose Transport and Renal PROtection in Chronic Kidney Disease (GLUTREPRO) Trial. Date: 2025 Dec 9 Abstract: INTRODUCTION: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) confer
PMID: 41366588 Title: Meta-Analysis of the Placebo Response in Chronic and Episodic Migraine: Insights from Migraine Preventive Drug Trials. Date: 2025 Dec 9 Abstract: Randomized, well-controlled trials are the gold-standard for evaluating novel
PMID: 41366561 Title: A Successful Pediatric ABO Incompatible Transplant Using Reusable Vitrosorb Column. Date: 2025 Dec Abstract: BACKGROUND: End-stage renal disease (ESRD) is a critical global health concern,
PMID: 41366502 Title: MoMA: a mixture-of-multimodal-agents architecture for enhancing clinical prediction modelling. Date: 2025 Dec 9 Abstract: Multimodal electronic health record (EHR) data provide richer, complementary
PMID: 41366490 Title: Oral health care during pregnancy to prevent preterm birth and low birth weight: study protocol for a randomized controlled trial. Date: 2025 Dec 10 Abstract: BACKGROUND: Periodontal disease during pregnancy has been associated with an
PMID: 41366468 Title: Complex mitral valve repair in a patient with surgically corrected pectus excavatum: a case report. Date: 2025 Dec 9 Abstract: BACKGROUND: The management of severe pectus excavatum (PEx) in patients with
PMID: 41366465 Title: Efficacy of pharmacological and non-pharmacological interventions for the treatment of anorexia nervosa in adolescents and adults (EfaNosa): protocol for a network meta-analysis. Date: 2025 Dec 9 Abstract: BACKGROUND: Anorexia nervosa (AN) is a severe eating disorder. With a lifetime
PMID: 41366457 Title: Transition from childhood to adulthood in neuromuscular disorders: results from the ERN EURO-NMD survey. Date: 2025 Dec 9 Abstract: BACKGROUND: Neuromuscular diseases (NMDs) are rare, progressive conditions that
PMID: 41366408 Title: How are duodenal trauma managed? A French nationwide study. Date: 2025 Dec 9 Abstract: BACKGROUND: Duodenal injuries are rare, associated with a significant morbidity.
PMID: 41366387 Title: Effect of electroacupuncture for pain relief in diabetic distal symmetric polyneuropathy: a pilot randomized clinical trial. Date: 2025 Dec 9 Abstract: BACKGROUND: Painful distal symmetric polyneuropathy (DSPN) is one of the most
PMID: 41366370 Title: Efficacy of preoperative electroacupuncture for ureteral access sheath placement during first-stage flexible ureteroscopy in urolithiasis: a multicenter, randomized, single-blind, sham-controlled trial protocol. Date: 2025 Dec 9 Abstract: INTRODUCTION: Retrograde intrarenal surgery (RIRS) is a primary treatment for
PMID: 41366355 Title: A case of pulmonary nodular lesion caused by Tropheryma whipplei infection: a case report and literature review. Date: 2025 Dec 10 Abstract: BACKGROUND: Tropheryma whipplei is a Gram-positive aerobic bacillus belonging to
PMID: 41366348 Title: Is injectable platelet rich fibrin beneficial in managing intracapsular temporomandibular disorders? A systematic review and meta-analysis. Date: 2025 Dec 9 Abstract: OBJECTIVE: To highlight the current knowledge of the effectiveness of injectable
PMID: 41366315 Title: Mobile app improves treatment of functional constipation in children: a randomized single-blind study. Date: 2025 Dec 9 Abstract: BACKGROUND: Functional constipation is one of the most prevalent functional
PMID: 41366311 Title: Post-COVID-19 subacute painless thyroiditis: a case report in an anabolic androgenic steroid user. Date: 2025 Dec 9 Abstract: PURPOSE: The coronavirus disease of 2019 is still a serious clinical problem.
PMID: 41366306 Title: Misdiagnosis of 99mTc-PYP-positive Danon disease as ATTR-CA: a case report and molecular imaging pitfalls. Date: 2025 Dec 9 Abstract: BACKGROUND: Transthyretin amyloid cardiomyopathy (ATTR-CA) results from
PMID: 41366286 Title: A phase 4, 24-week, open-label study to evaluate the safety and tolerability of once-daily dosing of 75 mg rimegepant for episodic migraine prevention. Date: 2025 Dec 9 Abstract: BACKGROUND: Rimegepant is a small-molecule calcitonin gene-related peptide
PMID: 41366251 Title: Brain-derived extracellular vesicle proteomics reveals neuroprotection induced by the ARB candesartan in Parkinson's disease patients. Date: 2025 Dec 10 Abstract: In models of Parkinson's disease (PD), angiotensin-II type-1 receptor (AT1)
PMID: 41366245 Title: An outer membrane vesicle vaccine prevents lung pathology in a macaque model of pneumonic melioidosis. Date: 2025 Dec 9 Abstract: Melioidosis is an emerging infectious disease caused by the intracellular
PMID: 41366239 Title: Experience and Satisfaction of Genetic Clinicians With Electronic Health Records (EHR). Date: 2025 Dec 9 Abstract: The objective of this study was to evaluate the EHR user experience and
PMID: 41366179 Title: JAK inhibitors in autoimmune ocular inflammatory diseases - A systematic review of case reports and series. Date: 2025 Dec 10 Abstract: BACKGROUND: Autoimmune inflammatory ocular diseases, including uveitis,
PMID: 41366174 Title: Intrasinusoidal ALK-positive anaplastic large cell lymphoma. Date: 2025 Dec 10 Abstract: ALK-positive anaplastic large cell lymphoma (ALCL) may show sinusoidal
PMID: 41366148 Title: Immunotherapy and targeted therapy for high grade gliomas: current and future directions. Date: 2025 Dec 9 Abstract: BACKGROUND: High grade gliomas are aggressive intrinsic brain tumors with limited
PMID: 41366145 Title: Surgical management of progressive spinal deformities in FKBP14-associated Ehlers-Danlos syndrome: a case report and literature review. Date: 2025 Dec 9 Abstract: PURPOSE: This report aims to present a comprehensive case of progressive spinal
PMID: 41366138 Title: Recent advances in the diagnosis and treatment of refractory ocular inflammatory diseases: focus on uveitic macular edema, acute retinal necrosis, and vitreoretinal lymphoma. Date: 2025 Dec 10 Abstract: Refractory inflammatory ocular diseases-uveitic macular edema (UME), acute
PMID: 41366124 Title: Evaluating Repetitive Transcranial Magnetic Stimulation in Spinocerebellar Ataxia: A Meta-Analysis of Efficacy and Safety. Date: 2025 Dec 10 Abstract: To evaluate the efficacy and safety of repetitive Transcranial Magnetic
PMID: 41366113 Title: Serum and CSF cytokine profile in patients with facial palsy (Bell's palsy): a pilot study. Date: 2025 Dec 9 Abstract: BACKGROUND AND PURPOSE: Facial nerve palsy is the most common cranial nerve
PMID: 41366092 Title: Spinal cord vascular autoregulation: key concepts and opportunities to improve management. Date: 2025 Dec 9 Abstract: STUDY DESIGN: Narrative review. OBJECTIVES: Vascular autoregulation in the
PMID: 41366050 Title: Clinical presentation, risk factors, and comorbidities of cutis marmorata telangiectatica congenita: a systematic review. Date: 2025 Dec 9 Abstract: BACKGROUND: Cutis marmorata telangiectatica congenita (CMTC) is a rare vascular
PMID: 41366017 Title: Prediction of drug approvals in oncology using explainable artificial intelligence. Date: 2025 Dec 9 Abstract: Oncology is characterized by vigorous drug development, including the
PMID: 41365963 Title: The Effect of progressive muscle relaxation and physical exercises on subjective well-being and fatigue of patients receiving hemodialysis: a randomized clinical trial. Date: 2025 Dec 9 Abstract: Patients receiving hemodialysis (HD) often experience fatigue and reduced quality
PMID: 41365947 Title: Do cognitive tests capture symptoms that matter to people with Huntington's disease? Date: 2025 Dec 9 Abstract: The Huntington's Disease Cognitive Assessment Battery (HD-CAB) is frequently used
PMID: 41365876 Title: Identification and targeting oxidative phosphorylation/glycolysis to overcome anti-CSF-1R therapy resistance in glioblastoma. Date: 2025 Dec 10 Abstract: The standard care of glioblastomas (GBM) confers limited survival benefit for
PMID: 41365861 Title: Chloroquine Overcomes Chemotherapy Resistance and Suppresses Cancer Metastasis by Eradicating Dormant Cancer Cells. Date: 2025 Dec 10 Abstract: Cancer cell resistance and tumor relapse remain major challenges in cancer
PMID: 41365810 Title: Endovascular Arterialization of the Venous Plantar Arch in a Patient with Advanced Peripheral Arterial Disease: A Case Report. Date: 2025 Dec 10 Abstract: Peripheral arterial disease (PAD) causes progressive arterial narrowing that
PMID: 41365773 Title: Energy drinks, hypertension and stroke. Date: 2025 Dec 9 Abstract: A man in his 50s, normally fit and well, had an ischaemic thalamic stroke
PMID: 41365769 Title: Nonmalignant findings on FAPI PET: An updated rapid systematic review of the literature. Date: 2025 Dec 8 Abstract: BACKGROUND/AIM: Fibroblast activation protein inhibitor (FAPI) PET has shown
PMID: 41365757 Title: A solid pseudopapillary neoplasm overlooked for a decade: Long-term stability and development of distal pancreatic atrophy. Date: 2025 Dec 8 Abstract: Solid pseudopapillary neoplasm (SPN) is a rare pancreatic tumor with low
PMID: 41365713 Title: Longitudinal changes in haemoglobin, iron stores, and inflammatory markers following surgery and in critical illness: an analysis from the Practical Anaemia Bundle for Sustained Blood Recovery randomised clinical trial. Date: 2025 Dec 8 Abstract: BACKGROUND: Intravenous iron improves haemoglobin recovery after surgery and in
PMID: 41365697 Title: Leukocytoclastic Vasculitis and Profound Cytopenias Following Teicoplanin Therapy: A Case Report on Glycopeptide Cross-Reactivity. Date: 2025 Dec 8 Abstract: PURPOSE: To report a case of teicoplanin-induced leukocytoclastic vasculitis with
PMID: 41365660 Title: Impact of EHR direct-to-patient outreach on ambulatory advance directives completion among older adults. Date: 2025 Dec 9 Abstract: BACKGROUND: Advance directives (AD) are crucial for aligning healthcare with
PMID: 41365642 Title: Herpes Simplex Virus Glycoprotein D Associated with Abeta(1-42) Tetramers Mediates Neurotoxicity by Perturbing Neuronal Membrane Integrity: A Molecular Dynamics Simulation. Date: 2025 Dec 9 Abstract: Alzheimer's disease (AD) is characterized by deleterious amyloid plaques
PMID: 41365627 Title: Evaluating the efficacy of the WHO QualityRights e-training in promoting the rights of persons with mental health conditions and psychosocial disabilities: a cluster randomised controlled trial in Ghana. Date: 2025 Dec 9 Abstract: INTRODUCTION: People with mental health conditions and psychosocial disabilities
PMID: 41365607 Title: Association of blood pressure control with atrial and ventricular ectopy in SPRINT. Date: 2025 Dec 9 Abstract: BACKGROUND: Previous epidemiological studies demonstrated that premature atrial
PMID: 41365587 Title: Efficacy and moderators of mindfulness-based cognitive therapy (MBCT) in 'Difficult to Treat' depression: protocol for a systematic review and individual participant data meta-analysis of randomised controlled trials. Date: 2025 Dec 8 Abstract: INTRODUCTION: About 30% of depressed patients suffer from a protracted course in
PMID: 41365524 Title: Development of a core outcome set for patients with epiretinal membranes: a Delphi consensus study. Date: 2025 Dec 8 Abstract: BACKGROUND/AIMS: Idiopathic epiretinal membrane (iERM) can affect vision in
PMID: 41365511 Title: Radionuclide Cisternography Revealed Neck Cyst Formed by Cerebrospinal Fluid Leakage After Cervical Spine Surgery. Date: 2026 Jan 1 Abstract: A 71-year-old man presented with nausea, vomiting, headache, and neck swelling
PMID: 41365510 Title: Mesenteric Panniculitis Mimicking Metastases From Melanoma on FDG PET/CT in a Pediatric Patient Receiving Immunotherapy. Date: 2026 Jan 1 Abstract: Inflammatory immune-related adverse events are known complications of
PMID: 41365509 Title: [68Ga]Ga-FAPI-46 PET/MRI for Therapy Monitoring of Desmoid Tumors. Date: 2026 Jan 1 Abstract: Desmoid tumors (DT) are locally aggressive and show a high potential for
PMID: 41365505 Title: Biodistribution and Radiation Dosimetry of [18F]AlF-NSFBP4 in Cancer Patients: First-in-Human Study. Date: 2026 Jan 1 Abstract: PURPOSE: This first-in-human study aimed to evaluate the radiation dosimetry and
PMID: 41365504 Title: [18F]AlF-NOTA-PCP2 PET/CT to Assess PD-L1 Status in Head and Neck Cancer: Head-to-Head Comparison With [18F]FDG PET/CT. Date: 2026 Jan 1 Abstract: PURPOSE: While PD-L1 expression heterogeneity limits the predictive value of
PMID: 41365490 Title: A Hidden Culprit in the Nasal Cavity: A Case Report on Bilateral Rhinolithiasis. Date: 2025 Nov Abstract: Rhinolithiasis is a rare condition characterized by the deposition of mineralized
PMID: 41365489 Title: Seborrheic Keratosis of the Nasal Vestibule: A Case Report and Literature Review. Date: 2025 Nov Abstract: Seborrheic keratosis (SK) is a common benign epithelial neoplasm most often found
PMID: 41365475 Title: Precision in Practice: A Critical Overview of Recent Advances in Nasopharyngeal Cancer Management. Date: 2025 Dec 7 Abstract: Outcomes for patients with nasopharyngeal carcinoma (NPC) have improved
PMID: 41365464 Title: Delayed Hemolytic Anemia After Artemether-Lumefantrine in Plasmodium falciparum Malaria: A Case Report. Date: 2025 Dec 7 Abstract: Delayed hemolytic anemia (DHA) is a rare, severe complication of
PMID: 41365463 Title: Nonthyroidal illness syndrome and diagnostic utility of CSF mNGS: insights from a case series of neurological scrub typhus. Date: 2025 Dec 7 Abstract: We describe five cases of neurological scrub typhus that highlight two critical,
PMID: 41365426 Title: Disengaged: A systematic review of community engagement in psychedelic-assisted therapy research. Date: 2025 Dec 7 Abstract: People of color have been significantly underincluded in psychedelic-assisted
PMID: 41365387 Title: A clinical trial loses access to some of its experimental treatment conditions: What can be done? Date: 2025 Dec 7 Abstract: This commentary examines methodological and ethical problems encountered when a
PMID: 41365382 Title: Refractory hypercalcemic crisis: A case of primary hyperparathyroidism with Gitelman syndrome. Date: 2025 Dec Abstract: Primary hyperparathyroidism is characterized by hypercalcemia and
PMID: 41365341 Title: [Preventive Pancreatic Surgery]. Date: 2025 Dec 9 Abstract: One of the principal reasons for the poor prognosis of pancreatic carcinoma is
PMID: 41365340 Title: A Novel Surgical Technique for Maxillary Alveolar Sealing: Use of a Tunneled Pedicled Connective Tissue Flap in Ridge Preservation Procedures. Date: 2025 Dec 9 Abstract: This case report illustrates the use of a novel design for a tunneled connective
PMID: 41365339 Title: Orthodontic Labial Tooth Movement for Implant Site Development: A Case Report of Immediate Placement for Ankylosis Tooth. Date: 2025 Dec 9 Abstract: This case report presents a novel orthodontic technique, orthodontic labial tooth
PMID: 41365336 Title: Horizontal Augmentation via Ridge Splitting and Expansion for Implant Placement in Atrophic Sites: A Prospective Non-Randomized Controlled Trial. Date: 2025 Dec 9 Abstract: The alveolar ridge split and expansion (ARSE) technique is a predictable approach
PMID: 41365335 Title: Effect of a Topical Oxygen-Releasing Gel on Osseous-Augmentation Following Socket Preservation in a Male Smoker With Type-2 Diabetes Mellitus: A Case Report. Date: 2025 Dec 9 Abstract: Socket preservation (SP) with bone grafting is often used to maintain alveolar
PMID: 41365133 Title: White matter hyperintensity regression: Fact or artifact? Date: 2025 Dec 3 Abstract: White matter hyperintensities (WMH) are an MRI-based biomarker associated with
PMID: 41365129 Title: Radiotherapy in the management of PDAC, from past to present. Date: 2025 Dec 8 Abstract: Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal forms of
PMID: 41365077 Title: Immune landscape and potential role of immune checkpoint inhibitors on uterine leiomyosarcoma: a review. Date: 2025 Nov 21 Abstract: Uterine leiomyosarcoma is a rare and aggressive malignancy with limited
PMID: 41364948 Title: Combined use of miniscrews, facemask and clear aligner appliances for the treatment of an 11-year-old girl with unilateral posterior scissor bite and skeletal class III malocclusion: A case report. Date: 2025 Dec 8 Abstract: This article illustrates the successful treatment of scissor bite correction
PMID: 41364947 Title: Clear aligner-based multidisciplinary camouflage treatment for adult skeletal class III malocclusion: A 7-year follow-up. Date: 2025 Dec 8 Abstract: This case report describes non-surgical camouflage treatment of a skeletal Class
PMID: 41364937 Title: The state of science convergence in implantable brain-computer interface clinical trials. Date: 2025 Dec 9 Abstract: Advances in implantable brain-computer interfaces (iBCI) have rapidly accelerated
PMID: 41364911 Title: Proactively Delivered Digital Mental Health Support for Health Care Workers: Usability and Acceptability Evaluation. Date: 2025 Dec 9 Abstract: BACKGROUND: Health systems are investing in mental health and well-being support
PMID: 41364896 Title: [Two cases of indigenous leptospirosis in Sweden]. Date: 2025 Oct 14 Abstract: Leptospirosis is a zoonotic infection caused by slow-growing spirochetes of the
PMID: 41364889 Title: Evaluating Plasma p-tau217 as an Endpoint for Alzheimer Disease Clinical Trials. Date: 2026 Jan 13 Abstract: BACKGROUND AND OBJECTIVES: Plasma phosphorylated tau 217 (p-tau217) levels have
PMID: 41364874 Title: Osimertinib Versus First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Metastatic EGFR-Mutant Non-Small Cell Lung Cancer: A Target Trial Emulation Study of Real-World Survival and Safety Outcomes. Date: 2025 Dec 9 Abstract: PURPOSE: Although clinical trials support osimertinib's efficacy over standard
PMID: 41364869 Title: Hyperbaric oxygen therapy for hypoglycaemic encephalopathy due to insulinoma: a case report. Date: 2025 Dec 20 Abstract: INTRODUCTION: Hypoglycaemic encephalopathy is a potentially life-threatening
PMID: 41364868 Title: Cutaneous decompression sickness after an air dive with oxygen breathed during decompression in a commercial diver with a persistent foramen ovale. Date: 2025 Dec 20 Abstract: A 43-year-old commercial diver had cutaneous decompression sickness after a dive
PMID: 41364867 Title: Hyperbaric oxygen therapy as salvage treatment for post-traumatic sudden sensorineural hearing loss: a case report. Date: 2025 Dec 20 Abstract: INTRODUCTION: We report the first case of hyperbaric oxygen therapy used to treat
PMID: 41364864 Title: Hyperbaric oxygen therapy for acute idiopathic sudden sensorineural hearing loss; a systematic review with meta-analysis. Date: 2025 Dec 20 Abstract: INTRODUCTION: Idiopathic sudden sensorineural hearing loss (ISSHL) is hearing
PMID: 41364861 Title: Use of in-water recompression for decompression illness after deep freediving: a case series. Date: 2025 Dec 20 Abstract: INTRODUCTION: There are increasing anecdotal reports of in-water recompression in
PMID: 41364859 Title: Quality of reporting in hyperbaric medicine clinical trials: a cross-sectional study. Date: 2025 Dec 20 Abstract: INTRODUCTION: Research in hyperbaric oxygen (HBO) medicine is growing, but the
PMID: 41364855 Title: Validation and clinical use of the Maquet (Getinge) original series Rotaflow extracorporeal membrane oxygenation device in hyperbaric conditions: a technical report. Date: 2025 Dec 20 Abstract: INTRODUCTION: Extracorporeal membrane oxygenation (ECMO) has not been previously
PMID: 41364854 Title: The process, logistics and governance behind a high-stakes novel intervention: the use of extracorporeal membrane oxygenation (ECMO) in the hyperbaric chamber. Date: 2025 Dec 20 Abstract: INTRODUCTION: A multi-trauma patient receiving extracorporeal membrane
PMID: 41364853 Title: Novel use of hyperbaric oxygen treatment for treatment-resistant disseminated Saksenaea and Fusarium in a patient on extracorporeal membrane oxygenation (ECMO): a case report. Date: 2025 Dec 20 Abstract: Filamentous soil moulds such as Saksenaea and Fusarium are angioinvasive fungi
PMID: 41364844 Title: Telehealth to Expedite Cardiogenic Shock Diagnosis and Treatment: A Case Report. Date: 2025 Dec 15 Abstract: In an increasingly complex health care environment, the prompt recognition of
PMID: 41364819 Title: Is it still useful to publish case reports? Date: 2025 Dec 9 Abstract: Although the medical literature is flooded with case descriptions, it is
PMID: 41364803 Title: Effectiveness of a Cardiovascular Management System on Triple Risk Factor Control in High-Risk Older Adults: Protocol for a Randomized Controlled Trial. Date: 2025 Dec 9 Abstract: BACKGROUND: Cardiovascular disease (CVD) remains a leading cause of morbidity and
PMID: 41364792 Title: Adoption of Machine Learning in US Hospital Electronic Health Record Systems: Retrospective Observational Study. Date: 2025 Dec 9 Abstract: BACKGROUND: While machine learning (ML) technologies have shifted from
PMID: 41364781 Title: New Technique for Humeral Head Grafting in the Treatment of Large Off-Track Hill-Sachs Lesions: A Case Report. Date: 2025 Oct 1 Abstract: CASE: The optimal treatment of large, medial Hill-Sachs lesions is unclear and
PMID: 41364779 Title: Fungating Hemangioma of the Foot Following Traumatic Laceration Mimicking Sarcoma: A Case Report. Date: 2025 Oct 1 Abstract: CASE: A 64-year-old man developed a rapidly enlarging, painless exophytic mass on
PMID: 41364778 Title: Surgical Management of a Tripartite Patella in an Adolescent: A Case Report. Date: 2025 Oct 1 Abstract: CASE: A 15-year-old adolescent boy presented with acute on chronic right knee
PMID: 41364777 Title: Sequelae of Infantile Elbow Infection in an Adolescent: A Case Report with 3D-Printed Assisted Preoperative Planning. Date: 2025 Oct 1 Abstract: CASE: A 17-year-old adolescent boy with a history of right elbow septic arthritis
PMID: 41364776 Title: Motorized Intramedullary Lengthening Nail for an Adolescent Femoral Shaft Fracture with Associated Bone Loss: A Case Report. Date: 2025 Oct 1 Abstract: CASE: A 16-year-old boy who sustained a type IIIA open segmental femoral shaft
PMID: 41364747 Title: The impact of discontinuation and non-publishing of osteoporosis clinical trials. Date: 2025 Dec 10 Abstract: CONTEXT: Osteoporosis is a prevalent chronic disease associated with fractures,
PMID: 41364682 Title: Myofilamental integrity of the myometrium due to cold ischaemia stress during autotransplantation in the experimental sheep model. Date: 2025 Abstract: Uterine transplantation is currently the only solution that enables women with
PMID: 41364659 Title: Association between Anti-Helicobacter pylori IgG seropositivity on coronary heart disease and potential pathogenesis: a Mendelian randomization study. Date: 2025 Abstract: BACKGROUND: Currently, observational studies and clinical trials have shown that
PMID: 41364649 Title: Effects of a 12-week dance program with two weekly frequency protocols on fine motor competence and balance in preschool children: A randomized controlled trial. Date: 2025 Abstract: This study examined the effects of structured dance programs on motor competence
PMID: 41364632 Title: A Rare Case of Emphysematous Pyelonephritis Following Retrograde Intrarenal Surgery in an Elderly Man. Date: 2025 Dec 9 Abstract: BACKGROUND Emphysematous pyelonephritis (EPN) is a severe, rare urinary tract
PMID: 41364611 Title: Reporting Quality of Randomised Trials on Vital Pulp Treatments Using the Preferred Reporting Items for RAndomised Trials in Endodontics. Date: 2025 Dec 9 Abstract: The aim was to critically evaluate the reporting quality of randomised clinical
PMID: 41364573 Title: Refine Medical Diagnosis Using Generation Augmented Retrieval and Clinical Practice Guidelines. Date: 2025 Dec 9 Abstract: Current medical language models, adapted from large language models, typically
PMID: 41364457 Title: YMCA Delivery of the National Diabetes Prevention Program: National Trends and Case Study Insights. Date: 2025 Dec 5 Abstract: YMCAs were instrumental in establishing the National Diabetes Prevention Program
PMID: 41364437 Title: Combined Gastric Electrical Stimulation and Pyloroplasty in Gastroparesis: A Randomized Clinical Trial. Date: 2025 Dec 1 Abstract: IMPORTANCE: Patients with gastroparesis who do not respond to medical therapy may
PMID: 41364435 Title: Obstructive Coronary Artery Disease and Health Status in Transcatheter Aortic Valve Replacement: A Post Hoc Analysis of the SCOPE I Randomized Clinical Trial. Date: 2025 Dec 1 Abstract: IMPORTANCE: Aortic stenosis (AS) and obstructive coronary artery disease (CAD)
PMID: 41364433 Title: Transient and Long-Term Risks of Common Physical Activities in People With Low Back Pain. Date: 2025 Dec 1 Abstract: IMPORTANCE: Physical activity is considered to have both detrimental and
PMID: 41364363 Title: Imaging and clinical features of emphysematous osteomyelitis. Date: 2025 Dec 9 Abstract: OBJECTIVE: To characterize the clinical and imaging features of emphysematous
PMID: 41364345 Title: Diaphragmatic ultrasound and thoracic fluid content for prediction of non-invasive ventilation failure in neonates: a randomized controlled trial. Date: 2025 Dec 9 Abstract: Non-invasive ventilation (NIV) remains the standard of care for preterm infants
PMID: 41364337 Title: Evolving our understanding of vitamin D, periostin levels and cardiovascular risk in the elderly: a cross sectional study. Date: 2025 Dec 9 Abstract: This cross-sectional study explored how vitamin D and the protein periostin are
PMID: 41364308 Title: Trevor Disease With Unusual Carpal Bone Involvement: A Case Report and Literature Review. Date: 2025 Dec 1 Abstract: Dysplasia epiphysealis hemimelica, also known as Trevor disease, is a rare and
PMID: 41364294 Title: Development and initial validation of the Communication Inventory Disability - Observer Reported (CID-OR): a measure of communication in CDKL5 deficiency disorder. WA, Australia. Jenny.Downs@thekids.org.au. Perth, WA, Australia. Jenny.Downs@thekids.org.au. WA, Australia. WA, Australia. University of Oregon, Eugene, OR, USA. WA, Australia. Medicine, Precision Medicine Institute, Children's Hospital Colorado, Aurora, CO, USA. WA, Australia. WA, Australia. University of Pennsylvania, Philadelphia, PA, USA. Medicine, Children's Hospital Colorado, Aurora, CO, USA. Medicine, Precision Medicine Institute, Children's Hospital Colorado, Aurora, CO, USA. by the Internal Review Board at University of Colorado COMIRB 19-2756, with reliance agreements at each clinical site, and University of Western Australia (RA/4/20/6198). The International CDKL5 Clinical Research Network (ICCRN) is registered with ClinicalTrials.gov (NCT0555837). Parents provided informed consent before participation. Consent for publication: All participants provided consent to participate including that their data would be published but with identifying information. Competing interests: Author JD: Consultancy for Marinus, Ultragenyx, Acadia, Avexis, Orion, Takeda, Neurogene, Taysha and Neurocrine. Clinical Trials with Anavex and Newron. Consulting/Advisory Board member for SCN2A Australia. All remuneration has been made to her department. Author JK: Consultancy for Taysha. All remuneration has been made to her department. Author HL: Consultancy for Marinus, Acadia, Avexis, Orion, Neurogene and Taysha. Clinical Trials with Anavex and Newron. All remuneration has been made to her department. Author EM: Site PI for industry sponsored trials of SK Life, Takeda, Epygenix, Ionis, UCB pharma (Zogenix), and Acadia Pharmaceuticals. Grant funding from NIH, State of Pennsylvania and IRSF, RSRT, and LouLou foundation. Consulting/Advisory Board member for Acadia Pharmacueticals, Stoke, and Taysha therapeutics. Author TB: Research funding from GRIN2B Foundation, the International Foundation for CDKL5 Research, Loulou Foundation, the National Institutes of Health, and Simons Foundation. Consultancy for Alcyone, AveXis, GRIN Therapeutics, GW Pharmaceuticals, the International Rett Syndrome Foundation, Marinus Pharmaceuticals, Neurogene, Ovid Therapeutics, and Takeda Pharmaceutical Company Limited. Clinical trials with Acadia Pharmaceuticals Inc., GW Pharmaceuticals, Ionis, Marinus Pharmaceuticals, Neurogene, Ovid Therapeutics, and Rett Syndrome Research Trust. All remuneration has been made to his department. Author SD: Consulted for Biomarin, Neurogene, Marinus, Tysha, Ultragenyx, UCB, Capsida, Encoded, Longboard, Mahzi therapeutics, and Ovid Therapeutics. Funding from NIH, Project 8P and Mila's Miracle Foundation. Advisory board member for non-profit foundations Rare X, SLC6A1 Connect, Project 8P, Ring14 USA, FamilieSCN2A and N of 1 Collaborative. None of the other authors have any declarations of interest. Date: 2025 Dec 9 Abstract: Development and initial validation of the Communication Inventory Disability - Observer Reported (CID-OR): a measure of communication in CDKL5 deficiency disorder. WA, Australia. Jenny.Downs@thekids.org.au. Perth, WA, Australia. Jenny.Downs@thekids.org.au. WA, Australia. WA, Australia. University of Oregon, Eugene, OR, USA. WA, Australia. Medicine, Precision Medicine Institute, Children's Hospital Colorado, Aurora, CO, USA. WA, Australia. WA, Australia. University of Pennsylvania, Philadelphia, PA, USA. Medicine, Children's Hospital Colorado, Aurora, CO, USA. Medicine, Precision Medicine Institute, Children's Hospital Colorado, Aurora, CO, USA. by the Internal Review Board at University of Colorado COMIRB 19-2756, with reliance agreements at each clinical site, and University of Western Australia (RA/4/20/6198). The International CDKL5 Clinical Research Network (ICCRN) is registered with ClinicalTrials.gov (NCT0555837). Parents provided informed consent before participation. Consent for publication: All participants provided consent to participate including that their data would be published but with identifying information. Competing interests: Author JD: Consultancy for Marinus, Ultragenyx, Acadia, Avexis, Orion, Takeda, Neurogene, Taysha and Neurocrine. Clinical Trials with Anavex and Newron. Consulting/Advisory Board member for SCN2A Australia. All remuneration has been made to her department. Author JK: Consultancy for Taysha. All remuneration has been made to her department. Author HL: Consultancy for Marinus, Acadia, Avexis, Orion, Neurogene and Taysha. Clinical Trials with Anavex and Newron. All remuneration has been made to her department. Author EM: Site PI for industry sponsored trials of SK Life, Takeda, Epygenix, Ionis, UCB pharma (Zogenix), and Acadia Pharmaceuticals. Grant funding from NIH, State of Pennsylvania and IRSF, RSRT, and LouLou foundation. Consulting/Advisory Board member for Acadia Pharmacueticals, Stoke, and Taysha therapeutics. Author TB: Research funding from GRIN2B Foundation, the International Foundation for CDKL5 Research, Loulou Foundation, the National Institutes of Health, and Simons Foundation. Consultancy for Alcyone, AveXis, GRIN Therapeutics, GW Pharmaceuticals, the International Rett Syndrome Foundation, Marinus Pharmaceuticals, Neurogene, Ovid Therapeutics, and Takeda Pharmaceutical Company Limited. Clinical trials with Acadia Pharmaceuticals Inc., GW Pharmaceuticals, Ionis, Marinus Pharmaceuticals, Neurogene, Ovid Therapeutics, and Rett Syndrome Research Trust. All remuneration has been made to his department. Author SD: Consulted for Biomarin, Neurogene, Marinus, Tysha, Ultragenyx, UCB, Capsida, Encoded, Longboard, Mahzi therapeutics, and Ovid Therapeutics. Funding from NIH, Project 8P and Mila's Miracle Foundation. Advisory board member for non-profit foundations Rare X, SLC6A1 Connect, Project 8P, Ring14 USA, FamilieSCN2A and N of 1 Collaborative. None of the other authors have any declarations of interest.
PMID: 41364284 Title: PET Imaging of CD38 and IND enabling studies of [(89)Zr]Zr-DFO-Isatuximab. Date: 2025 Dec 9 Abstract: BACKGROUND: CD38 is an excellent biomarker and therapeutic target for multiple
PMID: 41364279 Title: From misclassified AIP variant to carney complex: a case report and retrospective evaluation of PRKAR1A in pituitary tumor predisposition. Date: 2025 Dec 9 Abstract: CONTEXT: Carney Complex (CNC) is a rare multiple endocrine neoplasia syndrome,
PMID: 41364270 Title: Changes in peripheral blood B cell levels predict overall survival in patients with advanced liver cancer treated with immune target inhibitors. Date: 2025 Dec 9 Abstract: PD-1 inhibitors show efficacy in hepatocellular carcinoma (HCC), yet overall
PMID: 41364261 Title: Assessing endocrine resistance: monitoring circulating ESR1 mutations in Irosustat-treated ER positive breast cancer. Date: 2025 Dec 9 Abstract: PURPOSE: We aimed to investigate the prevalence and spectrum of ESR1 mutations
PMID: 41364260 Title: Amyloid A amyloidosis associated with Streptococcus suis infection in a young commercial pig with wild-type serum amyloid A. Date: 2025 Dec 9 Abstract: Amyloid A (AA) amyloidosis is a progressive disease caused by the deposition of
PMID: 41364253 Title: Efficacy and safety of sacituzumab govitecan in patients with metastatic metaplastic triple-negative breast cancer: a multinational retrospective case series from CEBCC-102 study. Date: 2025 Dec 9 Abstract: BACKGROUND: Metastatic metaplastic triple-negative breast cancer (mMpTNBC) is a
PMID: 41364240 Title: Bleeding risk associated with the co-use of direct oral anticoagulants and non-dihydropyridine calcium channel blockers: a meta-analysis. Date: 2025 Dec 9 Abstract: BACKGROUND: Oral anticoagulation is a cornerstone of stroke prevention in
PMID: 41364174 Title: Comparison of the effects of different general anesthesia methods on the quality of early postoperative recovery in patients undergoing metabolic bariatric surgery: A randomized controlled trial. Date: 2025 Oct Abstract: The optimal choice of general anesthesia technique for patients with obesity
PMID: 41364169 Title: Assessment of the effectiveness and safety of two-month oral supplementation with L-arginine depending on the type of lipid metabolism disorder in patients with atherosclerotic lower limb ischemia. Date: 2025 Oct Abstract: Lower limb arterial disease is among the most common vascular disorders, with its
PMID: 41364167 Title: Influence of anti-tumor necrosis factor (TNF) treatments on T cell cytokine production in patients with inflammatory joint diseases - comparison of etanercept and anti-TNF monoclonal antibodies. A double-blind, prospective, placebo-controlled study. Date: 2025 Oct Abstract: Despite similar clinical effectiveness of tumor necrosis factor (TNF) inhibitors
PMID: 41364157 Title: From famine to feast: a seesawing platelet count in severe iron deficiency anemia. Date: 2025 Dec 9 Abstract: A 22-month-old previously healthy girl presented with profound microcytic anemia
PMID: 41364152 Title: Confirmation and reproducibility of endotracheal tube position by tracheal ultrasonography in preterms: expert versus trainee. Date: 2025 Dec 9 Abstract: Tracheal intubation (TI) is critical in neonatal intensive care and delivery
PMID: 41364146 Title: Afternoon naps can improve prospective memory performance by strengthening cue monitoring. Date: 2025 Dec 9 Abstract: Afternoon naps can alleviate drowsiness, enhance alertness, and restore
PMID: 41364132 Title: LAMB1-associated leukoencephalopathy: a continuum from a prenatal, recessive syndrome to a dominant, adult-onset disorder. Date: 2025 Dec 9 Abstract: A 1 year 11 months-old female patient displayed focal seizures symptoms with good
PMID: 41364061 Title: Persistent Femoral Pseudoaneurysm Closure Using a Suture-Mediated Closure Device: A Novel Approach. Date: 2025 Dec 9 Abstract: OBJECTIVE: Present a novel, minimally-invasive approach for closing persistent
PMID: 41364060 Title: Mitral Valve Endocarditis Due to Whipple Disease: A Rare Cause of Subacute Endocarditis. Date: 2025 Dec 9 Abstract: BACKGROUND: Whipple disease is a rare chronic infection caused by Tropheryma
PMID: 41364059 Title: Left Atrial Appendage Closure Via Transhepatic Access in a Patient With Congenitally Interrupted Inferior Vena Cava. Date: 2025 Dec 9 Abstract: BACKGROUND: Left atrial appendage occlusion (LAAO) is indicated for patients with
PMID: 41364058 Title: Multidisciplinary Management of Heritable Aortopathy in Pregnancy Complicated by Postpartum Acute Type A Dissection. Date: 2025 Dec 9 Abstract: CASE SUMMARY: A 33-year-old patient at 20 weeks of gestation presented with a
PMID: 41364057 Title: Complete Heart Block and Nonsustained Ventricular Tachycardia Secondary to Cardiac Metastases From Breast Cancer. Date: 2025 Dec 9 Abstract: BACKGROUND: Although breast cancer is known to metastasize to the heart,
PMID: 41364048 Title: Cryopreserved organ donor bone marrow achieves robust engraftment and chimerism in mismatched allogeneic transplantation. Date: 2025 Nov 20 Abstract: BACKGROUND AIMS: Significant procedural variability exists across centers in the
PMID: 41364041 Title: The Impact of Anesthesia Duration on Postoperative Cognitive and Behavioral Outcomes in Pediatric Patients: A Meta-analysis. Date: 2025 Dec 9 Abstract: PURPOSE: To systematically assess and quantify the relationship between length of
PMID: 41364040 Title: Timing of Cardiovascular and Kidney Benefits With Finerenone in Heart Failure and Chronic Kidney Disease With Type 2 Diabetes. Boston, Massachusetts, USA. New South Wales, Australia; Department of Renal Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia. Boston, Massachusetts, USA. National and Kapodistrian University of Athens, Athens, Greece. Boston, Massachusetts, USA. and Metabolic Health, University of Glasgow, Glasgow, United Kingdom. and Metabolic Health, University of Glasgow, Glasgow, United Kingdom. Singapore. School of Medicine, Chicago, Illinois, USA. University of Copenhagen, Copenhagen, Denmark. Octubre, Madrid, Spain. Cardiovascular Research (DZHK) partner site Berlin, Charite Universitatsmedizin, Berlin, Germany. Michigan, USA. Medicine and RL Roudebush VA Medical Center, Indianapolis, Indiana, USA. and Metabolic Health, University of Glasgow, Glasgow, United Kingdom. Boston, Massachusetts, USA. Boston, Massachusetts, USA. Electronic address: mvaduganathan@bwh.harvard.edu. were funded by Bayer AG. Steering committees of each of the trials designed and oversaw their conduct in collaboration with the sponsor. However, the primary analyses, interpretation of the data, and initial manuscript drafting were conducted independently by the academic teams. Dr Neuen is supported by an Australian National Health and Medical Research Council Emerging Leader Investigator Grant (grant number 2026621) and a Ramaciotti Foundation Health Investment Grant (grant number 2023HIG69). Dr Ostrominski has received grant support from the National Institutes of Health (5T32HL007604-39 and L30HL175757); and has served on advisory boards for Corcept Therapeutics. Dr Neuen has received fees for travel support, advisory boards, and scientific presentations from AstraZeneca, Bayer, Boehringer and Ingelheim, Cambridge Healthcare Research, Cornerstone Medical Education, the Limbic, Janssen, Medscape, Novo Nordisk, and Travere Therapeutics; and has served on clinical trial committees for studies sponsored by AstraZeneca, Bayer, and CSL Behring. Dr Claggett has received personal consulting fees from Alnylam, Bristol Myers Squibb, Cardior, Cardurion, Corvia, CVRx, Eli Lilly, Intellia, and Rocket; and has served on a DSMB for Novo Nordisk. Dr Filippatos has received lecture fees and/or trial committee membership fees and/or consulting fees from Boehringer Ingelheim, Servier, Novartis, Bayer, Impulse Dynamics, Vifor, Medtronic, Cardior, and Novo Nordisk; and has received research grants from the European Union. Dr Desai has received institutional research grants (to Brigham and Women's Hospital) from Abbott, Alnylam, AstraZeneca, Bayer, Novartis, and Pfizer; and has received consulting fees from Abbott, Alnylam, AstraZeneca, Bayer, Biofourmis, Boston Scientific, Medpace, Medtronic, Merck, Novartis, Parexel, Porter Health, Regeneron, River2Renal, Roche, Veristat, Verily, and Zydus. Dr Jhund has received speaker fees from AstraZeneca and ProAdWise Communications; has received advisory board fees from AstraZeneca and Novartis; has received research funding from AstraZeneca, Analog Devices Inc and Roche Diagnostics; is director of GCTP Ltd; and his employer, the University of Glasgow, has been remunerated for clinical trial work from AstraZeneca, Bayer AG, Novartis, and Novo Nordisk. Dr Lam has received research grants from the National Medical Research Council of Singapore, Novo Nordisk, and Roche Diagnostic; has received consulting fees from Alnylam Pharma, AnaCardio AB, Applied Therapeutics, AstraZeneca, Bayer, Biopeutics, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Corteria, CPC Clinical Research, Cytokinetics, Eli Lilly, Impulse Dynamics, Intellia Therapeutics, Janssen Research & Development LLC, Medscape/WebMD Global LLC, Merck, Novartis, Novo Nordisk, Pfizer, Quidel Corporation, Radcliffe Group Ltd, Roche, and Us2.ai; has patent PCT/SG2016/050217 pending and patents US Patent No. 10,631,828 B1; US 10,702,247 B2; US 11,301,996 B2; US 11,446,009 B2; US 11,931,207 B2; US 12,001,939; US 12,400,762 B2; and is a cofounder and nonexecutive director of Us2.ai. Dr Senni has served on advisory boards, been a consultant for, and has received honoraria from Novartis, Abbott, Merck, MSD, Vifor, AstraZeneca, Cardurion, Novo Nordisk, Bayer, and Boehringer Ingelheim. Dr Shah has received research grants from the National Institutes of Health (U54 HL160273, X01 HL169712, R01 HL140731, R01 HL149423), American Heart Association (24SFRNPCN1291224), AstraZeneca, Corvia, and Pfizer; and has received consulting fees from Abbott, Alleviant, AstraZeneca, Amgen, Aria CV, Axon Therapies, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Cyclerion, Cytokinetics, Edwards Lifesciences, Eidos, Imara, Impulse Dynamics, Intellia, Ionis, Lilly, Merck, MyoKardia, Novartis, Novo Nordisk, Pfizer, Prothena, Regeneron, Rivus, Sardocor, Shifamed, Tenax, Tenaya, and Ultromics. Dr Voors has received consultancy fees and/or research support from Adrenomed, Anacardio, AstraZeneca, Bayer AG, BMS, Boehringer Ingelheim, Corteria, Eli Lilly, Merck, Moderna, Novartis, Novo Nordisk, Roche Diagnostics, and SalubrisBio paid to his institution. Dr Zannad has received personal fees from 89Bio, Abbott, Acceleron, Applied Therapeutics, Bayer, Betagenon, Boehringer, BMS, CVRx, Cambrian, Cardior, Cereno pharmaceutical, Cellprothera, CEVA, Inventiva, KBP, Merck, Novo Nordisk, Owkin, Otsuka, Roche Diagnostics, Northsea, and Us2.ai; has stock options in G3Pharmaceutical and holds equities in Cereno, Cardiorenal, and Eshmoun Clinical Research; and is the founder of Cardiovascular Clinical Trialists. Dr Rossing has received grants and honoraria for lectures, educational events, and steering group participation from AstraZeneca, Bayer, and Novo Nordisk (all to the Steno Diabetes Center Copenhagen); has received honoraria for lectures and participation in advisory boards from Boehringer Ingelheim, Sanofi, Gilead, and Astellas (all to the Steno Diabetes Center Copenhagen); and has received study drugs for free for investigator-initiated studies from Bayer, Novo Nordisk, and Lexicon. Dr Anker has received grants from Vifor International and Abbott; has received consulting fees from CVRx, AstraZeneca, Bioventrix, Repairon, Novo Nordisk, Brahms, Novartis, Actimed Therapeutics, Faraday Pharmaceuticals, Cytokinetics, HeartKinetics, GSK, Vectorious, Scirent, Sensible Medical. Edwards, Relaxera, Repairon, Regeneron Pharmaceuticals, and Cordio; has served on steering or advisory committees work for Vifor International, Bayer AG, Boehringer Ingelheim, Medtronic, Abbott, Impulse Dynamics, Cardior, V-Wave, Pfizer, Cardiac Dimensions, and Occlutech; and was named coinventor on patent applications regarding MR-proANP (DE 102007010834 & DE 102007022367), but he does not benefit personally from the related issued patents. Dr Pitt is a consultant for Bayer, AstraZeneca, Boehringer Ingelheim, Lexicon, Bristol Myers Squibb, KBP Biosciences, Sarfez Pharmaceuticals, SQinnovations, G3 Pharmaceuticals, Sea Star Medical, Vifor, Prointel, and Brainstorm Medical; holds stock/stock options in KBP Biosciences, Sarfez Pharmaceuticals, SQinnovations, Sea Star Medical, Vifor, Prointel, and Brainstorm Medical; and holds US Patent 9931412 (site-specific delivery of eplerenone to the myocardium) and U.S. Patent pending 63/045,783 (Histone modulating agents for the prevention and treatment of organ failure). Dr Agarwal has received support from Bayer; has received royalties or licenses from UpToDate; has received consulting fees from Boehringer Ingelheim, Novartis, Akebia, Intercept Pharma, and Alnylam; has received support for meetings from Boehringer Ingelheim, Novartis, Akebia, and Vertex; and has participated on data and safety monitoring or advisory boards for Vertex, Eloxx, and Chinook. Mr Lay-Flurrie is a full-time employee of Bayer plc. Drs Brinker and Hofmeister are full-time employees of Bayer AG. Dr Amarante is a full-time employee of Bayer SA. Dr McMurray has received payments through Glasgow University for work on clinical trials, consulting, and grants from Amgen, AstraZeneca, Bayer, Cardurion, Cytokinetics, GSK, and Novartis; has received consultant fees from Alnylam Pharmaceuticals, Amgen, AnaCardio, AstraZeneca, Bayer, Berlin Cures, BMS, Cardurion, Cytokinetics, Ionis Pharmaceuticals, Novartis, Regeneron Pharmaceuticals, River 2 Renal Corp, British Heart Foundation, National Institute for Health-National Heart, Lung, and Blood Institute (NIH-NHLBI), Boehringer Ingelheim, SQ Innovations, and Catalyze Group; has received lecture fees from Abbott, Alkem Metabolics, AstraZeneca, Blue Ocean Scientific Solutions Ltd, Boehringer Ingelheim, Canadian Medical and Surgical Knowledge, Emcure Pharmaceuticals Ltd, Eris Lifesciences, European Academy of CME, Hikma Pharmaceuticals, Imagica Health, Intas Pharmaceuticals, J.B. Chemicals & Pharmaceuticals Ltd., Lupin Pharmaceuticals, Medscape/Heart.Org, ProAdWise Communications, Radcliffe Cardiology, Sun Pharmaceuticals, The Corpus, Translation Research Group, and Translational Medicine Academy; has served on a data and safety monitoring board for WIRB-Copernicus Group Clinical Inc; and is a director of Global Clinical Trial Partners Ltd. Dr Solomon has received research grants from Alexion, Alnylam, AstraZeneca, Bellerophon, Bayer, BMS, Boston Scientific, Cytokinetics, Edgewise, Eidos, Gossamer, GSK, Ionis, Lilly, MyoKardia, NIH/NHLBI, Novartis, Novo Nordisk, Respicardia, Sanofi Pasteur, Theracos, and Us2.ai; and has consulted for Abbott, Action, Akros, Alexion, Alnylam, Amgen, Arena, AstraZeneca, Bayer, Boehringer Ingelheim, BMS, Cardior, Cardurion, Corvia, Cytokinetics, Daiichi Sankyo, GSK, Lilly, Merck, Myokardia, Novartis, Roche, Theracos, Quantum Genomics, Janssen, Cardiac Dimensions, Tenaya, Sanofi-Pasteur, Dinaqor, Tremeau, CellProThera, Moderna, American Regent, Sarepta, Lexicon, Anacardio, Akros, and Valo. Dr Vaduganathan has received research grant support, served on advisory boards, or had speaker engagements with Alnylam Pharmaceuticals, American Regent, Amgen, AstraZeneca, Bayer AG, Baxter Healthcare, BMS, Boehringer Ingelheim, Chiesi, Cytokinetics, Esperion, Fresenius Medical Care, Idorsia Pharmaceuticals, Lexicon Pharmaceuticals, Merck, Milestone Pharmaceuticals, Novartis, Novo Nordisk, Pharmacosmos, Recordati, Relypsa, Roche Diagnostics, Sanofi, and Tricog Health; and has served on clinical trial committees for studies sponsored by Amgen, AstraZeneca, Bayer AG, Boehringer Ingelheim, Galmed, Impulse Dynamics, Novartis, Occlutech, and Pharmacosmos. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. 10.1016/j.jacc.2025.10.060. Date: 2025 Nov 18 Abstract: Timing of Cardiovascular and Kidney Benefits With Finerenone in Heart Failure and Chronic Kidney Disease With Type 2 Diabetes. Boston, Massachusetts, USA. New South Wales, Australia; Department of Renal Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia. Boston, Massachusetts, USA. National and Kapodistrian University of Athens, Athens, Greece. Boston, Massachusetts, USA. and Metabolic Health, University of Glasgow, Glasgow, United Kingdom. and Metabolic Health, University of Glasgow, Glasgow, United Kingdom. Singapore. School of Medicine, Chicago, Illinois, USA. University of Copenhagen, Copenhagen, Denmark. Octubre, Madrid, Spain. Cardiovascular Research (DZHK) partner site Berlin, Charite Universitatsmedizin, Berlin, Germany. Michigan, USA. Medicine and RL Roudebush VA Medical Center, Indianapolis, Indiana, USA. and Metabolic Health, University of Glasgow, Glasgow, United Kingdom. Boston, Massachusetts, USA. Boston, Massachusetts, USA. Electronic address: mvaduganathan@bwh.harvard.edu. were funded by Bayer AG. Steering committees of each of the trials designed and oversaw their conduct in collaboration with the sponsor. However, the primary analyses, interpretation of the data, and initial manuscript drafting were conducted independently by the academic teams. Dr Neuen is supported by an Australian National Health and Medical Research Council Emerging Leader Investigator Grant (grant number 2026621) and a Ramaciotti Foundation Health Investment Grant (grant number 2023HIG69). Dr Ostrominski has received grant support from the National Institutes of Health (5T32HL007604-39 and L30HL175757); and has served on advisory boards for Corcept Therapeutics. Dr Neuen has received fees for travel support, advisory boards, and scientific presentations from AstraZeneca, Bayer, Boehringer and Ingelheim, Cambridge Healthcare Research, Cornerstone Medical Education, the Limbic, Janssen, Medscape, Novo Nordisk, and Travere Therapeutics; and has served on clinical trial committees for studies sponsored by AstraZeneca, Bayer, and CSL Behring. Dr Claggett has received personal consulting fees from Alnylam, Bristol Myers Squibb, Cardior, Cardurion, Corvia, CVRx, Eli Lilly, Intellia, and Rocket; and has served on a DSMB for Novo Nordisk. Dr Filippatos has received lecture fees and/or trial committee membership fees and/or consulting fees from Boehringer Ingelheim, Servier, Novartis, Bayer, Impulse Dynamics, Vifor, Medtronic, Cardior, and Novo Nordisk; and has received research grants from the European Union. Dr Desai has received institutional research grants (to Brigham and Women's Hospital) from Abbott, Alnylam, AstraZeneca, Bayer, Novartis, and Pfizer; and has received consulting fees from Abbott, Alnylam, AstraZeneca, Bayer, Biofourmis, Boston Scientific, Medpace, Medtronic, Merck, Novartis, Parexel, Porter Health, Regeneron, River2Renal, Roche, Veristat, Verily, and Zydus. Dr Jhund has received speaker fees from AstraZeneca and ProAdWise Communications; has received advisory board fees from AstraZeneca and Novartis; has received research funding from AstraZeneca, Analog Devices Inc and Roche Diagnostics; is director of GCTP Ltd; and his employer, the University of Glasgow, has been remunerated for clinical trial work from AstraZeneca, Bayer AG, Novartis, and Novo Nordisk. Dr Lam has received research grants from the National Medical Research Council of Singapore, Novo Nordisk, and Roche Diagnostic; has received consulting fees from Alnylam Pharma, AnaCardio AB, Applied Therapeutics, AstraZeneca, Bayer, Biopeutics, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Corteria, CPC Clinical Research, Cytokinetics, Eli Lilly, Impulse Dynamics, Intellia Therapeutics, Janssen Research & Development LLC, Medscape/WebMD Global LLC, Merck, Novartis, Novo Nordisk, Pfizer, Quidel Corporation, Radcliffe Group Ltd, Roche, and Us2.ai; has patent PCT/SG2016/050217 pending and patents US Patent No. 10,631,828 B1; US 10,702,247 B2; US 11,301,996 B2; US 11,446,009 B2; US 11,931,207 B2; US 12,001,939; US 12,400,762 B2; and is a cofounder and nonexecutive director of Us2.ai. Dr Senni has served on advisory boards, been a consultant for, and has received honoraria from Novartis, Abbott, Merck, MSD, Vifor, AstraZeneca, Cardurion, Novo Nordisk, Bayer, and Boehringer Ingelheim. Dr Shah has received research grants from the National Institutes of Health (U54 HL160273, X01 HL169712, R01 HL140731, R01 HL149423), American Heart Association (24SFRNPCN1291224), AstraZeneca, Corvia, and Pfizer; and has received consulting fees from Abbott, Alleviant, AstraZeneca, Amgen, Aria CV, Axon Therapies, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Cyclerion, Cytokinetics, Edwards Lifesciences, Eidos, Imara, Impulse Dynamics, Intellia, Ionis, Lilly, Merck, MyoKardia, Novartis, Novo Nordisk, Pfizer, Prothena, Regeneron, Rivus, Sardocor, Shifamed, Tenax, Tenaya, and Ultromics. Dr Voors has received consultancy fees and/or research support from Adrenomed, Anacardio, AstraZeneca, Bayer AG, BMS, Boehringer Ingelheim, Corteria, Eli Lilly, Merck, Moderna, Novartis, Novo Nordisk, Roche Diagnostics, and SalubrisBio paid to his institution. Dr Zannad has received personal fees from 89Bio, Abbott, Acceleron, Applied Therapeutics, Bayer, Betagenon, Boehringer, BMS, CVRx, Cambrian, Cardior, Cereno pharmaceutical, Cellprothera, CEVA, Inventiva, KBP, Merck, Novo Nordisk, Owkin, Otsuka, Roche Diagnostics, Northsea, and Us2.ai; has stock options in G3Pharmaceutical and holds equities in Cereno, Cardiorenal, and Eshmoun Clinical Research; and is the founder of Cardiovascular Clinical Trialists. Dr Rossing has received grants and honoraria for lectures, educational events, and steering group participation from AstraZeneca, Bayer, and Novo Nordisk (all to the Steno Diabetes Center Copenhagen); has received honoraria for lectures and participation in advisory boards from Boehringer Ingelheim, Sanofi, Gilead, and Astellas (all to the Steno Diabetes Center Copenhagen); and has received study drugs for free for investigator-initiated studies from Bayer, Novo Nordisk, and Lexicon. Dr Anker has received grants from Vifor International and Abbott; has received consulting fees from CVRx, AstraZeneca, Bioventrix, Repairon, Novo Nordisk, Brahms, Novartis, Actimed Therapeutics, Faraday Pharmaceuticals, Cytokinetics, HeartKinetics, GSK, Vectorious, Scirent, Sensible Medical. Edwards, Relaxera, Repairon, Regeneron Pharmaceuticals, and Cordio; has served on steering or advisory committees work for Vifor International, Bayer AG, Boehringer Ingelheim, Medtronic, Abbott, Impulse Dynamics, Cardior, V-Wave, Pfizer, Cardiac Dimensions, and Occlutech; and was named coinventor on patent applications regarding MR-proANP (DE 102007010834 & DE 102007022367), but he does not benefit personally from the related issued patents. Dr Pitt is a consultant for Bayer, AstraZeneca, Boehringer Ingelheim, Lexicon, Bristol Myers Squibb, KBP Biosciences, Sarfez Pharmaceuticals, SQinnovations, G3 Pharmaceuticals, Sea Star Medical, Vifor, Prointel, and Brainstorm Medical; holds stock/stock options in KBP Biosciences, Sarfez Pharmaceuticals, SQinnovations, Sea Star Medical, Vifor, Prointel, and Brainstorm Medical; and holds US Patent 9931412 (site-specific delivery of eplerenone to the myocardium) and U.S. Patent pending 63/045,783 (Histone modulating agents for the prevention and treatment of organ failure). Dr Agarwal has received support from Bayer; has received royalties or licenses from UpToDate; has received consulting fees from Boehringer Ingelheim, Novartis, Akebia, Intercept Pharma, and Alnylam; has received support for meetings from Boehringer Ingelheim, Novartis, Akebia, and Vertex; and has participated on data and safety monitoring or advisory boards for Vertex, Eloxx, and Chinook. Mr Lay-Flurrie is a full-time employee of Bayer plc. Drs Brinker and Hofmeister are full-time employees of Bayer AG. Dr Amarante is a full-time employee of Bayer SA. Dr McMurray has received payments through Glasgow University for work on clinical trials, consulting, and grants from Amgen, AstraZeneca, Bayer, Cardurion, Cytokinetics, GSK, and Novartis; has received consultant fees from Alnylam Pharmaceuticals, Amgen, AnaCardio, AstraZeneca, Bayer, Berlin Cures, BMS, Cardurion, Cytokinetics, Ionis Pharmaceuticals, Novartis, Regeneron Pharmaceuticals, River 2 Renal Corp, British Heart Foundation, National Institute for Health-National Heart, Lung, and Blood Institute (NIH-NHLBI), Boehringer Ingelheim, SQ Innovations, and Catalyze Group; has received lecture fees from Abbott, Alkem Metabolics, AstraZeneca, Blue Ocean Scientific Solutions Ltd, Boehringer Ingelheim, Canadian Medical and Surgical Knowledge, Emcure Pharmaceuticals Ltd, Eris Lifesciences, European Academy of CME, Hikma Pharmaceuticals, Imagica Health, Intas Pharmaceuticals, J.B. Chemicals & Pharmaceuticals Ltd., Lupin Pharmaceuticals, Medscape/Heart.Org, ProAdWise Communications, Radcliffe Cardiology, Sun Pharmaceuticals, The Corpus, Translation Research Group, and Translational Medicine Academy; has served on a data and safety monitoring board for WIRB-Copernicus Group Clinical Inc; and is a director of Global Clinical Trial Partners Ltd. Dr Solomon has received research grants from Alexion, Alnylam, AstraZeneca, Bellerophon, Bayer, BMS, Boston Scientific, Cytokinetics, Edgewise, Eidos, Gossamer, GSK, Ionis, Lilly, MyoKardia, NIH/NHLBI, Novartis, Novo Nordisk, Respicardia, Sanofi Pasteur, Theracos, and Us2.ai; and has consulted for Abbott, Action, Akros, Alexion, Alnylam, Amgen, Arena, AstraZeneca, Bayer, Boehringer Ingelheim, BMS, Cardior, Cardurion, Corvia, Cytokinetics, Daiichi Sankyo, GSK, Lilly, Merck, Myokardia, Novartis, Roche, Theracos, Quantum Genomics, Janssen, Cardiac Dimensions, Tenaya, Sanofi-Pasteur, Dinaqor, Tremeau, CellProThera, Moderna, American Regent, Sarepta, Lexicon, Anacardio, Akros, and Valo. Dr Vaduganathan has received research grant support, served on advisory boards, or had speaker engagements with Alnylam Pharmaceuticals, American Regent, Amgen, AstraZeneca, Bayer AG, Baxter Healthcare, BMS, Boehringer Ingelheim, Chiesi, Cytokinetics, Esperion, Fresenius Medical Care, Idorsia Pharmaceuticals, Lexicon Pharmaceuticals, Merck, Milestone Pharmaceuticals, Novartis, Novo Nordisk, Pharmacosmos, Recordati, Relypsa, Roche Diagnostics, Sanofi, and Tricog Health; and has served on clinical trial committees for studies sponsored by Amgen, AstraZeneca, Bayer AG, Boehringer Ingelheim, Galmed, Impulse Dynamics, Novartis, Occlutech, and Pharmacosmos. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. 10.1016/j.jacc.2025.10.060.
PMID: 41364021 Title: Impact of single-event multilevel surgery on gait efficiency in children with cerebral palsy: a retrospective study. Date: 2025 Dec 9 Abstract: BACKGROUND: Single-event multilevel surgery is a widely used intervention for
PMID: 41363974 Title: (61)Cu-NODAGA Prostate-specific Membrane Antigen Imaging and Therapy for Prostate Cancer: Phase 1 Trial of a New Class of (61)Cu-labeled PET Radiotracers. Date: 2025 Dec Abstract: Background Prostate-specific membrane antigen (PSMA)-targeted PET has
PMID: 41363966 Title: Destructive Facial Granuloma Following Self-Treatment With Vitamin E Oil and an At-Home Microneedling Device. Date: 2025 Oct Abstract: Use of cosmeceuticals such as vitamin E oil with at-home microneedling (MN)
PMID: 41363962 Title: Botulinum Toxin as a Tool to Reduce Hyperhidrosis in Amputees. Date: 2025 Oct Abstract: Botulinum toxin (BTX) is an effective treatment for improving prosthetic
PMID: 41363959 Title: Diagnostic Value of Deep Punch Biopsies in Intravascular Large B-cell Lymphoma. Date: 2025 Oct Abstract: The purpose of this study was to determine the diagnostic efficacy of skin
PMID: 41363956 Title: Dermoscopic Documentation of a No-see-um Bite. Date: 2025 Oct Abstract: Biting midges, commonly known as no-see-ums, are year-round pests found in
PMID: 41363943 Title: Visual and Quantitative Analysis of 123I-Ioflupane SPECT Reveals Asymmetric Neuronal Degeneration in Fahr's Disease. Date: 2025 Nov 20 Abstract: Fahr's disease is a rare disorder characterized by bilateral and symmetric
PMID: 41363922 Title: Pyridoxine-Dependent Epilepsy in Newborn - A Rare and Challenging Diagnosis. Date: 2025 Nov 1 Abstract: Pyridoxine-dependent epilepsy (PDE) is a developmental, epileptic encephalopathy
PMID: 41363919 Title: Postherpetic Abdominal Pseudohernia Possibly Associated With Myasthenia Gravis: A Case Report. Date: 2025 Nov 1 Abstract: Herpes zoster, caused by the reactivation of the varicella-zoster virus,
PMID: 41363914 Title: Effect of Insulin Sensitizers on Glycemic and Lipid Profile in Patients with Polycystic Ovary Syndrome (PCOS). Date: 2025 Nov 1 Abstract: Introduction: Polycystic ovary syndrome (PCOS) is associated with increased
PMID: 41363871 Title: Anesthesia Type during Cancer Surgery: Results of the GA-CARES Randomized, Multicenter Trial. Date: 2026 Jan 1 Abstract: BACKGROUND: Surgical resection is a widely used treatment for cancer. Patients
PMID: 41363853 Title: [Effectiveness of virtual reality distraction in reducing anxiety among children with neurodevelopmental disorders during orthodontic assessment: a prospective study]. Date: 2025 Dec 9 Abstract: INTRODUCTION: In dentistry, managing anxious children is a daily challenge.
PMID: 41363852 Title: [Adherence in orthodontics: A review of the literature]. Date: 2025 Dec 9 Abstract: INTRODUCTION: The aim of this study was to investigate the factors influencing
PMID: 41363834 Title: Long-term outcomes of ripretinib versus sunitinib in Chinese patients with advanced gastrointestinal stromal tumor: An updated analysis of a phase 2 randomized clinical trial. Date: 2025 Dec 1 Abstract: BACKGROUND: In a bridging study of INTRIGUE, second-line ripretinib demonstrated
PMID: 41363831 Title: Doubly Robust Estimation and Sensitivity Analysis With Outcomes Truncated by Death in Multi-Arm Clinical Trials. Date: 2025 Dec Abstract: In clinical trials, the observation of participant outcomes may frequently be
PMID: 41363823 Title: Total arch replacement and classic elephant trunk in a patient with an anomalous left vertebral artery. Date: 2025 Dec 9 Abstract: This video tutorial explains how to treat an aortic aneurysm affecting the arch,
PMID: 41363816 Title: Discovery and Targeted Proteomic Studies Reveal Striatal Markers Validated for Huntington's Disease. Date: 2025 Dec 9 Abstract: OBJECTIVE: Clinical trials for Huntington's disease (HD) enrolling persons before
PMID: 41363784 Title: Anti-IgLON5 Disease: A Systematic Review and Meta-Analysis. Date: 2025 Dec Abstract: BACKGROUND: Anti-IgLON5 disease is now considered a complex and heterogeneous
PMID: 41363773 Title: BRUIN CLL-313: Randomized Phase III Trial of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Date: 2025 Dec 9 Abstract: PURPOSE: BRUIN CLL-313 is a randomized, open-label, global phase III study
PMID: 41363716 Title: Heuristics, biases, and cognitive pitfalls of emergency teledermatology: Navigating the fine line between making and avoiding diagnostic errors. Paris-Saclay, Boulogne-Billancourt, France. Paris-Saclay, Boulogne-Billancourt, France. (IMRB), INSERM U955, Creteil, France. Gif-sur-Yvette, France. Society of Dermatology : JDDG Date: 2025 Dec 9 Abstract: Heuristics, biases, and cognitive pitfalls of emergency teledermatology: Navigating the fine line between making and avoiding diagnostic errors. Paris-Saclay, Boulogne-Billancourt, France. Paris-Saclay, Boulogne-Billancourt, France. (IMRB), INSERM U955, Creteil, France. Gif-sur-Yvette, France. Society of Dermatology : JDDG
PMID: 41363702 Title: Acute Myeloid Leukemia Secondary to Radiation Therapy for Rectal Cancer: A Case Report. Date: 2025 Dec Abstract: BACKGROUND: Therapy-related AML (t-AML) is a subtype of acute myeloid leukemia
PMID: 41363541 Title: Predicting Anxiety in Children Aged 2-6 During Preoperative Anesthesia Consultation-A Prospective Observational Study. Date: 2025 Dec 9 Abstract: BACKGROUND: Preoperative Anxiety in Young Children Is Common and Can Lead to
PMID: 41363407 Title: Fertility Restoration After Vasectomy: AUA Guideline Part II. Date: 2025 Dec 9 Abstract: PURPOSE: This Guideline aims to provide a contemporary overview of options for
PMID: 41363403 Title: Vasectomy: AUA Guideline Part I. Date: 2025 Dec 9 Abstract: PURPOSE: This Guideline provides a contemporary overview of vasectomy, including
PMID: 41363232 Title: [Christmas article: CPR under the Christmas tree - can Christmas carols disturb the rhythm?]. Date: 2025 Dec 8 Abstract: INTRODUCTION: Dancing around the Christmas tree combines physical activity with a
PMID: 41363231 Title: [Christmas article: The ideal Christmas gift - a randomised crossover study]. Date: 2025 Dec 8 Abstract: INTRODUCTION: The joy of Christmas gifts depends not only on their content but
PMID: 41363227 Title: [Christmas article: Alcohol induced rhinitis]. Date: 2025 Dec 8 Abstract: In Denmark, December brings two certainties: upper respiratory symptoms and
PMID: 41363226 Title: [Christmas article: Crystal clear result: No effect of amethyst on KRAM-S factors and health after Christmas]. Date: 2025 Dec 8 Abstract: INTRODUCTION: For centuries, amethyst has been celebrated as a crystal capable of
PMID: 41363222 Title: Feasibility of Designing, Manufacturing and Delivering 3D Printed Ankle-Foot Orthoses: An Updated Systematic Review. Date: 2025 Dec Abstract: BACKGROUND: Ankle-foot orthoses (AFOs) are commonly prescribed to manage lower
PMID: 41363217 Title: [Cerebral malaria after travel to Indonesia]. Date: 2025 Dec 1 Abstract: A young Danish boy developed severe Plasmodium falciparum malaria after travel to
PMID: 41363216 Title: [Bilateral testicular torsion with unilateral symptoms]. Date: 2025 Dec 1 Abstract: Testicular torsion (TT) is an acute urological emergency where the testicle
PMID: 41363211 Title: High-flow nasal cannula oxygen therapy for asthma exacerbation. Date: 2025 Dec 9 Abstract: This is a protocol for a Cochrane Review (intervention). The objectives are as
PMID: 41363192 Title: Targeted therapies and PARPi therapy response following ICI therapy failure in advanced melanoma: a case series. Date: 2025 Dec Abstract: Poly (ADP-ribose) polymerase inhibitors (PARPi) have shown efficacy in treating
PMID: 41363185 Title: Management of pediatric bone sarcomas. Date: 2025 Dec 8 Abstract: PURPOSE OF REVIEW: Pediatric bone sarcomas - principally osteosarcoma (OS) and
PMID: 41363177 Title: Conservative kidney management versus dialysis for stage 5 chronic kidney disease in older people. Date: 2025 Dec 9 Abstract: RATIONALE: The prevalence of kidney failure in people aged 65 years and above is
PMID: 41363159 Title: Manual therapy with exercise for neck pain. Date: 2025 Dec 9 Abstract: RATIONALE: Manual therapy and exercise are supported by evidence of effectiveness
PMID: 41363147 Title: Recruiting patients with persistent physical symptoms and no specific diagnosis for clinical trials in primary care: a qualitative study of four scenarios. Date: 2025 Dec 9 Abstract: AIM: To investigate how to recruit patients rigosrously in general practice for
PMID: 41363079 Title: Acute Reduction in Blood Flow in the Right Coronary Artery After PCI Facilitates Pacemaker-Induced Ventricular Fibrillation. Date: 2026 Jan Abstract: Asynchronous pacing itself does not directly lead to the development of malignant
PMID: 41363062 Title: Depigmentation Therapy of Refractory Facial Vitiligo Using 532-Nm Picosecond Laser: Two Case Reports and Literature Review. Date: 2025 Dec Abstract: BACKGROUND: Vitiligo is a common depigmenting disorder resulting from the loss of
PMID: 41363026 Title: A comparative study between mindfulness-enhanced exercise training with tai chi and resistance training for college students' mental health: Efficacy, trajectories, and mechanisms. Date: 2025 Dec Abstract: Previous studies have demonstrated that mindfulness-enhanced exercise training
PMID: 41363019 Title: Novel Dominant Splicing Variant in MPZ Associated With Unusual Charcot-Marie-Tooth Disease. Date: 2025 Dec Abstract: BACKGROUND AND AIMS: Variants in the myelin protein zero coding MPZ gene are
PMID: 41363005 Title: Augmentation of psychotherapy with exercise in adult populations affected by posttraumatic stress disorder: a systematic review of randomized controlled trials. Date: 2025 Dec Abstract: Background: Several studies have demonstrated positive effects of exercise in
PMID: 41362979 Title: [Repeated unilateral FUS thalamotomy in patients with tremor-dominant forms of Parkinson's disease]. Date: 2025 Abstract: Magnetic resonance-guided focused ultrasound (MRgFUS) is a non-invasive therapy
PMID: 41362913 Title: Guided Endodontic Management of Pulp Canal Obliteration in a Maxillary Canine with Root Resorption and Prior Iatrogenic Deviation: A Case Report. Date: 2025 Abstract: This case report describes the successful guided endodontic treatment of a
PMID: 41362912 Title: Non-surgical Management of a C-shaped Mandibular Second Molar with Apical Periodontitis and External Root Resorption: A Case Report. Date: 2025 Abstract: This case report describes the successful nonsurgical endodontic management of a
PMID: 41362909 Title: A novel use of the Finesse Flex Loop in retinal detachment with rolled edge of retinal tear. Date: 2025 Dec Abstract: PURPOSE: To describe a new use of Finesse Flex loop to unfold the rolled edge of
PMID: 41362908 Title: Case report of secondary angle closure glaucoma from a Soemmering's ring presenting with episodes of transient total monocular vision loss. Date: 2025 Dec Abstract: PURPOSE: To describe an interesting case of a Soemmering's ring causing
PMID: 41362907 Title: Optical coherence tomography in the emergency department setting: a case series. Date: 2025 Dec Abstract: PURPOSE: To demonstrate the utility of optical coherence tomography (OCT) in the
PMID: 41362903 Title: Diagnosis of a Neonate With Long QT Syndrome and Severe Complications Delayed due to an Unrecognized Familial History. Date: 2025 Abstract: Long QT syndrome (LQTS) is a hereditary arrhythmic disorder associated with
PMID: 41362902 Title: New Insights: P.I.G in Preterm Infants With Isolated PDA and Severe Pulmonary Hypertension. Date: 2025 Abstract: We present a case of a premature infant who had a persistent patent ductus
PMID: 41362894 Title: Brief Diet Screener for Assessing Adherence to the Dietary Approaches to Stop Hypertension (DASH) Diet: Development and Validation. Date: 2025 Nov Abstract: BACKGROUND: Although poor diet quality is a main risk factor for cardiovascular
PMID: 41362888 Title: Citrobacter koseri infection of the nose masquerading as keratoacanthoma: A case report and review of the literature. California. California. California. California. California. eCollection 2025 Dec. Date: 2025 Dec Abstract: Citrobacter koseri infection of the nose masquerading as keratoacanthoma: A case report and review of the literature. California. California. California. California. California. eCollection 2025 Dec.
PMID: 41362887 Title: Scalp necrotizing fasciitis after resection of angiolymphoid hyperplasia with eosinophilia misdiagnosed as pyoderma gangrenosum. Beijing. University, Chaoyang District, Beijing. Beijing. Beijing. District, Beijing. Beijing. Beijing. Beijing. Beijing. Beijing. Charleston, South Carolina. Beijing. eCollection 2025 Dec. Date: 2025 Dec Abstract: Scalp necrotizing fasciitis after resection of angiolymphoid hyperplasia with eosinophilia misdiagnosed as pyoderma gangrenosum. Beijing. University, Chaoyang District, Beijing. Beijing. Beijing. District, Beijing. Beijing. Beijing. Beijing. Beijing. Beijing. Charleston, South Carolina. Beijing. eCollection 2025 Dec.
PMID: 41362880 Title: Preventive Effect of Shenfu Injection on Arrhythmia After Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: A Prospective Randomized Controlled Trial. Date: 2025 Abstract: BACKGROUND AND AIMS: Arrhythmias and major adverse cardiac events remain
PMID: 41362875 Title: An atypical case of pemphigus herpetiformis with erythroderma. Arkansas. at the University of California, Los Angeles, California. at the University of California, Los Angeles, California. at the University of California, Los Angeles, California. at the University of California, Los Angeles, California. at the University of California, Los Angeles, California. at the University of California, Los Angeles, California. at the University of California, Los Angeles, California. at the University of California, Los Angeles, California. speaker to AbbVie, Arcutis, BI, BMS, Leo, UCB, Janssen, Lilly, Novartis, Ortho, Sun, Dermavant, Sanofi, Takeda, Regeneron, and Pfizer. Drs Dong, Shen, McKenzie, Smart, Kang, Kasperkiewicz, and Authors Jeong, Chou, and Lane have no conflicts of interest to declare. 2026 Jan. Date: 2026 Jan Abstract: An atypical case of pemphigus herpetiformis with erythroderma. Arkansas. at the University of California, Los Angeles, California. at the University of California, Los Angeles, California. at the University of California, Los Angeles, California. at the University of California, Los Angeles, California. at the University of California, Los Angeles, California. at the University of California, Los Angeles, California. at the University of California, Los Angeles, California. at the University of California, Los Angeles, California. speaker to AbbVie, Arcutis, BI, BMS, Leo, UCB, Janssen, Lilly, Novartis, Ortho, Sun, Dermavant, Sanofi, Takeda, Regeneron, and Pfizer. Drs Dong, Shen, McKenzie, Smart, Kang, Kasperkiewicz, and Authors Jeong, Chou, and Lane have no conflicts of interest to declare. 2026 Jan.
PMID: 41362873 Title: Rare presentation of lues maligna and nodular syphilis in an immunocompetent patient. Qatar. Corporation, Doha, Qatar. Qatar. Qatar. Qatar. Corporation, Doha, Qatar. Sanofi/Regeneron, Novartis, Pfizer, Eli Lilly, Galderma, Leo, BMS, and MenloTx, has been a consultant for AbbVie, Amgen, Galderma, Novartis, Janssen, Pfizer, Eli Lilly, Sanofi, MenloTx, Janssen, Union Tx, Galderma, and Leo, and has received research funding from Galderma, AbbVie, Leo, Pfizer, Novartis, and Sanofi. Drs Al-Abdulla, AlSrami, Takiddin, and Murshed have no conflicts of interest to declare. 2026 Jan. Date: 2026 Jan Abstract: Rare presentation of lues maligna and nodular syphilis in an immunocompetent patient. Qatar. Corporation, Doha, Qatar. Qatar. Qatar. Qatar. Corporation, Doha, Qatar. Sanofi/Regeneron, Novartis, Pfizer, Eli Lilly, Galderma, Leo, BMS, and MenloTx, has been a consultant for AbbVie, Amgen, Galderma, Novartis, Janssen, Pfizer, Eli Lilly, Sanofi, MenloTx, Janssen, Union Tx, Galderma, and Leo, and has received research funding from Galderma, AbbVie, Leo, Pfizer, Novartis, and Sanofi. Drs Al-Abdulla, AlSrami, Takiddin, and Murshed have no conflicts of interest to declare. 2026 Jan.
PMID: 41362872 Title: A case of intravascular histiocytosis associated with septic arthritis of a nonnative joint. Health, Madison, Wisconsin. Health, Madison, Wisconsin. Health, Madison, Wisconsin. 2026 Jan. Date: 2026 Jan Abstract: A case of intravascular histiocytosis associated with septic arthritis of a nonnative joint. Health, Madison, Wisconsin. Health, Madison, Wisconsin. Health, Madison, Wisconsin. 2026 Jan.
PMID: 41362871 Title: Disseminated Mycobacterium marinum presenting as bursitis in a patient with psoriatic arthritis on adalimumab. Largo, Florida. Illinois. Largo, Florida. Largo, Florida. Largo, Florida. 2026 Jan. Date: 2026 Jan Abstract: Disseminated Mycobacterium marinum presenting as bursitis in a patient with psoriatic arthritis on adalimumab. Largo, Florida. Illinois. Largo, Florida. Largo, Florida. Largo, Florida. 2026 Jan.
PMID: 41362870 Title: Evolution of retiform hemangioendothelioma into angiosarcoma. Farmington, Connecticut. of Medicine, Farmington, Connecticut. Farmington, Connecticut. 2026 Jan. Date: 2026 Jan Abstract: Evolution of retiform hemangioendothelioma into angiosarcoma. Farmington, Connecticut. of Medicine, Farmington, Connecticut. Farmington, Connecticut. 2026 Jan.
PMID: 41362869 Title: Thumbprint purpura from disseminated strongyloidiasis in a heart transplant recipient. 2026 Jan. Date: 2026 Jan Abstract: Thumbprint purpura from disseminated strongyloidiasis in a heart transplant recipient. 2026 Jan.
PMID: 41362868 Title: Flagellate erythema-like persistent eruption of Still's disease treated with a Janus kinase inhibitor. received royalty payments from McGraw Hill. Drs Pham, Moon, Lee, and Author Kassels have no conflicts of interest to declare. 2026 Jan. Date: 2026 Jan Abstract: Flagellate erythema-like persistent eruption of Still's disease treated with a Janus kinase inhibitor. received royalty payments from McGraw Hill. Drs Pham, Moon, Lee, and Author Kassels have no conflicts of interest to declare. 2026 Jan.
PMID: 41362867 Title: Discrete papular lichen myxedematosus successfully treated with isotretinoin. Wisconsin. 2026 Jan. Date: 2026 Jan Abstract: Discrete papular lichen myxedematosus successfully treated with isotretinoin. Wisconsin. 2026 Jan.
PMID: 41362866 Title: A rare case of dystrophic calcinosis cutis in an infant. California, Los Angeles, Los Angeles, California. Health, Boston, Massachusetts. California, Los Angeles, Los Angeles, California. California, Los Angeles, Los Angeles, California. California, Los Angeles, Los Angeles, California. California, Los Angeles, Los Angeles, California. connection with this article. 2026 Jan. Date: 2026 Jan Abstract: A rare case of dystrophic calcinosis cutis in an infant. California, Los Angeles, Los Angeles, California. Health, Boston, Massachusetts. California, Los Angeles, Los Angeles, California. California, Los Angeles, Los Angeles, California. California, Los Angeles, Los Angeles, California. California, Los Angeles, Los Angeles, California. connection with this article. 2026 Jan.
PMID: 41362865 Title: A recalcitrant case of pemphigus treated with inebilizumab. New York. New York. New York. 2026 Jan. Date: 2026 Jan Abstract: A recalcitrant case of pemphigus treated with inebilizumab. New York. New York. New York. 2026 Jan.
PMID: 41362864 Title: Multiple calcified basal cell carcinomas in an asymptomatic patient with a very elevated coronary calcium score. 2026 Jan. Date: 2026 Jan Abstract: Multiple calcified basal cell carcinomas in an asymptomatic patient with a very elevated coronary calcium score. 2026 Jan.
PMID: 41362861 Title: Overlap MCAP-CLAPO syndrome associated with malignant ovarian tumor in a 11 year old girl. Spain. Spain. Spain. 2026 Jan. Date: 2026 Jan Abstract: Overlap MCAP-CLAPO syndrome associated with malignant ovarian tumor in a 11 year old girl. Spain. Spain. Spain. 2026 Jan.
PMID: 41362860 Title: Successful treatment of an MBTPS2-linked Olmsted syndrome patient using erlotinib. University of Medical Sciences, Tehran, Iran. Medicine, Iran University of Medical Sciences, Tehran, Iran. University of Medical Sciences, Tehran, Iran. University of Medical Sciences, Tehran, Iran. University of Medical Sciences, Tehran, Iran. Center, Irwindale, California. University of Medical Sciences, Tehran, Iran. Pennsylvania, Philadelphia, Pennsylvania. Pennsylvania. Pennsylvania, Philadelphia, Pennsylvania. 2026 Jan. Date: 2026 Jan Abstract: Successful treatment of an MBTPS2-linked Olmsted syndrome patient using erlotinib. University of Medical Sciences, Tehran, Iran. Medicine, Iran University of Medical Sciences, Tehran, Iran. University of Medical Sciences, Tehran, Iran. University of Medical Sciences, Tehran, Iran. University of Medical Sciences, Tehran, Iran. Center, Irwindale, California. University of Medical Sciences, Tehran, Iran. Pennsylvania, Philadelphia, Pennsylvania. Pennsylvania. Pennsylvania, Philadelphia, Pennsylvania. 2026 Jan.
PMID: 41362859 Title: Graham-Little-Piccardi-Lassueur syndrome: A rare case associated with a chromosomal anomaly and unusual histopathologic characterization of keratosis pilaris-like lesions. 2026 Jan. Date: 2026 Jan Abstract: Graham-Little-Piccardi-Lassueur syndrome: A rare case associated with a chromosomal anomaly and unusual histopathologic characterization of keratosis pilaris-like lesions. 2026 Jan.
PMID: 41362858 Title: From self-harm to shock: A case report of mercury poisoning and cutaneous injury. Bethesda, Maryland. Nevada. Ohio. Health Education Consortium, San Antonio, Texas. Consortium, San Antonio, Texas. 2026 Jan. Date: 2026 Jan Abstract: From self-harm to shock: A case report of mercury poisoning and cutaneous injury. Bethesda, Maryland. Nevada. Ohio. Health Education Consortium, San Antonio, Texas. Consortium, San Antonio, Texas. 2026 Jan.
PMID: 41362857 Title: Two-photon microscopy allows for rapid imaging and diagnosis of Mohs specimens. York. York. York. York. York. 2026 Jan. Date: 2026 Jan Abstract: Two-photon microscopy allows for rapid imaging and diagnosis of Mohs specimens. York. York. York. York. York. 2026 Jan.
PMID: 41362856 Title: Nondestructive lingual variant of isolated mucosal leishmaniasis in an endemic zone: A case report from Nepal. Teaching Hospital, Kathmandu, Nepal. Hospital, Kathmandu, Nepal. Teaching Hospital, Kathmandu, Nepal. Teaching Hospital, Kathmandu, Nepal. Hospital, Kathmandu, Nepal. 2026 Jan. Date: 2026 Jan Abstract: Nondestructive lingual variant of isolated mucosal leishmaniasis in an endemic zone: A case report from Nepal. Teaching Hospital, Kathmandu, Nepal. Hospital, Kathmandu, Nepal. Teaching Hospital, Kathmandu, Nepal. Teaching Hospital, Kathmandu, Nepal. Hospital, Kathmandu, Nepal. 2026 Jan.
PMID: 41362855 Title: A case of blastic plasmacytoid dendritic cell neoplasm in a young male with atypical cutaneous findings. 2026 Jan. Date: 2026 Jan Abstract: A case of blastic plasmacytoid dendritic cell neoplasm in a young male with atypical cutaneous findings. 2026 Jan.
PMID: 41362854 Title: Remission of recalcitrant pyoderma gangrenosum following chemotherapy for iatrogenic Kaposi sarcoma. Houston, Houston, Texas. Houston, Houston, Texas. Texas Health Science Center at Houston, Houston, Texas. Health Science Center at Houston, Houston, Texas. 2026 Jan. Date: 2026 Jan Abstract: Remission of recalcitrant pyoderma gangrenosum following chemotherapy for iatrogenic Kaposi sarcoma. Houston, Houston, Texas. Houston, Houston, Texas. Texas Health Science Center at Houston, Houston, Texas. Health Science Center at Houston, Houston, Texas. 2026 Jan.
PMID: 41362852 Title: A novel case of acute localized and generalized exanthematous pustulosis following IL-2 analogue injection amplified by immune checkpoint inhibition. Angeles, California. Angeles, California. Seattle, Washington. Angeles, California. Angeles, California. 2026 Jan. Date: 2026 Jan Abstract: A novel case of acute localized and generalized exanthematous pustulosis following IL-2 analogue injection amplified by immune checkpoint inhibition. Angeles, California. Angeles, California. Seattle, Washington. Angeles, California. Angeles, California. 2026 Jan.
PMID: 41362851 Title: Disseminated cutaneous blastomycosis in a liver transplant recipient: A case report. Date: 2025 Dec Abstract: Blastomyces dermatitidis, a dimorphic fungal infection endemic to North America,
PMID: 41362850 Title: Hemophagocytic lymphohistiocytosis secondary to disseminated histoplasmosis in an HIV-negative patient: A case of misdiagnosis. Date: 2025 Dec Abstract: Hemophagocytic lymphohistiocytosis (HLH) secondary to disseminated histoplasmosis
PMID: 41362838 Title: True Spontaneous Splenic Rupture Mimicking Peptic Ulcer Disease: A Case Report. Date: 2025 Abstract: INTRODUCTION: Spontaneous splenic rupture (SSR) is an uncommon and potentially
PMID: 41362837 Title: Band Acro-Osteolysis as a Less Common Radiologic Pattern in Systemic Scleroderma: A Case Report. Date: 2025 Abstract: BACKGROUND: Acro-osteolysis is a less common radiological condition characterized
PMID: 41362835 Title: Decellularized corneal-based 3D scaffolds: methods decellularization, characterization, mechanical properties, and species source. Date: 2026 Mar Abstract: Corneal blindness is a significant worldwide health issue owing to low number of
PMID: 41362832 Title: Cardiac Septal Metastasis From Poorly Differentiated Colorectal Adenocarcinoma: A Rare Case Illustrating the Role of Multimodal Imaging and Multidisciplinary Management. Date: 2025 Abstract: BACKGROUND: Cardiac metastases from colorectal adenocarcinoma are rare and may
PMID: 41362826 Title: Type 1 Autoimmune Pancreatitis in a Teenager With Ulcerative Colitis: A Case Report. Date: 2026 Abstract: Type 2 autoimmune pancreatitis (AIP) is a recognized complication of ulcerative
PMID: 41362818 Title: Follicular Cholecystitis: A Case Report Highlighting the Diagnostic Challenges and Management Implications. Date: 2026 Abstract: Follicular cholecystitis (FC), a rare benign entity, represents <2% of
PMID: 41362809 Title: Key findings and the importance of tangential views in gastrostomy tube evaluation: a rare case of a malpositioned gastrostomy tube within the anterior abdominal wall after surgical placement. Date: 2026 Feb Abstract: Gastrostomy tube placement is a commonly performed procedure that is generally
PMID: 41362808 Title: Transient lateral patellar dislocation resulting in osteochondral lesion of the lateral femoral condyle: a case series of findings on cone beam CT. Date: 2026 Feb Abstract: Transient lateral patellar dislocation (TLPD) occurs most often in young active
PMID: 41362807 Title: INI1-Deficient malignancy involving the pancreas and jejunum: Expanding the clinical spectrum. Date: 2026 Feb Abstract: SMARCB1/integrase interactor 1(INI1)-deficient malignancies of the
PMID: 41362806 Title: Role of ultrasound in the prenatal diagnosis of sacrococcygeal teratoma: A case study. Date: 2026 Feb Abstract: Sacrococcygeal teratoma (SCT) is the most common congenital tumor arising from
PMID: 41362805 Title: Disseminated pulmonary involvement in multiple myeloma: A rare extramedullary manifestation on CT. Date: 2026 Feb Abstract: Pulmonary involvement in multiple myeloma (MM) is exceedingly rare and poses a
PMID: 41362804 Title: Double gallbladder mimicking choledochal cyst: a rare anatomical variation. Date: 2026 Feb Abstract: Double gallbladder is a rare congenital anomaly that can be mistaken for a
PMID: 41362803 Title: Isolated tuberculous osteomyelitis of the wrist: A case report. Date: 2026 Feb Abstract: Extrapulmonary tuberculosis is an infection by Mycobacterium tuberculosis (MTB)
PMID: 41362802 Title: The Role of genetic sonography in chromosomal anomaly detection in low-resource settings: A case report of Edwards syndrome. Date: 2026 Feb Abstract: Edwards syndrome (trisomy 18) is a severe chromosomal disorder associated with
PMID: 41362801 Title: Muscular hydatidosis in an exceptional location: Contribution of ultrasound and MRI in diagnosis. Date: 2026 Feb Abstract: Hydatidosis is a parasitic disease caused by Echinococcus granulosus. It most
PMID: 41362800 Title: Left-sided omental torsion secondary to recurrent inguinal hernia in a 24-year-old male: A case report and review of literature. Date: 2026 Feb Abstract: Omental torsion is an infrequent but important cause of acute abdominal pain that
PMID: 41362799 Title: The double trouble: A case report on central vein dual stenosis. Date: 2026 Feb Abstract: Central vein stenosis is a common complication in patients with chronic kidney
PMID: 41362798 Title: "Multifocal, intra-axial Langerhans cell histiocytosis presenting with central diabetes insipidus in teenage pregnancy: A case report". Date: 2026 Feb Abstract: Langerhans cell histiocytosis (LCH) is a rare disorder of clonal dendritic cells
PMID: 41362797 Title: Bilateral orbital pseudotumor as the initial manifestation of granulomatosis con poliangeitis (GPA) in a child: A case report. Date: 2026 Feb Abstract: Orbital pseudotumor is uncommon in children and may rarely herald antineutrophil
PMID: 41362796 Title: Cervical osteophytes resulting in dysphagia: A case report with literature review. Date: 2026 Feb Abstract: Dysphagia may result from either organic or structural conditions, whether
PMID: 41362753 Title: Atypical manifestation of pulmonary lymphatic perfusion syndrome treated with percutaneous lymphatic embolization. Date: 2025 Abstract: We report a case of a 62-year-old male with a history of obesity, COPD, diabetes,
PMID: 41362752 Title: Infection with Nocardia pneumoniae in a 54-year-old woman with bronchiectasis - a case report and review of the literature. Date: 2025 Abstract: BACKGROUND/PURPOSE: Nocardia spp. are rare but clinically relevant pathogens in
PMID: 41362735 Title: KRAS-Driven Hypertranscription and Metastatic Dissemination in Colorectal Cancer Could be Overcome by Targeting the NMHC IIA/ PLK1 Signaling Axis with a Novel Acridine Derivative. Date: 2026 Abstract: Colorectal cancer (CRC) becomes highly lethal upon progression to advanced or
PMID: 41362721 Title: Low-grade non-muscle-invasive urothelial carcinoma of the bladder in a 16-year-old boy with UGT1A1 polymorphism and Gilbert's syndrome: A case report. Date: 2026 Jan Abstract: Bladder cancer in the pediatric and adolescent population is exceedingly
PMID: 41362720 Title: Non-ischaemic priapism without trauma in a patient with relapsing Henoch-Schonlein purpura. Date: 2026 Jan Abstract: Non-ischaemic priapism is a rare subtype, almost always associated with trauma.
PMID: 41362719 Title: A rare case of scrotal vascular fibroblastoma with rapid growth: diagnostic challenges and pathological features. City, Yunnan Province, 6710032, China. City, Yunnan Province, 6710032, China. Avenue, Kunming City, Yunnan Province, 650000, China. City, Yunnan Province, 6710032, China. City, Yunnan Province, 6710032, China. Yunnan Province, Kunming City, Yunnan Province, 650000, China. City, Yunnan Province, 6710032, China. 6710032, China. 6710032, China. eCollection 2026 Jan. Date: 2026 Jan Abstract: A rare case of scrotal vascular fibroblastoma with rapid growth: diagnostic challenges and pathological features. City, Yunnan Province, 6710032, China. City, Yunnan Province, 6710032, China. Avenue, Kunming City, Yunnan Province, 650000, China. City, Yunnan Province, 6710032, China. City, Yunnan Province, 6710032, China. Yunnan Province, Kunming City, Yunnan Province, 650000, China. City, Yunnan Province, 6710032, China. 6710032, China. 6710032, China. eCollection 2026 Jan.
PMID: 41362718 Title: Bilateral testicular ischemia caused by heterozygous factor V Leiden. Date: 2026 Jan Abstract: Testicular ischemia is a urologic emergency that is most commonly caused by
PMID: 41362717 Title: Identifiying the ideal point of injection in ICG-assisted lymphatic-sparing Palomo procedure: A case report. Date: 2026 Jan Abstract: We report a 13-year-old boy with varicocele, testicular hypotrophy, and recurrent
PMID: 41362713 Title: Viral sequence analysis of chronic hepatitis B patients treated with the siRNA JNJ-73763989 in phase II clinical trials. Date: 2025 Dec Abstract: BACKGROUND & AIMS: JNJ-73763989 (JNJ-3989) is a small-interfering RNA composed of
PMID: 41362708 Title: The efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytes. Date: 2025 Dec Abstract: BACKGROUND & AIMS: Atezolizumab plus bevacizumab (Atez/Bev) improves prognosis in
PMID: 41362706 Title: DESTINY of Immunotherapy in Patients With HER2 Mutant Lung Cancer: Case Report. Date: 2025 Dec Abstract: Immunotherapy has significantly transformed the landscape of non-oncogene-driven
PMID: 41362703 Title: Rapid-onset Severe Cytokine Release Syndrome With Marked Interleukin-6 Increase and Acute Liver Injury After the First Tarlatamab Dose in SCLC: Case Report. Date: 2025 Dec Abstract: Tarlatamab is a novel bispecific T-cell engager therapy with promising efficacy
PMID: 41362698 Title: Massive Intracranial Lesion in an AIDS Patient: Diagnostic Challenge Between Brain Tumor and Toxoplasmic Encephalitis Resolved by Empirical Therapy. Date: 2025 Abstract: BACKGROUND: Human immunodeficiency virus (HIV)-associated cerebral toxoplasmosis
PMID: 41362683 Title: Transdermal laser associated with sclerotherapy in tumescent anesthesia for the treatment of telangiectatic matting. Date: 2026 Feb Abstract: Telangiectatic matting refers to the proliferation of fine vessels with less than
PMID: 41362682 Title: Aortic pseudoaneurysm secondary to suprarenal inferior vena cava filter penetration treated with coil embolization. Date: 2026 Feb Abstract: Inferior vena cava filter strut penetration is a recognized complication. Damage
PMID: 41362674 Title: Non-clinical safety considerations on genome editing using the CRISPR/Cas system. Date: 2026 Mar Abstract: Recent advances in gene editing using the CRISPR/Cas system have revolutionized
PMID: 41362663 Title: Successful treatment of lichen spinulosis with topical roflumilast: A case report. Date: 2025 Abstract: Lichen spinulosis is an uncommon, follicular keratotic disorder characterized by
PMID: 41362662 Title: Henoch-Schonlein purpura induced by sitagliptin: A case report. Date: 2025 Abstract: Dipeptidyl peptidase-4 inhibitors are oral antihyperglycemic medications often
PMID: 41362658 Title: First case of bloodstream infection caused by Cupriavidus metallidurans in Japan. Date: 2025 Abstract: We report the first case in Japan of a bloodstream infection caused by
PMID: 41362657 Title: Non-O1/non-O139 Vibrio cholerae bacteremia from ingesting untreated water: A case report. Date: 2025 Abstract: Non-O1/non-O139 Vibrio cholerae (NOVC) infections are of rising global incidence
PMID: 41362645 Title: Successful Pregnancy Outcome in a Patient with Recurrent Miscarriage Due to PCOS Complicated by Hereditary Protein C Deficiency. Date: 2025 Abstract: On December 28, 2016, a 35-year-old female patient presenting with chest pain and
PMID: 41362600 Title: A Successful Rechallenge in a Patient With Oxaliplatin-Induced Tonic-Clonic Seizures Under Anticonvulsant Therapy. Date: 2025 Abstract: BACKGROUND: Oxaliplatin is an alkylating chemotherapeutic agent which is
PMID: 41362589 Title: Early severe immune-related pneumonitis, hepatitis, and agranulocytosis with radiographic response in sarcomatoid malignant pleural mesothelioma treated with nivolumab and ipilimumab: a case report highlighting dual liver biopsies and rechallenge decision-making. Date: 2025 Abstract: Sarcomatoid malignant pleural mesothelioma (MPM) is a rare and aggressive cancer
PMID: 41362578 Title: Reversible sensorineural hearing loss linked to chronic allergic rhinitis. Date: 2026 Jan Abstract: Sensorineural hearing loss (SNHL) is traditionally regarded as irreversible.
PMID: 41362577 Title: Mycotic Hepatic Artery Aneurysm in Staphylococcus aureus Infective Endocarditis. Date: 2025 Nov Abstract: We present the case of a woman in her 70s with a history of rheumatoid arthritis
PMID: 41362573 Title: Percutaneous Treatment of a Giant Coronary Artery Aneurysm Using a Covered Stent With a Drug-Eluting Stent "Sandwich" Technique: A Case Report. Date: 2025 Nov Abstract: Coronary artery aneurysms (CAAs) pose diagnostic and therapeutic challenges due
PMID: 41362572 Title: Inveterate Section of Deep Flexor in Pediatric Hand, Periosteum Clues. Date: 2025 Nov Abstract: Diagnostic delay in flexor tendon injuries is common in pediatric patients, and
PMID: 41362571 Title: Laparoscopic Removal of a Vaginal Foreign Body (Aerosol Cap): A Case Report. Date: 2025 Nov Abstract: Vaginal foreign bodies, although uncommon, may cause significant complications
PMID: 41362569 Title: Slow-Channel Congenital Myasthenic Syndrome due to a CHRNA1 Variant Masquerading as Atypical Anorexia Nervosa: A Case Report. Date: 2025 Nov Abstract: Congenital myasthenic syndrome (CMS) is a group of inherited disorders
PMID: 41362568 Title: Calcitriol as a Therapeutic Strategy for Ferric Carboxymaltose-Induced Hypophosphatemia. Date: 2025 Nov Abstract: We describe an 83-year-old man with idiopathic protein-losing enteropathy on
PMID: 41362565 Title: South African Flag Sign in Acute Myocardial Infarction: A Case Report and Literature Review Highlighting the Superiority of the Occlusion Myocardial Infarction (OMI)/Non-Occlusion Myocardial Infarction (NOMI) Paradigm. Date: 2025 Nov Abstract: The South African flag sign (SAFS) is a recently described electrocardiographic
PMID: 41362562 Title: Early-Onset Leukonychia as a Diagnostic Clue in Familial Hailey-Hailey Disease. Date: 2025 Nov Abstract: Hailey-Hailey disease (HHD) is a rare autosomal dominant genodermatosis
PMID: 41362560 Title: Late Manifestation of Invasive Adenocarcinoma in a Right-Colon Interposition for Esophageal Atresia. Date: 2025 Nov Abstract: Colonic interposition is a recognized surgical technique for esophageal
PMID: 41362559 Title: A Case Report of Takotsubo Cardiomyopathy Masquerading as Acute Coronary Syndrome: A Diagnostic Challenge. Date: 2025 Nov Abstract: Presentations of Takotsubo cardiomyopathy (TTC) may resemble those of acute
PMID: 41362557 Title: A Case of a Rare Vascular Phenomenon: Superior Vena Cava Aneurysm. Date: 2025 Nov Abstract: Superior vena cava (SVC) aneurysms are exceedingly rare vascular abnormalities
PMID: 41362556 Title: Laparoscopic Mesh Repair of a Strangulated Right Obturator Hernia With Intraoperative Indocyanine Green Assessment of Bowel Viability: A Case Report. Date: 2025 Nov Abstract: Obturator hernia is a rare condition. Due to its deep pelvic location, surgical
PMID: 41362555 Title: Pulmonary Leiomyosarcoma: A Diagnostic Challenge. Date: 2025 Nov Abstract: Primary pulmonary leiomyosarcoma (PPL) is an extremely rare form of lung cancer,
PMID: 41362554 Title: A Rare Presentation of Knee Pain in a Patient With History of Lung Cancer. Date: 2025 Nov Abstract: Intra-articular malignancies affecting the knee and hip joint are extraordinarily
PMID: 41362553 Title: Infective Endocarditis Caused by Serratia marcescens: A Case Report and Literature Review. Date: 2025 Nov Abstract: Serratia (S.) marcescens is an opportunistic, gram-negative pathogen most
PMID: 41362551 Title: Subclinical Tuberculosis Diagnosis in Lusaka, Zambia: A Case Report. Date: 2025 Nov Abstract: Identifying subclinical tuberculosis (TB) remains a significant challenge due to
PMID: 41362550 Title: Multifocal Dural Arteriovenous Fistula Formation Following Successful Endovascular Treatment of a Traumatic Direct Carotid Cavernous Fistula. Date: 2025 Nov Abstract: The development of dural arteriovenous fistulas (DAVFs) following treatment of a
PMID: 41362548 Title: The Presence of an Anterior Tubercle in the Foramen Magnum of the Cranium: A Case Report With Potential Clinical Consequences. Date: 2025 Nov Abstract: There are not so many variants regarding the foramen magnum (FM). However, the
PMID: 41362544 Title: Concurrent Computed Tomography Angiography Spot Signs in Cerebral Contusion and Subdural Hematoma Following Severe Traumatic Brain Injury: A Case Report. Date: 2025 Nov Abstract: The spot sign is a well-established radiologic marker associated with hematoma
PMID: 41362542 Title: The Silent Obstruction: A Rare Complication of Non-steroidal Anti-inflammatory Drug (NSAID)-Induced Diaphragm Disease. Date: 2025 Nov Abstract: Diaphragm disease is a rare but significant complication of prolonged
PMID: 41362539 Title: Ileostomy Adenocarcinoma After Recurrent Rectal and Colon Cancer: A Case Report and Literature Review. Date: 2025 Nov Abstract: Numerous complications of stoma have been documented in the literature, yet only
PMID: 41362538 Title: Peripheral Neuromodulation: Type 2 Complex Regional Pain Syndrome Secondary to an Excisional Biopsy. Date: 2025 Nov Abstract: Complex regional pain syndrome (CRPS) is a multifactorial and often refractory
PMID: 41362536 Title: The Hidden Threat: Maxillary Hardware-Associated Actinomycosis in Diabetes. Date: 2025 Nov Abstract: Actinomycosis is a chronic granulomatous infection caused by anaerobic
PMID: 41362535 Title: Dental Management of a Child With Temtamy Syndrome: A Case Report. Date: 2025 Nov Abstract: Temtamy syndrome is a rare genetic disorder that follows an autosomal recessive
PMID: 41362531 Title: Radiological Management of Chyle Leaks Following Oesophagectomy: A Systematic Review. Date: 2025 Nov Abstract: A chyle leak is a rare but potentially life-threatening complication following
PMID: 41362530 Title: An Atypical Presentation of Enteroviral Meningitis in an Immunocompetent Adult Man. Date: 2025 Nov Abstract: Aseptic meningitis is inflammation of the meninges characterized by cerebrospinal
PMID: 41362529 Title: Late Recurrence of Renal Cell Carcinoma Presenting With Skeletal Muscle Metastases: A Case Report. Date: 2025 Nov Abstract: Metastatic spread from renal cell carcinoma (RCC) can occur in unusual locations,
PMID: 41362528 Title: Stenting the Unexpected: Endovascular Management of a Common Carotid Artery Pseudoaneurysm in a 79-Year-Old Woman. Date: 2025 Nov Abstract: Arterial pseudoaneurysms (PsA) are uncommon vascular abnormalities that may have
PMID: 41362524 Title: Acute Kidney Injury Secondary to Vitamin D Intoxication: A Case of Oxalate Nephropathy. Date: 2025 Nov Abstract: In recent years, vitamin D supplements have gained popularity in the media,
PMID: 41362521 Title: Successful Use of Midodrine in a Normotensive, Non-cirrhotic Patient With Chylous Ascites Due to Chronic Porto-Mesenteric Thrombosis: A Multidisciplinary Challenge. Date: 2025 Nov Abstract: Chylous ascites (CA), the pathological accumulation of triglyceride-rich
PMID: 41362520 Title: Drug-Induced Liver Injury Secondary to Meropenem: Diagnostic Challenge and Therapeutic Role of Hemoadsorption. Date: 2025 Nov Abstract: Meropenem is a broad-spectrum carbapenem antibiotic commonly used in critically
PMID: 41362517 Title: Pneumomediastinum Masquerading As Superior Vena Cava Obstruction in a Patient With Metastatic Colorectal Cancer: A Diagnostic Challenge. Date: 2025 Nov Abstract: Pneumomediastinum refers to the presence of free air within the mediastinum and
PMID: 41362516 Title: Infantile Acute Myeloid Leukemia Presenting As Intussusception: A Case Report and Review of the Literature. Date: 2025 Nov Abstract: A 10-month-old male infant presented to the emergency department with acute
PMID: 41362515 Title: Refractory Lupus Nephritis in a Woman With Systemic Lupus Erythematosus on Immunosuppressive Therapy: A Case Report. Date: 2025 Nov Abstract: Systemic lupus erythematosus (SLE) is a multisystem rheumatologic condition that
PMID: 41362513 Title: Not All Bone Lesions After Breast Cancer Treatment Indicate Metastasis: A Case Report and Review of the Literature. Date: 2025 Nov Abstract: Breast cancer is one of the osteophilic cancers. However, the appearance of
PMID: 41362508 Title: Atrial Fibrillation in a Young Healthy Adult: A Case Report From Anaphylaxis to Arrhythmia. Date: 2025 Nov Abstract: Atrial fibrillation (AF) is rare in young adults without underlying cardiac
PMID: 41362507 Title: Spontaneous Coronary Artery Dissection in a Lactating Mother Three Years Postpartum: A Rare Case Report. Date: 2025 Nov Abstract: Spontaneous coronary artery dissection (SCAD) is a rare cause of acute coronary
PMID: 41362506 Title: Anterior Hyaloid Staining With Trypan Blue During Phacoemulsification. Date: 2025 Nov Abstract: A semi-professional football player diagnosed with a left eye cataract was
PMID: 41362504 Title: Very Late Iliac Venous Stent Migration Into the Right Ventricle With Tricuspid Valve Injury Five Years After Implantation: A Case Report. Date: 2025 Nov Abstract: Stent migration into the right heart chambers is an uncommon but potentially
PMID: 41362503 Title: Anti-Hu Paraneoplastic Polyradiculoneuropathy Masquerading As Guillain-Barre Syndrome: A Case Report. Date: 2025 Nov Abstract: Paraneoplastic neurological syndromes (PNS) can precede the detection of an
PMID: 41362499 Title: An Indeterminate Choroidal Melanocytic Lesion: A Case Report. Date: 2025 Nov Abstract: Choroidal nevi are common, benign growths in the eye that are usually harmless
PMID: 41362498 Title: A Rare Case of Aggressive Tongue Malignant Melanoma: Clinical Presentation and Treatment Approach. Date: 2025 Nov Abstract: Tongue malignant melanoma is a very rare and highly aggressive subtype of oral
PMID: 41362496 Title: A rare case of repeat severe facial dog bite injuries requiring two free flap reconstructions. Date: 2026 Mar Abstract: Whilst the majority of dog bites result in minor injuries requiring treatment
PMID: 41362495 Title: Yin-Yang NAC sharing: Full-thickness split graft from a single NAC for bilateral immediate reconstruction after skin-reducing mastectomy. Date: 2026 Mar Abstract: Nipple-areola complex (NAC) reconstruction significantly contributes to
PMID: 41362481 Title: Pediatric CNS relapse of neuroblastoma treated with upright proton craniospinal irradiation. Date: 2026 Jan Abstract: Craniospinal irradiation (CSI) is a technically demanding treatment in pediatric
PMID: 41362460 Title: Subclinical primary portal vein hypoplasia in a cat: early diagnosis through CT and histopathology. Date: 2025 Jul-Dec Abstract: CASE SUMMARY: Primary portal vein hypoplasia (PVH) is a rare congenital vascular
PMID: 41362454 Title: Bioengineering methods for tailoring treatment of Osteomyelitis: Advancing strategies and application. Date: 2025 Dec Abstract: Osteomyelitis (OM), an inflammatory disease of the bone due to pathogenic
PMID: 41362450 Title: A case report of total epidermal necrosis following mirvetuximab soravtansine extravasation. Date: 2025 Dec Abstract: BACKGROUND: Mirvetuximab soravtansine (MIRV) is an antibody-drug conjugate (ADC)
PMID: 41362447 Title: Fertility-sparing management of perivascular epithelioid cell tumors: A case report and literature review. Date: 2025 Dec Abstract: Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms.
PMID: 41362446 Title: Vaginal polypoid endometriosis in a woman in her 30s with advanced pelvic endometriosis: A case report and literature review. Date: 2025 Dec Abstract: Polypoid endometriosis is a remarkably rare variant of endometriosis that may
PMID: 41362433 Title: Antimicrobial and Anti-Infective Potential of Herbal Creams in Dermatology: Efficacy, Safety, and Challenges in Skin Infection Management. Date: 2025 Abstract: Herbal creams are becoming increasingly popular in dermatology due to their
PMID: 41362432 Title: Agrobacterium radiobacter Bacteremia in a Gastric Cancer Patient: A Case Report and Literature Review. Date: 2025 Abstract: BACKGROUND: Agrobacterium radiobacter (A. radiobacter) is a gram-negative
PMID: 41362431 Title: Follicular Dendritic Cell Sarcoma Complicated With Preeclampsia and Fetal Growth Restriction in Pregnancy. Date: 2025 Abstract: Follicular dendritic cell sarcoma (FDCS) is a rare neoplasm of mesenchymal origin
PMID: 41362407 Title: Hydrothorax as a Complication of Peritoneal Dialysis: A Case Report. Date: 2025 Abstract: Hydrothorax is a possible complication of peritoneal dialysis due to migration of
PMID: 41362398 Title: Gastropleural Fistula Following Combined TACE, Immunotherapy, and Bevacizumab in HCC: A Case Report. Date: 2025 Abstract: Gastropleural fistula (GPF) is an extremely rare complication after treatment for
PMID: 41362392 Title: Juvenile Xanthogranuloma: A Visual Clinical Diagnosis. Date: 2025 Dec Abstract: Juvenile xanthogranuloma (JXG) is a benign non-Langerhans cell histiocytosis that
PMID: 41362391 Title: Progression From Isolated Posterior Pituitary Dysfunction to Combined Anterior Hormone Deficiencies With Pituitary Stalk Enlargement in Suspected Lymphocytic Hypophysitis: A Case Report. Date: 2025 Dec Abstract: Lymphocytic hypophysitis (LYH) is a rare autoimmune inflammatory disorder of the
PMID: 41362386 Title: Tumor Lysis Syndrome Induced by Hormonal Therapy in Metastatic Prostate Cancer: A Case Report. Date: 2025 Dec Abstract: Tumor lysis syndrome (TLS) is a life-threatening oncological emergency resulting
PMID: 41362385 Title: Quality of Life Over Quantity: Conscious Refusal of Treatment and Stable Course of Gastric Signet-Ring Cell Carcinoma in a 94-Year-Old Woman. Date: 2025 Dec Abstract: We report the case of a 94-year-old woman with histologically confirmed
PMID: 41362384 Title: Between Blood and Tumor: Retroperitoneal Hematoma Look-Alike Revealed as Diffuse Large B-Cell Lymphoma. Date: 2025 Dec Abstract: Diffuse large B-cell lymphoma (DLBCL) frequently involves the abdomen and
PMID: 41362383 Title: ClinicoRadiologic Probable Acute Haemorrhagic Leukoencephalitis Triggered by Legionella Pneumonia. Date: 2025 Dec Abstract: Acute haemorrhagic leukoencephalitis (AHLE) is a rare disease characterised by
PMID: 41362366 Title: Pull-out technique with footprint rivet repair of femoral-sided avulsion fracture of the anterior cruciate ligament: A case report. Date: 2025 Dec Abstract: In children, most of the avulsion fractures of the anterior cruciate ligament
PMID: 41362365 Title: A rare presentation of a complex Galeazzi fracture-dislocation and a review of literature on complications: dislocation and interposition of the deep flexor of the fifth finger. Date: 2025 Dec Abstract: Fractures of the distal third of the radius often involve instability of the
PMID: 41362364 Title: A case of open skull fracture, subdural hematoma, and brain contusion complicated by traumatic brain injury-associated coagulopathy caused by a lawn trimmer; A case report. Date: 2025 Dec Abstract: Penetrating head injury is less common than blunt head injury in Japan but causes
PMID: 41362363 Title: Serial FAST scans reveal delayed mesenteric injury in a polytrauma patient: A case report. Date: 2025 Dec Abstract: BACKGROUND: Focused Assessment with Sonography for Trauma (FAST) is a cornerstone
PMID: 41362358 Title: Biomarker-Specific Test-Retest Repeatabilities of Microperimetry in Neovascular Age-Related Macular Degeneration. Date: 2026 Jan Abstract: PURPOSE: To evaluate the biomarker-specific intradevice and interdevice
PMID: 41362306 Title: Insights Into the Pathological Glycosylation Associated With COG6-CDG. Date: 2025 Abstract: BACKGROUND AND AIMS: Congenital disorders of glycosylation (CDG) are rare
PMID: 41362305 Title: (18)F-MK-6240 uptake in cortical tau and hemorrhagic lesions in a case of Alzheimer's disease with possible crossed aphasia. Date: 2025 Dec Abstract: We report neuroimaging findings from a 74-year-old right-handed male with
PMID: 41362257 Title: Clinical Application of Ultra-Slim Peroral Cholangioscopy for a Giant Common Bile Duct Stone: An Initial Experience. Japan. Japan. Japan. Japan. Japan. Japan. Japan. Japan. Date: 2025 Dec 9 Abstract: Clinical Application of Ultra-Slim Peroral Cholangioscopy for a Giant Common Bile Duct Stone: An Initial Experience. Japan. Japan. Japan. Japan. Japan. Japan. Japan. Japan.
PMID: 41362246 Title: Impaired SERPINF1 Expression due to c.[-37C>A];[829_831del] Causes Osteogenesis Imperfecta VI. Date: 2025 Dec 9 Abstract: Osteogenesis imperfecta type VI is a rare genetic disorder caused by biallelic
PMID: 41362207 Title: A Rare Case of Cefoperazone/Sulbactam-Induced Significant Prolongation of INR. Date: 2025 Dec 1 Abstract: BACKGROUND: Cefoperazone/sulbactam (CPZ/SAM) is a first-line antibacterial drug
PMID: 41362206 Title: Fetal Double Partial Trisomy 6 and 9 Due to Maternal 3:1 Meiotic Segregation of a Balanced Translocation. Date: 2025 Dec 1 Abstract: BACKGROUND: The aim is to investigate the origin of a rare fetal double partial
PMID: 41362202 Title: Bone Marrow Metastasis from a Pancreatic Neuroendocrine Tumor: Morphologic Mimicry of Acute Leukemia. Date: 2025 Dec 1 Abstract: BACKGROUND: Pancreatic neuroendocrine tumors (pNETs), rare neoplasms originating
PMID: 41362199 Title: Lymphocytic Hypereosinophilic Syndrome Evolving to Fatal Hemophagocytic Lymphohistiocytosis: Cytokine Signatures. Date: 2025 Dec 1 Abstract: BACKGROUND: This study documents a rare case of lymphocytic variant
PMID: 41362196 Title: Diagnostic Pitfalls in Primary Biliary Cholangitis: Delta Bilirubin and Lipoprotein-X Interferences. Date: 2025 Dec 1 Abstract: BACKGROUND: Cholestasis in primary biliary cholangitis (PBC) induces delta
PMID: 41362194 Title: Clinical Features and Prognosis Analysis of Acute Myeloid Leukemia in Children with DEK-CAN-Positive. Date: 2025 Dec 1 Abstract: BACKGROUND: The goal of the study is to investigate the clinical characteristics
PMID: 41362193 Title: Fecal Contamination Leading to Falsely Elevated Urinary Amylase: Insights into Pre-analytical Quality Control. Date: 2025 Dec 1 Abstract: BACKGROUND: Elevated urinary amylase is usually associated with pancreatic
PMID: 41362191 Title: Combating Lipemia in Severe Hypertriglyceridemia Pancreatitis: Dilution and Centrifugal Tactics. Date: 2025 Dec 1 Abstract: BACKGROUND: Severe hypertriglyceridemia (HTG) is a critical risk factor for acute
PMID: 41362190 Title: Osteonecrosis of Femoral Head with Antiphospholipid Syndrome and Acquired Subclinical Hemophilia A. Date: 2025 Dec 1 Abstract: BACKGROUND: Osteonecrosis of the femoral head is a common orthopedic disease,
PMID: 41362146 Title: [Endotracheal mantle cell lymphoma: a case report]. Date: 2025 Dec 12 Abstract: Mantle cell lymphoma (MCL) is a subtype of B-cell non-Hodgkin lymphoma, typically
PMID: 41362145 Title: [Combination drug therapy with individualized bronchoscopic intervention for pulmonary mucormycosis]. Date: 2025 Dec 12 Abstract: This article reported a 46-year-old male patient with pulmonary mucormycosis and
PMID: 41362144 Title: [Therapy of follicular lymphoma associated bronchiolitis obliterans with lung transplantation: 2 cases and literature review]. Date: 2025 Dec 12 Abstract: Objective: To summarize the clinical features of bronchiolitis obliterans (BO)
PMID: 41362143 Title: [A case of pulmonary alveolar proteinosis secondary to GATA2 deficiency combined with splenic M. kansasii infection and literature review]. Date: 2025 Dec 12 Abstract: Objective: To enhance the understanding of the rare disease GATA2 deficiency
PMID: 41362128 Title: Preclinical Efficacy of TSL2109 in Prostate Cancer Treatment and Overcoming Enzalutamide Resistance. Date: 2025 Dec 8 Abstract: Prostate cancer (PCa) is a highly prevalent and aggressive malignancy that poses
PMID: 41362117 Title: Next-Generation Proteolysis-Targeting Chimeras in Precision Oncology: Multifunctional Designs, Emerging Modalities, and Translational Prospects in Targeted Protein Degradation. Date: 2025 Dec Abstract: Proteolysis-targeting chimeras (PROTACs)-mediated protein degradation has been
PMID: 41362110 Title: Muscle Loss in Obesity Therapy as a Therapeutic Target: Trial Design and Endpoints for Regulatory Discussions. Date: 2025 Dec Abstract: The Society on Cachexia and Wasting Disorders (SCWD) convened a Regulatory and
PMID: 41362107 Title: Nudging Emergency Department Clinicians to Reduce Unnecessary Diagnostic Test Ordering: A Multi-Arm Vignette-Based Experiment. Date: 2025 Dec Abstract: BACKGROUND: Diagnostic testing is overused in emergency departments, and clinical
PMID: 41362099 Title: Changes in cardiovascular health following ischemic preconditioning in older adults with knee osteoarthritis. Date: 2025 Dec Abstract: Ischemic preconditioning (IC) has been studied for its cardiovascular benefits,
PMID: 41362084 Title: Online Cognitive-Behavioral Programs for Women Living With Endometriosis: Protocol for a Scoping Review. Date: 2025 Dec 8 Abstract: BACKGROUND: Endometriosis is a chronic inflammatory condition experienced by
PMID: 41362052 Title: The Impact of Prolonged Exposure Therapy on Posttraumatic Stress Disorder Symptom Clusters in Adults Maintained on Medications for Opioid Use Disorder. Date: 2025 Nov-Dec Abstract: Although prolonged exposure (PE) therapy has shown promise for improving overall
PMID: 41362037 Title: [Current Status and Future Perspectives of Clinical Trials for Diffuse Intrinsic Pontine Gliomas(DIPG)]. Date: 2025 Nov Abstract: Diffuse intrinsic pontine glioma (DIPG) remains one of the most devastating
PMID: 41362036 Title: [Current Status and Prospects of Clinical Trials for Ependymoma]. Date: 2025 Nov Abstract: Due to the sharp decline in the birth rate in Japan, a severe decline in
PMID: 41362035 Title: [Current Status and Prospects of Clinical Trials for Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor]. Date: 2025 Nov Abstract: Medulloblastoma (MB) and atypical teratoid/rhabdoid tumors (ATRT) are highly
PMID: 41362032 Title: [Emerging Targeted Therapies and Ongoing Clinical Trials in Pediatric Brain Tumors]. Date: 2025 Nov Abstract: Recent advances in molecular profiling have transformed pediatric brain tumors
PMID: 41362004 Title: Behcet Disease and Cognitive Impairment: A Case Study of an Overlooked Symptom. Date: 2025 Dec 9 Abstract: BACKGROUND Behcet disease (BD) is a rare systemic vasculitis with diverse
PMID: 41361997 Title: Enhanced Eustachian Tube Function and Hearing Recovery with Combined Balloon Dilatation and Tympanic Membrane Catheterization in Secretory Otitis Media. Date: 2025 Dec 9 Abstract: BACKGROUND Secretory otitis media (SOM), a common otorhinolaryngological
PMID: 41361987 Title: [Mediastinal Lymphangioma:Report of a Case]. Date: 2025 Dec Abstract: A 76-year-old woman was admitted to our hospital with an abnormal shadow on a
PMID: 41361986 Title: [Invasive Mucinous Adenocarcinoma Diagnosed During the Follow-up of Atelectasis:Report of a Case]. Date: 2025 Dec Abstract: A 72-year-old man underwent bronchoscopy for an abnormal shadow on chest imaging,
PMID: 41361985 Title: [Surgical Treatment of Primary Cardiac Intimal Sarcoma:Report of a Case]. Date: 2025 Dec Abstract: Primary cardiac malignant tumor is rare and is associated with poor survival. We
PMID: 41361984 Title: [Reoperation for Pseudoaneurysm Late After Bentall Procedure:Report of a Case]. Date: 2025 Dec Abstract: We report a case of reoperation for pseudoaneurysm late after Bentall procedure.
PMID: 41361983 Title: [Two-stage Hybrid Repair for Extensive Thoracic Aortic Aneurysm with Ischemic Mitral Regurgitation:Report of a Case]. Date: 2025 Dec Abstract: The patient was a 71-year-old man with a history of hypertension and myocardial
PMID: 41361982 Title: [Annuloaortic Ectasia Induced by Takayasu's Arteritis:Report of a Case]. Date: 2025 Dec Abstract: A 50-year-old male was diagnosed with aortic annulus ectasia (AAE) and aortic
PMID: 41361981 Title: [Guidewire Migration into the Right Ventricle During Leadless Pacemaker Insertion, Requiring Surgical Removal of the Guidewire and Tricuspid Valve Repair:Report of a Case]. Date: 2025 Dec Abstract: In a 77-year-old man, there was difficulty in removing a guidewire that had
PMID: 41361979 Title: [Two Surgical Cases of Pulmonary Nontuberculous Mycobacterial Disease with the Lupus Anticoagulant]. Date: 2025 Dec Abstract: The lupus anticoagulant is one of the antiphospholipid antibodies that inhibit
PMID: 41361978 Title: [Surgical Resection of Metastatic Cardiac Tumors]. Date: 2025 Dec Abstract: We report two cases of metastatic cardiac tumors managed surgically. Case 1
PMID: 41361977 Title: [Usefulness of Insufflation into the Abdominal Cavity for Repair of Pleuroperitoneal Communication]. Date: 2025 Dec Abstract: The patient is an 86-year-old woman. She had ascites and was being treated with
PMID: 41361976 Title: [Left Coronary Artery Stenosis Long-term After Original Jatene Procedure]. Date: 2025 Dec Abstract: An eight-day-old boy with the transposition of the great arteries (TGA) with
PMID: 41361975 Title: [Esophageal Perforation from a Migrated Temporary Pacing Wire Undetected for Five Years After Cardiac Surgery]. Date: 2025 Dec Abstract: The patient is a 58-year-old male who underwent aortic valve replacement and
PMID: 41361936 Title: Implementing a suicide risk management protocol as part of a multisite clinical trial: Findings and lessons learned. Date: 2025 Dec 8 Abstract: INTRODUCTION: Although people with mental health disorders are more likely to die
PMID: 41361931 Title: HER2-Targeted Antibody-Drug Conjugate Toxicities in Breast Cancer. Date: 2025 Dec Abstract: BACKGROUND: HER2-targeted antibody-drug conjugates (ADCs) have dramatically
PMID: 41361897 Title: Utility of patient subgrouping in ALS clinical trials: a World Federation of Neurology white paper. Date: 2025 Dec 8 Abstract: The heterogeneity among the amyotrophic lateral sclerosis (ALS)/MND patient
PMID: 41361879 Title: Implementation of hip replacement surgery recommendations: a qualitative study of orthopaedic surgeons' perspectives. Date: 2025 Dec 8 Abstract: BACKGROUND: Total hip replacement is a common surgical procedure in which the
PMID: 41361871 Title: Mental health and body mass index in early pregnancy: a secondary analysis of three randomised controlled trials. Date: 2025 Dec 8 Abstract: OBJECTIVE: Overweight and obesity in pregnant women have been associated with an
PMID: 41361858 Title: Natriuretic peptides testing and survival prediction models for chronic heart failure: a systematic review of added prognostic value. Date: 2025 Dec 9 Abstract: BACKGROUND: High natriuretic peptide levels are associated with a poor outcome in
PMID: 41361846 Title: Effects of Video Game Based Hand Therapy on Motor Functions in Stroke Rehabilitation: A Randomized Trial. Date: 2026 Jan Abstract: BACKGROUND: Technological approaches such as virtual reality therapy, video -
PMID: 41361842 Title: Unveiling Hidden Threats: Intravascular Ultrasound-Guided Precise Intervention for Coronary Ostium Obstruction Risk in Bicuspid Transcatheter Aortic Valve Replacement. Date: 2025 Dec 8 Abstract: Coronary obstruction during transcatheter aortic valve replacement (TAVR) in
PMID: 41361833 Title: Methylome-wide association studies and epigenetic biomarker development for 133 mass spectrometry-assessed circulating proteins in 14,671 Generation Scotland participants. UK. of Edinburgh, Edinburgh, UK. Edinburgh, UK. Edinburgh, Edinburgh, UK. University of Edinburgh, Edinburgh, UK. Edinburgh, Edinburgh, UK. of Edinburgh, Edinburgh, UK. UK. UK. UK. UK. University of Zurich, Zurich, Switzerland. Edinburgh, Edinburgh, UK. Edinburgh, UK. UK. House, Guy's Campus, London, SE1 1UL, UK. Technology, Kemivagen 10, Gothenburg, SE-412 96, Sweden. al. 7, Vilnius, LT10257, Lithuania. UK. riccardo.marioni@ed.ac.uk. the GS cohort was received from the NHS Tayside Committee on Medical Research Ethics (REC Reference Number: 05/S1401/89) and Research Tissue Bank status was granted by the East of Scotland Research Ethics Service (REC Reference Number: 20/ES/0021). Participants provided written informed consent. Consent for publication: Not applicable. Competing interests: C.B., A.Z. and M.R. are co-founders of Eliptica Ltd. C.B.M. is a consultant and shareholder of Eliptica Ltd (London, UK). R.E.M. is a scientific advisor to the Epigenetic Clock Development Foundation and Optima Partners. D.L.M. is employed by Optima Partners Ltd. The other authors have no competing interests to declare. Date: 2025 Dec 8 Abstract: Methylome-wide association studies and epigenetic biomarker development for 133 mass spectrometry-assessed circulating proteins in 14,671 Generation Scotland participants. UK. of Edinburgh, Edinburgh, UK. Edinburgh, UK. Edinburgh, Edinburgh, UK. University of Edinburgh, Edinburgh, UK. Edinburgh, Edinburgh, UK. of Edinburgh, Edinburgh, UK. UK. UK. UK. UK. University of Zurich, Zurich, Switzerland. Edinburgh, Edinburgh, UK. Edinburgh, UK. UK. House, Guy's Campus, London, SE1 1UL, UK. Technology, Kemivagen 10, Gothenburg, SE-412 96, Sweden. al. 7, Vilnius, LT10257, Lithuania. UK. riccardo.marioni@ed.ac.uk. the GS cohort was received from the NHS Tayside Committee on Medical Research Ethics (REC Reference Number: 05/S1401/89) and Research Tissue Bank status was granted by the East of Scotland Research Ethics Service (REC Reference Number: 20/ES/0021). Participants provided written informed consent. Consent for publication: Not applicable. Competing interests: C.B., A.Z. and M.R. are co-founders of Eliptica Ltd. C.B.M. is a consultant and shareholder of Eliptica Ltd (London, UK). R.E.M. is a scientific advisor to the Epigenetic Clock Development Foundation and Optima Partners. D.L.M. is employed by Optima Partners Ltd. The other authors have no competing interests to declare.
PMID: 41361831 Title: The impact of DASH diet and concurrent training on cardiometabolic risk factors and gut microbiota in individuals with ischemic heart disease: a study protocol for a randomized controlled trial. Date: 2025 Dec 8 Abstract: BACKGROUND: Ischemic heart disease (IHD) has a substantial burden on individuals
PMID: 41361823 Title: Tumor marker-guided precision BNCT for CA19-9-positive cancers: a new paradigm in molecularly targeted chemoradiation therapy. Date: 2025 Dec 8 Abstract: BACKGROUND: Boron neutron capture therapy (BNCT) is a molecularly targeted
PMID: 41361814 Title: Evaluation of colorectal cancer awareness of pharmacy faculty students. Date: 2025 Dec 9 Abstract: BACKGROUND: Colorectal cancer (CRC) is the third most common type of cancer
PMID: 41361783 Title: Four cases of unique thoracic duct anatomical characteristics identified by fluorescence thoracoscopy. Date: 2025 Dec 8 Abstract: We identified one unique kind of anatomical characteristics of thoracic duct (TD)
PMID: 41361763 Title: Stent graft kinking after total arch replacement using frozen elephant trunk with E-Vita open Neo. Date: 2025 Dec 8 Abstract: BACKGROUND: Postoperative kinking of a stent graft following total arch
PMID: 41361566 Title: Biochemical and pharmacological characterization of propofol infusion syndrome risk markers following high-dose propofol. Date: 2025 Dec 8 Abstract: Propofol infusion syndrome (PRIS) is a rare, severe complication from prolonged
PMID: 41361506 Title: Comprehensive Cytopathologic, Flow Cytometric and Immunocytochemical Analysis of a Challenging Case of Small Cell Variant of Anaplastic Large T-Cell Lymphoma in a Child. Date: 2025 Dec 8 Abstract: INTRODUCTION: Anaplastic large cell lymphoma (ALCL) is a high-grade non-Hodgkin
PMID: 41361494 Title: Depression in patients with severe somatic disease - study protocol of the prospective DESIE-study. Date: 2025 Dec 9 Abstract: BACKGROUND: Depression is a big health concern and a leading cause of disability
PMID: 41361483 Title: Efficacy based on dose-response and safety of bone marrow-derived mesenchymal stem cells for the treatment of osteoarthritis: a systematic review and meta-analysis. Date: 2025 Dec 8 Abstract: INTRODUCTION: In recent years, the use of mesenchymal stem cells (MSCs),
PMID: 41361435 Title: Effectiveness of self-compassion training on resilience and reflective thinking among nursing and midwifery students: a clinical trial. Date: 2025 Dec 8 Abstract: INTRODUCTION: Challenges of academic life are major sources of stress and anxiety
PMID: 41361375 Title: Efficacy of pharmacotherapies on pediatric patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis. Date: 2025 Dec 8 Abstract: BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD)
PMID: 41361318 Title: Association analysis between CD45 lymphocyte counts and the risk of major depressive disorder: a cross-sectional study. Date: 2025 Dec 8 Abstract: The onset and progression of major depression have been closely linked to the
PMID: 41361306 Title: The effect of Kinesio tape application on postoperative pain in patients undergoing laparoscopic gynecological surgery for benign reasons: a randomized controlled study. Date: 2025 Dec 9 Abstract: OBJECTIVE: Postoperative pain management remains a significant challenge in
PMID: 41361300 Title: Salivary metabolic profile landscape for gastric cancer screening: a metabolomic approach. Date: 2025 Dec 8 Abstract: This study employed non-targeted liquid chromatography-mass spectrometry (LC-MS)
PMID: 41361289 Title: Acceptability and feasibility of Reframe-IT+U for suicidal ideation in university students: protocol of a quasi-experimental pilot study. Date: 2025 Dec 8 Abstract: BACKGROUND: Mental health in university students is a growing concern worldwide.
PMID: 41361285 Title: The Cambridge Centre for Myelin Repair trial Two (CCMR Two): a trial protocol for a phase 2a, randomised, double-blind, placebo-controlled clinical trial of the ability of the combination of metformin and clemastine to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapy. Date: 2025 Dec 8 Abstract: BACKGROUND: In multiple sclerosis (MS), progressive disability occurs following
PMID: 41361269 Title: A digitally designed and 3D-printed customized device for the three-dimensional traction of complex maxillary impacted canines: case reports. Date: 2025 Dec 8 Abstract: BACKGROUND: The traction of an impacted canine is complicated and challenging due
PMID: 41361266 Title: Comprehensive analysis of bHLH transcription factors reveals candidate regulators of flower development and heat stress response in Rhododendron simsii. Date: 2025 Dec 8 Abstract: BACKGROUND: The basic helix-loop-helix (bHLH) transcription factors constitute
PMID: 41361244 Title: Brain age gap as predictor of disease progression in Parkinson's disease. Date: 2025 Dec 8 Abstract: Parkinson's disease (PD) exhibits high heterogeneity in disease progression,
PMID: 41361237 Title: Effects of neuromuscular versus plyometric training on physical fitness and mental well-being in male pubertal soccer players. Date: 2025 Dec 8 Abstract: Neuromuscular training (NMT) and plyometric training (PT) are commonly used
PMID: 41361198 Title: Implementation of the nutrition care process on mortality risk in critically ill COVID-19 patients - a registry longitudinal cohort study. Date: 2025 Dec Abstract: BACKGROUND: COVID-19 impacts the nutritional status of patients. There is limited
PMID: 41361197 Title: Repeatability of Rapid Human Cardiac Phosphorus MRSI ((31)P-MRSI) Using Concentric Ring Trajectory Readouts at 7 T. Date: 2025 Dec 8 Abstract: PURPOSE: PCr/ATP ratio is determined at 7 T typically using Fourier-transform
PMID: 41361183 Title: Monitoring rapid degradation of NANOG reveals UTP15 maintains pluripotency by regulating nascent transcripts. Date: 2025 Dec 8 Abstract: Master transcription factors (MTFs) are key regulators in cell fate
PMID: 41361176 Title: Urate-lowering therapy and kidney outcomes in patients with chronic kidney disease and hyperuricemia. Date: 2025 Dec 9 Abstract: Hyperuricemia is considered a modifiable risk factor for the development and
PMID: 41361175 Title: Adjuvant benmelstobart plus anlotinib in patients with high-risk recurrence after resection of hepatocellular carcinoma: a phase II study (ALTER-H006). Date: 2025 Dec 8 Abstract: This phase II study (ALTER-H006; NCT05111366) evaluates adjuvant benmelstobart
PMID: 41361170 Title: ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer. Date: 2025 Dec 9 Abstract: Small cell lung cancer (SCLC) is characterized by its highly aggressive phenotype
PMID: 41361156 Title: Aerobic training conducted at different times of day in elderly patients with hypertension: a controlled trial. Date: 2025 Dec 9 Abstract: Previous data showed greater blood pressure (BP) reduction after aerobic training
PMID: 41361151 Title: Impact of Tranexamic Acid in Breast Plastic Surgery: A Systematic Review and Meta-Analysis. Date: 2025 Dec 8 Abstract: BACKGROUND: Tranexamic acid (TXA) is increasingly used in plastic surgery because
PMID: 41361133 Title: [Iron deficiency in heart failure - a practical guide for diagnosis and therapy]. Date: 2025 Dec Abstract: BACKGROUND: A common comorbidity in heart failure is iron deficiency, which
PMID: 41361072 Title: Predictors of virological outcomes after analytical interruption of antiretroviral therapy and HTI vaccination in early treated people with HIV-1._. Date: 2025 Dec 8 Abstract: BACKGROUND: Randomized, placebo-controlled clinical trials (RCTs) that include
PMID: 41361069 Title: Effect of ozone therapy on post-operative pain following mandibular third molar surgical extraction: a split-mouth randomized clinical trial. Date: 2025 Dec 9 Abstract: OBJECTIVES: To evaluate the efficacy of ozone therapy on pain reduction, trisma
PMID: 41361045 Title: Preparing to Meet the Needs of a Growing Older Adult Population with Type 1 Diabetes: A Narrative Review. Date: 2025 Dec 8 Abstract: The prevalence of diabetes is rising among older adults. While most diabetes
PMID: 41361044 Title: Peripheral Artery Disease in US Primary Care Practices: A Retrospective EHR-Based Analysis from 2018 to 2022. Date: 2025 Dec 8 Abstract: BACKGROUND: Peripheral artery disease (PAD) affects > 10 million adults over age
PMID: 41361015 Title: Comparing content within a culturally-adapted digital treatment for Hispanic patients with alcohol use disorder. Date: 2025 Dec 8 Abstract: Hispanic people in the U.S. experience alcohol-related harms comparable to
PMID: 41361008 Title: Saturation mutagenesis identifies activating and resistance-inducing FGFR kinase domain mutations. Date: 2025 Dec 8 Abstract: Variants of uncertain significance represent the biggest challenge for
PMID: 41360995 Title: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial. Date: 2025 Dec 8 Abstract: Intrathecal onasemnogene abeparvovec (OAV101 IT) may enable a one-time gene
PMID: 41360993 Title: Intrathecal onasemnogene abeparvovec in treatment-naive patients with spinal muscular atrophy: a phase 3, randomized controlled trial. Date: 2025 Dec 8 Abstract: STEER ( NCT05089656 ) was a 52-week, phase 3, multicenter, randomized,
PMID: 41360986 Title: Targeting phagocytosis checkpoints for cancer immunotherapy. Date: 2025 Dec 8 Abstract: The ability of macrophages to eliminate cancer cells through phagocytosis is
PMID: 41360842 Title: Whole mastic resin ameliorates halitosis and gingivitis in dogs and cats infected with Porphyromonas gulae. Date: 2025 Dec 8 Abstract: Mastic, a natural resin, has long been used to prevent periodontal disease, but
PMID: 41360775 Title: Predictive models of melanoma metastasis based on dermatoscopy in an international retrospective human reader study. Date: 2025 Dec 8 Abstract: Current melanoma prognostic tools have limited clinical use at the bedside,
PMID: 41360730 Title: Humoral and functional SARS-CoV-2-specific T-cell responses elicited in chronic lymphocytic leukaemia patients with GEO-CM04S1 a synthetic MVA-vectored COVID-19 vaccine. City of Hope National Medical Center, Duarte, California, USA. Mexico. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. USA. USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. Date: 2025 Dec 8 Abstract: Humoral and functional SARS-CoV-2-specific T-cell responses elicited in chronic lymphocytic leukaemia patients with GEO-CM04S1 a synthetic MVA-vectored COVID-19 vaccine. City of Hope National Medical Center, Duarte, California, USA. Mexico. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. USA. USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA. City of Hope National Medical Center, Duarte, California, USA.
PMID: 41360729 Title: Cost-Effectiveness of Cryopreserved vs Liquid-Stored Platelets for Managing Surgical Bleeding. Date: 2025 Dec 1 Abstract: IMPORTANCE: Platelet transfusion is critical in managing major bleeding, but
PMID: 41360717 Title: Cryopreserved vs Liquid-Stored Platelets for the Treatment of Surgical Bleeding: The CLIP-II Randomized Noninferiority Clinical Trial. Date: 2025 Dec 8 Abstract: IMPORTANCE: Liquid-stored platelets have a shelf-life of 5 to 7 days, limiting
PMID: 41360681 Title: Riding a Golf Cart Versus Walking: A Study on the Physiological and Performance Differences in Tournament Golf. Date: 2026 Jan Abstract: Golf demands sustained physical effort and effective fatigue management,
PMID: 41360656 Title: A systematic review of randomized controlled trials on telecommunication technologies for pain management in patients with advanced cancer: incorporating electronic patient-reported outcomes (ePROs). Date: 2025 Nov Abstract: BACKGROUND: Pain is prevalent among cancer patients and impairs quality of life.
PMID: 41360639 Title: A Phase II Pilot Study of Anti-PD-L1, Durvalumab, and a PARP Inhibitor, Olaparib in Patients With Metastatic Triple-Negative Breast Cancer With or Without Germline BRCA Mutation. Date: 2025 Dec Abstract: BACKGROUND: Immunostimulatory effects of PARP inhibitors could increase
PMID: 41360613 Title: Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol. Date: 2025 Dec 7 Abstract: INTRODUCTION: International organisations, scientists and the tuberculosis (TB)
PMID: 41360583 Title: Multidrug-resistant tuberculosis of the knee: A case report describing challenges in diagnosis and treatment. Date: 2025 Dec Abstract: Multidrug-resistant tuberculosis (MDR-TB) of osteoarticular sites poses
PMID: 41360582 Title: The spectrum of extra pulmonary tuberculosis: Emphasizing the importance of microbiological diagnosis- A case series. Date: 2025 Dec Abstract: Infections caused by Mycobacterium tuberculosis mostly involve the lungs.
PMID: 41360497 Title: Vaginal repair of a complex supratrigonal vesicovaginal fistula. Date: 2025 Dec 5 Abstract: Vesicovaginal fistula (VVF) is one of the most common iatrogenic complications of
PMID: 41360496 Title: Carisoprodol poisoning with serotonin toxicity. Date: 2025 Dec 7 Abstract: Due to the implementation of stricter regulations in many countries, carisoprodol
PMID: 41360495 Title: Silent yet severe: inferior vena cava thrombosis associated with platypnoea-orthodeoxia. Is uterine sarcoma the culprit? Date: 2025 Dec 5 Abstract: An elderly lady with a background of surgically treated uterine stromal sarcoma
PMID: 41360494 Title: Umbilical cord haemangioma with pseudocyst detected in the first trimester of pregnancy. Date: 2025 Dec 5 Abstract: This study describes a case of an umbilical cord haemangioma diagnosed during a
PMID: 41360493 Title: Reversible pulmonary hypertension in a patient diagnosed with scurvy. Date: 2025 Dec 5 Abstract: This case report describes a woman in her late 50s with reversible pulmonary
PMID: 41360492 Title: Aggregatibacter actinomycetocomitans prosthetic valve endocarditis causing sequential transient ischaemic attack, rheumatoid factor-positive inflammatory polyarthritis and intracerebral haemorrhage. Date: 2025 Dec 7 Abstract: Subacute bacterial endocarditis is often associated with non-specific symptoms
PMID: 41360491 Title: Osteoid osteoma of coracoid. Date: 2025 Dec 7 Abstract: Most common pathologies resulting in shoulder pain are usually a consequence of
PMID: 41360490 Title: Two-stage management of a large tibial tunnel cyst and secondary meniscal root tear after anterior cruciate ligament reconstruction. Date: 2025 Dec 5 Abstract: This report describes the case of a woman in her 40s who developed debilitating
PMID: 41360489 Title: Expectant management of missed miscarriage in a post-trachelectomy patient with permanent cervical cerclage. Date: 2025 Dec 7 Abstract: A woman in her 30s with a history of simple trachelectomy and permanent cervical
PMID: 41360488 Title: Suicide attempt by cutting an LVAD wire: psychiatric complications in patients with heart failure. Date: 2025 Dec 5 Abstract: A man in his 50s known to have heart failure with left ventricular assist device
PMID: 41360487 Title: Primary bladder perivascular epithelioid cell tumour in an early adolescent. Date: 2025 Dec 7 Abstract: Primary bladder perivascular epithelioid cell tumours (PEComas) are rare tumours
PMID: 41360486 Title: Acute necrotising encephalopathy (ANE) due to influenza: an unrecognised encephalopathy in childhood. Date: 2025 Dec 7 Abstract: Acute necrotising encephalopathy (ANE) of childhood is a rare, rapidly
PMID: 41360476 Title: Intranasal dexmedetomidine for perioperative sleep disturbance: a protocol for a systematic review with meta-analysis and trial sequential analysis. Date: 2025 Dec 5 Abstract: INTRODUCTION: Perioperative sleep disturbance (PSD) can adversely affect
PMID: 41360470 Title: International evaluation of the SEIZUre Risk in Encephalitis (SEIZURE) score for predicting acute seizure risk. Date: 2025 Dec 7 Abstract: OBJECTIVE: Encephalitis is brain parenchyma inflammation, frequently resulting in
PMID: 41360461 Title: Assessing the feasibility of a platform trial for Gram negative bloodstream infections: results from the vanguard phase of BALANCE. Date: 2025 Dec 5 Abstract: OBJECTIVES: Gram negative bloodstream infections (GN BSI) are a leading cause of
PMID: 41360460 Title: Matrix-directed therapy losartan to identify the effect on the bone resorption marker carboxy-terminal crosslink of type I collagen telopeptide (CTX) in older adolescents and adults with osteogenesis imperfecta recruited from secondary care sites: the 'MOI-A' study; a randomised, phase 2/pilot, dose-escalating trial. Date: 2025 Dec 7 Abstract: INTRODUCTION: Osteogenesis imperfecta (OI) is the most common inherited cause of
PMID: 41360452 Title: Digital App for Speech and Health Monitoring Study (DASH): protocol for a prospective longitudinal case-control observational study for developing speech datasets in neurodegenerative disorders and dementia. Date: 2025 Dec 5 Abstract: INTRODUCTION: Neurodegenerative disorders (NDDs) represent an unprecedented
PMID: 41360445 Title: NeuroMusic: protocol for a randomised-controlled trial of keyboard and singing music training programmes for older adults with mild cognitive impairment. Date: 2025 Dec 7 Abstract: INTRODUCTION: Music-based training programmes, such as learning how to play an
PMID: 41360441 Title: Comparative evaluation of a hybrid machine learning-human adjudication paradigm for endoscopic scoring in ulcerative colitis. Date: 2025 Dec 7 Abstract: OBJECTIVE: Endoscopic scoring of disease activity is essential in ulcerative
PMID: 41360440 Title: Parasitic colitis misdiagnosis as inflammatory bowel disease in high-income settings and association with poor clinical outcomes when exposed to corticosteroids: a systematic review of case reports. Date: 2025 Dec 5 Abstract: OBJECTIVES: Parasitic colitis is highly prevalent worldwide, may mimic
PMID: 41360427 Title: Synergistic potential of sipuleucel-T in enhancing immunotherapy for metastatic castration-resistant prostate cancer. Date: 2025 Dec 5 Abstract: Clinical trials of immunotherapy in metastatic castration-resistant prostate
PMID: 41360408 Title: Ischemic Stroke in Hypereosinophilic Syndrome: A Clinicopathologic Study of Two Cases. Date: 2026 Feb Abstract: Ischemic stroke is a rare complication of hypereosinophilic syndrome (HES).
PMID: 41360356 Title: The Association Between Common NSAID Use and Early Dental Implant Failure: A Large-Scale Retrospective Cohort Study. Date: 2025 Dec 6 Abstract: INTRODUCTION: The impact of NSAIDs on osseointegration remains controversial,
PMID: 41360348 Title: Sex Differences in Immunotherapy Plus Chemotherapy: A Systematic Review and Meta-Analysis. Date: 2025 Dec 6 Abstract: BACKGROUND: Sex-based differences in immune response and cancer biology may
PMID: 41360327 Title: Subconjunctival Seeding of Ciliary Body Melanoma After Trabeculectomy: A Surgical Pitfall. Date: 2025 Dec 6 Abstract: A rare case of ciliary body melanoma (CBM) with subconjunctival extension
PMID: 41360285 Title: A Rare Case of Acquired Reactive Perforating Collagenosis in a Child With Type 1 Diabetes. Electronic address: rroman.med@gmail.com. Date: 2025 Dec 6 Abstract: A Rare Case of Acquired Reactive Perforating Collagenosis in a Child With Type 1 Diabetes. Electronic address: rroman.med@gmail.com.
PMID: 41360284 Title: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Topical Carbonic Anhydrase Inhibitors: A Literature review. Electronic address: laaguilar12@gmail.com. Date: 2025 Dec 6 Abstract: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Topical Carbonic Anhydrase Inhibitors: A Literature review. Electronic address: laaguilar12@gmail.com.
PMID: 41360221 Title: Shifting global drug discovery landscape and the critical role of startups in strengthening national capabilities. Date: 2025 Dec 6 Abstract: This study examines the relationship between startup growth and national drug
PMID: 41360166 Title: Association of Cardiometabolic and Lifestyle Risk Variables with High-Density Lipoprotein Metabolites in Hypertensive and Normotensive Overweight Women: Findings from a Randomized Trial of Mixed Dietary Fibers. Date: 2025 Dec 6 Abstract: BACKGROUND & AIMS: Limited knowledge exists regarding the protective effects of
PMID: 41360153 Title: Clinical translation and landscape of superparamagnetic iron oxide nanoparticles. Date: 2025 Dec 6 Abstract: Since their initial clinical approval as liver imaging agents nearly three
PMID: 41360151 Title: Anesthetic Management of a Patient With Ankylosing Spondylitis Undergoing Orthognathic Surgery. Date: 2025 Dec 9 Abstract: Ankylosing spondylitis (AS) is a chronic disease that causes inflammation in the
PMID: 41360141 Title: Bio-Monitor Detects Reduced Obstructive Sleep Apnea and Susceptibility to Arrhythmia in Spaceflight. Date: 2025 Dec Abstract: BACKGROUND: Attenuation of sleep disordered breathing in astronauts entering
PMID: 41360140 Title: Anesthetic Management of a Patient With Myhre Syndrome. Date: 2025 Dec 9 Abstract: Myhre syndrome (MS) is a rare genetic connective tissue disorder characterized by
PMID: 41360139 Title: Comparing Etizolam and Music Distraction on Inferior Alveolar Nerve Block Success in Patients With Symptomatic Irreversible Pulpitis: A Randomized Clinical Trial. Date: 2025 Dec 9 Abstract: OBJECTIVE: Anxious patients report more pain during endodontic therapy. This
PMID: 41360138 Title: Two Cases of Incidental Pulmonary Nodules and Rare Lung Neoplasms. Date: 2025 Dec Abstract: BACKGROUND: Growing access to and use of chest CT has increased the incidental
PMID: 41360136 Title: Anesthetic Management of a Dental Patient With Familial Mediterranean Fever. Date: 2025 Dec 9 Abstract: We present the anesthetic management of a 32-year-old patient diagnosed with
PMID: 41360116 Title: Validation of US Consensus Eligibility Criteria for Front-Line DLBCL Trials. Date: 2025 Dec 8 Abstract: Identifying patients eligible for front-line clinical trials with diffuse large
PMID: 41360113 Title: Anesthetic Management Using Remimazolam for Dental Treatment in a Pediatric Patient With Dravet Syndrome. Date: 2025 Dec 9 Abstract: Dravet syndrome (DS) is a rare, severe form of epilepsy characterized by seizures
PMID: 41360106 Title: Ambulatory General Anesthesia for Dental Treatment in a Patient With Williams Syndrome and Supravalvular Aortic Restenosis: A Case Report. Date: 2025 Dec 9 Abstract: Williams syndrome (WS) is a genetic disorder marked by intellectual disability,
PMID: 41360071 Title: The association of pain with intrinsic capacity and the moderating role of inflammation in France: a cross-sectional analysis of the INSPIRE-T project. Date: 2025 Dec 5 Abstract: BACKGROUND: Although pain singularly impacts most critical domains of health
PMID: 41359994 Title: Recommendations for Improving EHR Transitions: Nursing Perspectives From Three Healthcare Systems. Date: 2026 Jan 1 Abstract: BACKGROUND: Transitions from one electronic health record (EHR) to another are
PMID: 41359984 Title: Predictors of Inpatient RN Turnover in Rural and Urban VHA Hospitals. Date: 2026 Jan 1 Abstract: BACKGROUND: The rising demand for health care delivery and an aging workforce is
PMID: 41359953 Title: Virtual Standardized Patients for Improving Clinical Thinking Ability Training in Residents: Randomized Controlled Trial. Date: 2025 Dec 8 Abstract: BACKGROUND: Clinical internal medicine practice training traditionally relies on
PMID: 41359937 Title: The Effects of Teleinterventions on Pediatric Weight Control: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Date: 2025 Dec 8 Abstract: BACKGROUND: Childhood overweight or obesity has become one of the world's most
PMID: 41359921 Title: Outcomes of Team-Based Digital Monitoring of Patients With Multiple Chronic Conditions: Semiparametric Event Study. Date: 2025 Dec 8 Abstract: BACKGROUND: Remote patient monitoring (RPM) has emerged as an effective strategy
PMID: 41359897 Title: GNE Mutation-Related Congenital Thrombocytopenia in 2 Siblings: Case Reports and Literature Review. Date: 2025 Nov 20 Abstract: BACKGROUND: GNE mutations are rare pathologic conditions that can cause severe
PMID: 41359860 Title: Intrusive Memory Frequency and Related Inner Tension Following Dialectical Behavior Therapy or Cognitive Processing Therapy for Posttraumatic Stress Disorder: An e-Diary Study. Date: 2025 Dec 8 Abstract: BACKGROUND: Intrusive memories are a core symptom of posttraumatic stress
PMID: 41359796 Title: Immune thrombocytopenia in patients treated with immune checkpoint inhibitors. Date: 2025 Dec 8 Abstract: Immune checkpoint inhibitor-associated immune thrombocytopenia (ICI-ITP) has been
PMID: 41359794 Title: Incretin receptor agonism during pregnancy: implications for mother and baby. Date: 2025 Dec 8 Abstract: Obesity has been described by the WHO as the largest health threat facing
PMID: 41359790 Title: Myocarditis and Pericarditis as a Complication of Mpox: Case Series and Literature Review. Date: 2026 Jan 1 Abstract: Monkeypox virus is a DNA virus in the orthopoxvirus family, and a multicountry
PMID: 41359696 Title: A Ubiquitous Platform for Camera-Based Multi-Parameter Vital Signs Monitoring in Hospital ICUs: A Double-Center Clinical Study. Date: 2025 Dec Abstract: Conventional physiological monitoring relies on multiple contact-based biomedical
PMID: 41359652 Title: A multi-mineral intervention to improve disease-related and mechanistic biomarkers in ulcerative colitis patients: Results from a randomized trial. Date: 2025 Abstract: INTRODUCTION: The long-term goal of our ongoing studies is to determine if, and
PMID: 41359611 Title: Smartphone-supported Positive Adjustment Coping Intervention (PACI) for couples undergoing fertility treatment: A randomised controlled trial. Date: 2025 Abstract: BACKGROUND: Couples undergoing fertility treatment experience emotional stress.
PMID: 41359603 Title: Primary ALK-Negative Anaplastic Large Cell Lymphoma Mimicking Septic Arthritis in a Diabetic Patient: Diagnostic and Therapeutic Challenges. Date: 2025 Nov 18 Abstract: Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma (ALCL)
PMID: 41359595 Title: Clinical Efficacy of Combined Internal and External Fixation with Nanosilver Dressing and Vacuum Closure for Gustilo Type I/II Open Tibial Fractures. Date: 2025 Nov 18 Abstract: Gustilo type I and II open tibial fractures (OTFs) are associated with
PMID: 41359564 Title: Diagnosis and Management of Duodenal Bulb Neuroendocrine Carcinoma with Liver Metastases: A Case Report and Literature Review. Date: 2025 Nov 21 Abstract: Duodenal bulb neuroendocrine carcinoma (NEC), a subtype of neuroendocrine
PMID: 41359563 Title: Diagnostic Challenges of Cerebral Venous Thrombosis Mimicking Brain Tumor: A Case Report. Date: 2025 Dec 8 Abstract: BACKGROUND Cerebral venous thrombosis is a rare but critical stroke subtype that
PMID: 41359540 Title: Phase 1, randomized, crossover study comparing intravenous GTX-104 to oral nimodipine in healthy human subjects. Date: 2025 Abstract: Enterally-administered nimodipine is the only approved drug formulation available
PMID: 41359501 Title: A systematic review of pregabalin: Therapeutic benefits, psychological risks, and case reports analysis. Date: 2025 Dec 8 Abstract: Pregabalin, a gamma-aminobutyric acid analogue, is extensively used for
PMID: 41359484 Title: Bilateral Obstructive Uropathy From Enormous Inguinoscrotal Bladder Hernia. Wales, Australia. Wales, Australia. Wales, Australia. Date: 2025 Dec 8 Abstract: Bilateral Obstructive Uropathy From Enormous Inguinoscrotal Bladder Hernia. Wales, Australia. Wales, Australia. Wales, Australia.
PMID: 41359436 Title: Technological advances in mRNA delivery and engineering for therapeutic cancer vaccines. Date: 2025 Dec 8 Abstract: Messenger RNA (mRNA) offers a powerful platform for therapeutic cancer vaccines.
PMID: 41359430 Title: Pediatric Giant-Cell Tumor of Bone With Secondary Aneurysmal Bone Cyst Causing Orbital Apex Syndrome. Date: 2025 Nov-Dec Abstract: Giant-cell tumors of bone (GCTBs) are benign, expansile lesions usually found in
PMID: 41359429 Title: Leukemic Optic Neuropathy Secondary to Blastic Plasmacytoid Dendritic Cell Neoplasm in a Child. Date: 2025 Nov-Dec Abstract: A healthy 17-year-old boy was diagnosed as having blastic plasmacytoid dendritic
PMID: 41359425 Title: Whole Exome Sequencing in Incontinentia Pigmenti: A ROP Mimicker and the Genetic Detection Dilemma. Date: 2025 Nov-Dec Abstract: Incontinentia pigmenti is an X-linked dominant multisystemic disorder caused by
PMID: 41359350 Title: Toripalimab-Based Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma-Reply. Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China. Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China. Date: 2025 Dec 8 Abstract: Toripalimab-Based Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma-Reply. Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China. Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.
PMID: 41359336 Title: Effects of Hatha Yoga vs Physical Conditioning on Sleep in Women With Urinary Incontinence: A Secondary Analysis of a Randomized Clinical Trial. Date: 2025 Dec 1 Abstract: IMPORTANCE: Yoga, an integrative health practice combining movement and
PMID: 41359335 Title: Home-Based Gamma Transcranial Alternating Current Stimulation in Patients With Alzheimer Disease: A Randomized Clinical Trial. Date: 2025 Dec 1 Abstract: IMPORTANCE: Alzheimer disease (AD) is characterized by dysregulated gamma brain
PMID: 41359334 Title: Preoperative Weight Loss in Patients With Excess Weight and Colorectal Cancer: The CARE Feasibility Randomized Clinical Trial. Date: 2025 Dec 1 Abstract: IMPORTANCE: Excess weight increases morbidity risk after colorectal cancer
PMID: 41359294 Title: Fatal Triad of Subarachnoid Hemorrhage, Cervical Hematoma, and Upper Airway Obstruction in a Patient With Neurofibromatosis Type 1: A Case Report. Date: 2025 Dec 1 Abstract: BACKGROUND: Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic
PMID: 41359276 Title: Effects of self-management on quality of life in patients with head and neck cancer: a systematic review. Date: 2025 Dec 8 Abstract: PURPOSE: Head and neck cancer is the seventh most common cancer globally. With
PMID: 41359273 Title: Fourth ventricular hamartoma presenting with epileptic spasms: case-based review and surgical considerations. Date: 2025 Dec 8 Abstract: INTRODUCTION: Fourth ventricular hamartomas (FVHs) are extremely rare lesions,
PMID: 41359255 Title: Development of mRNA Cancer Vaccines: Delivery Strategies and Immunogenicity Optimization. Date: 2025 Dec 8 Abstract: mRNA vaccines have emerged as a transformative platform in oncology, offering
PMID: 41359232 Title: Pulsed field ablation and the risk of hemolysis-driven acute kidney injury: a systematic review and meta-analysis. Date: 2025 Dec 8 Abstract: BACKGROUND: Pulsed-field ablation (PFA) has emerged as a potentially safer
PMID: 41359217 Title: Bimekizumab Impact on Patient-Reported Outcomes in Plaque Psoriasis: 4-Year Results from BE SURE, BE VIVID, BE READY, and BE BRIGHT. Date: 2025 Dec 8 Abstract: INTRODUCTION: While bimekizumab has demonstrated rapid, superior clinical
PMID: 41359216 Title: A Post Hoc Analysis of Atopic Dermatitis of the Head and Neck and Other Body Regions from the Amlitelimab STREAM-AD Phase 2b Study. Date: 2025 Dec 8 Abstract: INTRODUCTION: Amlitelimab (SAR445229, KY1005), a nondepleting anti-OX40 ligand
PMID: 41359133 Title: Curcumin-based biocompatible nanocarriers: a contemporary perspective in functional foods and biomedical applications. Date: 2025 Dec 8 Abstract: Curcumin, a naturally occurring polyphenolic compound derived from Curcuma longa,
PMID: 41359127 Title: Methotrexate osteopathy in rheumatoid arthritis. Date: 2025 Dec 8 Abstract: Methotrexate (MTX) is one of the most commonly used therapeutic agents for
PMID: 41359125 Title: Thoracic Ultrasound-Guided Regional Nerve Blockade for Pain Management Following Open Heart Surgery in Children: A Systematic Review and Network Meta-analysis of Analgesic Efficacy and Impact on Postoperative Opioid Requirements. Date: 2025 Dec 8 Abstract: A new era of multimodal opioid-sparing pain management strategies has begun,
PMID: 41359114 Title: Is our food safe? Microplastic occurrence and characteristics in vegetables cultivated in the vicinity of a municipal solid waste dumping ground-insights from Kolkata, India. Date: 2025 Dec 8 Abstract: The propagation of plastic pollution has triggered widespread microplastics (MPs)
PMID: 41359092 Title: Systematic review: The management of unhealed wounds and persistent perineal sinuses following proctectomy in inflammatory bowel disease. Date: 2025 Dec 8 Abstract: INTRODUCTION: Unhealed wounds and persistent perineal sinuses (PPS) may occur in
PMID: 41359083 Title: Rilzabrutinib: First Approval. Date: 2025 Dec 8 Abstract: Rilzabrutinib (WAYRILZ) is a small-molecule, reversible, highly specific,
PMID: 41359080 Title: Management of hypopituitarism during pregnancy in patients with PROP1-related combined pituitary hormone deficiency: Review of the literature with a case report. Date: 2025 Dec 8 Abstract: BACKGROUND: The management of pregnancy in patients with combined pituitary
PMID: 41359077 Title: Scaphoid nonunion in the presence of a Scapho-Lunate coalition: a rare case report. Date: 2025 Dec 8 Abstract: INTRODUCTION: Carpal coalitions are rare congenital anomalies, with an estimated

SafetyReportID: 5801206-7 Date: 20080707 Report: SafetyReportID: 5801206-7 | ReceiveDate: 20080707 | Drugs: DURAGESIC-100 | Reactions: DRUG ADMINISTRATION ERROR, OVERDOSE
SafetyReportID: 10003300 Date: 20140306 Report: SafetyReportID: 10003300 | ReceiveDate: 20140306 | Drugs: BONIVA | Reactions: Vomiting, Diarrhoea, Arthralgia, Headache
SafetyReportID: 10003301 Date: 20140228 Report: SafetyReportID: 10003301 | ReceiveDate: 20140228 | Drugs: IBUPROFEN | Reactions: Dyspepsia, Renal impairment
SafetyReportID: 10003302 Date: 20140312 Report: SafetyReportID: 10003302 | ReceiveDate: 20140312 | Drugs: LYRICA | Reactions: Drug ineffective
SafetyReportID: 10003304 Date: 20140312 Report: SafetyReportID: 10003304 | ReceiveDate: 20140312 | Drugs: DOXYCYCLINE HYCLATE, TRAMADOL HYDROCHLORIDE, OXYCONTIN, TALWIN, CODEINE, IODINE, ASPIRIN, LORTAB, FIORINAL | Reactions: Drug hypersensitivity
SafetyReportID: 10003305 Date: 20140312 Report: SafetyReportID: 10003305 | ReceiveDate: 20140312 | Drugs: LIPITOR, LISINOPRIL, LOSARTAN POTASSIUM, METOPROLOL TARTRATE, MINOCYCLINE, BACTRIM | Reactions: Drug hypersensitivity
SafetyReportID: 10003306 Date: 20140312 Report: SafetyReportID: 10003306 | ReceiveDate: 20140312 | Drugs: LETAIRIS, TYVASO | Reactions: Cough, Throat irritation
SafetyReportID: 10003307 Date: 20140312 Report: SafetyReportID: 10003307 | ReceiveDate: 20140312 | Drugs: LETAIRIS, OXYGEN., LETAIRIS | Reactions: Rhinorrhoea
SafetyReportID: 10003308 Date: 20140312 Report: SafetyReportID: 10003308 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Unevaluable event, Malaise
SafetyReportID: 10003309 Date: 20140312 Report: SafetyReportID: 10003309 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Hepatic enzyme increased
SafetyReportID: 10003310 Date: 20140312 Report: SafetyReportID: 10003310 | ReceiveDate: 20140312 | Drugs: LYRICA, METOPROLOL, XANAX, LETAIRIS, ADCIRCA, ZOCOR, ADVAIR HFA, ASPIRIN., NEXIUM, TRIAMTERENE., SPIRIVA | Reactions: Back pain
SafetyReportID: 10003311 Date: 20140312 Report: SafetyReportID: 10003311 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS, LETAIRIS, TRACLEER | Reactions: Oedema peripheral, Fluid retention
SafetyReportID: 10003312 Date: 20140312 Report: SafetyReportID: 10003312 | ReceiveDate: 20140312 | Drugs: ILARIS, ILARIS, PREDNISONE, RELPAX, ULTRACET, AMBIEN | Reactions: Pneumonia, Drug ineffective
SafetyReportID: 10003313 Date: 20140312 Report: SafetyReportID: 10003313 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS, LETAIRIS | Reactions: Swelling, Jaundice
SafetyReportID: 10003314 Date: 20140312 Report: SafetyReportID: 10003314 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Back pain
SafetyReportID: 10003315 Date: 20140312 Report: SafetyReportID: 10003315 | ReceiveDate: 20140312 | Drugs: RANOLAZINE | Reactions: Death
SafetyReportID: 10003316 Date: 20140312 Report: SafetyReportID: 10003316 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Oedema, Fatigue, Dyspnoea exertional, Fluid retention
SafetyReportID: 10003317 Date: 20140312 Report: SafetyReportID: 10003317 | ReceiveDate: 20140312 | Drugs: BENLYSTA, PLAQUENIL, PREDNISONE | Reactions: Angioedema, Laryngeal oedema, Face oedema
SafetyReportID: 10003318 Date: 20140312 Report: SafetyReportID: 10003318 | ReceiveDate: 20140312 | Drugs: BELIMUMAB, AZATHIOPRINE, PREDNISONE, FLUOXETINE, CLONAZEPAM, CALCIUM CARBONATE, VITAMIN D, OMEPRAZOLE | Reactions: Tuberculosis of central nervous system
SafetyReportID: 10003319 Date: 20140312 Report: SafetyReportID: 10003319 | ReceiveDate: 20140312 | Drugs: BENLYSTA, PLAQUENIL, FOLTX, CYMBALTA, XANAX, PERCOCET, NEXIUM, SUMATRIPTAN, METHOTREXATE, IBUPROFEN | Reactions: Cholecystectomy, Nephrolithiasis, Biliary tract disorder, Malaise
SafetyReportID: 10003320 Date: 20140312 Report: SafetyReportID: 10003320 | ReceiveDate: 20140312 | Drugs: TYVASO, LOSARTAN., LETAIRIS, LOSARTAN., LETAIRIS | Reactions: Headache, Hypotension
SafetyReportID: 10003321 Date: 20140312 Report: SafetyReportID: 10003321 | ReceiveDate: 20140312 | Drugs: ACETAMINOPHEN., OFATUMUMAB, BAKTAR, ZYLORIC, CHINESE MEDICINE, TAKEPRON, ITRIZOLE, PREDNISOLONE., PREDNISOLONE., OFATUMUMAB, ACETAMINOPHEN., POLARAMINE, POLARAMINE | Reactions: Adenoviral haemorrhagic cystitis, Pyrexia
SafetyReportID: 10003322 Date: 20140312 Report: SafetyReportID: 10003322 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Tremor
SafetyReportID: 10003323 Date: 20140312 Report: SafetyReportID: 10003323 | ReceiveDate: 20140312 | Drugs: PRADAXA | Reactions: Fall, Pain in extremity, Hiccups
SafetyReportID: 10003324 Date: 20140312 Report: SafetyReportID: 10003324 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Malaise, Ocular hyperaemia
SafetyReportID: 10003325 Date: 20140312 Report: SafetyReportID: 10003325 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Swelling
SafetyReportID: 10003326 Date: 20140312 Report: SafetyReportID: 10003326 | ReceiveDate: 20140312 | Drugs: CEFTRIAXONE, METRONIDAZOLE | Reactions: Meconium stain, Amniotic cavity infection, Maternal exposure during pregnancy
SafetyReportID: 10003327 Date: 20140312 Report: SafetyReportID: 10003327 | ReceiveDate: 20140312 | Drugs: PREDNISONE, DEXAMETHASONE, METHOTREXATE | Reactions: Respiratory failure, Listeriosis, Pyrexia, Headache, Vomiting, Mental status changes, Meningitis, Pneumonia staphylococcal
SafetyReportID: 10003328 Date: 20140312 Report: SafetyReportID: 10003328 | ReceiveDate: 20140312 | Drugs: PACLITAXEL, DOCETAXEL, ADRIAMYCIN, CYCLOPHOSPHAMIDE | Reactions: Type IV hypersensitivity reaction, Skin toxicity, Palmar-plantar erythrodysaesthesia syndrome, Nail toxicity, Arthralgia, Myalgia, Asthenia, Diarrhoea, Neuropathy peripheral
SafetyReportID: 10003329 Date: 20140312 Report: SafetyReportID: 10003329 | ReceiveDate: 20140312 | Drugs: PARACETAMOLO, BIBW 2992, LANSOPRAZOLO, INSULINA GLARGINE, IDROCLOROTIAZ, IRBESARTAN., POTASSIUM CHLORIDE., BIBW 2992, INSULINA GLULISINA, PARACETAMOLO, FUROSEMIDE., ZOLPIDEM, NEBIVOLOLO, IDROCLOROTIAZ, OSSICODONE, OSSICODONE, ALLOPURINOLO, CALCIUM CARBONATE., NORITREN, RANITIDINE, IRBESARTAN., RANITIDINE | Reactions: Diarrhoea, Abdominal pain, Asthenia, Diarrhoea, Weight decreased, Abdominal pain, Blood creatinine increased, C-reactive protein increased, Dysuria, Pyrexia, Blood creatinine increased, C-reactive protein increased, Pleural effusion
SafetyReportID: 10003330 Date: 20140312 Report: SafetyReportID: 10003330 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Feeling abnormal
SafetyReportID: 10003331 Date: 20140312 Report: SafetyReportID: 10003331 | ReceiveDate: 20140312 | Drugs: MIRENA, CARBAMAZEPINE | Reactions: Chemical poisoning, Neck pain, Back pain, Paraesthesia
SafetyReportID: 10003332 Date: 20140312 Report: SafetyReportID: 10003332 | ReceiveDate: 20140312 | Drugs: PRADAXA, LOSARTAN, CRESTOR, DIABETES MEDICATION | Reactions: Proctalgia, Anorectal discomfort, Rectal haemorrhage
SafetyReportID: 10003333 Date: 20140312 Report: SafetyReportID: 10003333 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Swelling
SafetyReportID: 10003334 Date: 20140312 Report: SafetyReportID: 10003334 | ReceiveDate: 20140312 | Drugs: SPIRIVA | Reactions: Dry mouth, Product quality issue
SafetyReportID: 10003335 Date: 20140312 Report: SafetyReportID: 10003335 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Localised oedema, Oedema peripheral, Fluid retention, Nasal congestion
SafetyReportID: 10003336 Date: 20140312 Report: SafetyReportID: 10003336 | ReceiveDate: 20140312 | Drugs: JANUMET, JANUVIA | Reactions: Metastases to spine, Anxiety, Renal cyst, Metastases to thorax, Metastases to retroperitoneum, Emotional disorder, Pancreatic carcinoma metastatic, Metastases to liver, Metastases to lung, Emotional distress, Lymphadenopathy, Prostate cancer, Peripheral venous disease
SafetyReportID: 10003337 Date: 20140312 Report: SafetyReportID: 10003337 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Dysphonia, Throat irritation
SafetyReportID: 10003338 Date: 20140312 Report: SafetyReportID: 10003338 | ReceiveDate: 20140312 | Drugs: KLACID, CLAVULIN, OKI, TACHIPIRINA | Reactions: Swollen tongue, Pruritus, Rash generalised
SafetyReportID: 10003339 Date: 20140312 Report: SafetyReportID: 10003339 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Anaemia
SafetyReportID: 10003340 Date: 20140312 Report: SafetyReportID: 10003340 | ReceiveDate: 20140312 | Drugs: PREDNISONE, METHYLPREDNISOLONE, HYDROXYCHLOROQUINE, MYCOPHENOLATE MOFETIL, CICLOSPORIN, DAPSONE | Reactions: Listeriosis, Pyrexia, Diarrhoea, Meningitis
SafetyReportID: 10003341 Date: 20140312 Report: SafetyReportID: 10003341 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Dizziness, Oedema, Dyspnoea
SafetyReportID: 10003342 Date: 20140312 Report: SafetyReportID: 10003342 | ReceiveDate: 20140312 | Drugs: TASIGNA | Reactions: Overdose, General physical health deterioration, Malaise, Drug ineffective
SafetyReportID: 10003343 Date: 20140312 Report: SafetyReportID: 10003343 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Liver function test abnormal, Liver disorder
SafetyReportID: 10003344 Date: 20140312 Report: SafetyReportID: 10003344 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Headache
SafetyReportID: 10003345 Date: 20140312 Report: SafetyReportID: 10003345 | ReceiveDate: 20140312 | Drugs: CITALOPRAM, PREVISCAN, DAFALGAN | Reactions: Haematoma, Thrombocytopenia, International normalised ratio increased
SafetyReportID: 10003346 Date: 20140312 Report: SafetyReportID: 10003346 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Dyspnoea, Hypoxia
SafetyReportID: 10003347 Date: 20140312 Report: SafetyReportID: 10003347 | ReceiveDate: 20140312 | Drugs: MIRENA, MIRENA | Reactions: Device dislocation
SafetyReportID: 10003348 Date: 20140312 Report: SafetyReportID: 10003348 | ReceiveDate: 20140312 | Drugs: OXYGEN., LETAIRIS | Reactions: Epistaxis, Cough, Nasal dryness, Nasal congestion, Haemoptysis, Asthenia
SafetyReportID: 10003349 Date: 20140312 Report: SafetyReportID: 10003349 | ReceiveDate: 20140312 | Drugs: MORPHINE SULFATE EXTENDED-RELEASE TABLETS (RHODES 74-862), MORPHINE SULFATE (SIMILAR TO NDA 19-516), AMLODIPINE, TRIAMTERENE AND HYDROCHLOROTHIAZID, ASPIRIN, CELEXA /00582602/, CLOBETASOL PROPRIONATE, FIORICET | Reactions: Cerebrovascular accident, Blood pressure increased, Pain
SafetyReportID: 10003350 Date: 20140312 Report: SafetyReportID: 10003350 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Malaise, Gingivitis
SafetyReportID: 10003351 Date: 20140312 Report: SafetyReportID: 10003351 | ReceiveDate: 20140312 | Drugs: MIRTAZAPINE (UNKNOWN), LANSOPRAZOLE, NASONEX | Reactions: Aggression, Violence-related symptom, Anger, Blepharospasm, Suicidal ideation
SafetyReportID: 10003352 Date: 20140312 Report: SafetyReportID: 10003352 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Oedema peripheral
SafetyReportID: 10003353 Date: 20140312 Report: SafetyReportID: 10003353 | ReceiveDate: 20140312 | Drugs: CASODEX, CASODEX | Reactions: Dyspnoea, Drug ineffective
SafetyReportID: 10003354 Date: 20140312 Report: SafetyReportID: 10003354 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Haemoglobin decreased
SafetyReportID: 10003355 Date: 20140312 Report: SafetyReportID: 10003355 | ReceiveDate: 20140312 | Drugs: CASODEX | Reactions: Heart rate decreased
SafetyReportID: 10003356 Date: 20140312 Report: SafetyReportID: 10003356 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Oedema peripheral
SafetyReportID: 10003357 Date: 20140312 Report: SafetyReportID: 10003357 | ReceiveDate: 20140312 | Drugs: TACROLIMUS (WATSON LABORATORIES), PREDNISONE, PREDNISONE, AZATHIOPRINE | Reactions: Posterior reversible encephalopathy syndrome, Cerebral haemorrhage, Subarachnoid haemorrhage
SafetyReportID: 10003358 Date: 20140312 Report: SafetyReportID: 10003358 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Dyspnoea
SafetyReportID: 10003359 Date: 20140312 Report: SafetyReportID: 10003359 | ReceiveDate: 20140312 | Drugs: DOXYCYCLINE, AMLODIPINE, PARACETAMOL, ENALAPRIL, DOXAZOSIN (UNKNOWN), INDAPAMIDE | Reactions: Erection increased
SafetyReportID: 10003360 Date: 20140312 Report: SafetyReportID: 10003360 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Hypertension
SafetyReportID: 10003361 Date: 20140312 Report: SafetyReportID: 10003361 | ReceiveDate: 20140312 | Drugs: CITALOPRAM (UNKNOWN), PROPRANOLOL, RANITIDINE, THIAMINE HYDROCHLORIDE, VITAMIN B COMPLEX /00212701/ | Reactions: Hyponatraemia
SafetyReportID: 10003362 Date: 20140312 Report: SafetyReportID: 10003362 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Gastric disorder, Dyspnoea
SafetyReportID: 10003363 Date: 20140312 Report: SafetyReportID: 10003363 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Unevaluable event
SafetyReportID: 10003364 Date: 20140312 Report: SafetyReportID: 10003364 | ReceiveDate: 20140312 | Drugs: ADCIRCA, LETAIRIS | Reactions: Drug hypersensitivity, Pruritus, Rash
SafetyReportID: 10003365 Date: 20140312 Report: SafetyReportID: 10003365 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Oedema, Fluid retention
SafetyReportID: 10003366 Date: 20140312 Report: SafetyReportID: 10003366 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Oedema
SafetyReportID: 10003367 Date: 20140312 Report: SafetyReportID: 10003367 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Unevaluable event, Eructation, Chest discomfort
SafetyReportID: 10003368 Date: 20140312 Report: SafetyReportID: 10003368 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Pollakiuria, Poor quality sleep, Dyspnoea
SafetyReportID: 10003369 Date: 20140312 Report: SafetyReportID: 10003369 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Feeling abnormal
SafetyReportID: 10003370 Date: 20140312 Report: SafetyReportID: 10003370 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Swelling
SafetyReportID: 10003371 Date: 20140312 Report: SafetyReportID: 10003371 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Nasal congestion, Seasonal allergy
SafetyReportID: 10003372 Date: 20140312 Report: SafetyReportID: 10003372 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Nausea
SafetyReportID: 10003373 Date: 20140312 Report: SafetyReportID: 10003373 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Nasal congestion
SafetyReportID: 10003375 Date: 20140312 Report: SafetyReportID: 10003375 | ReceiveDate: 20140312 | Drugs: PREDNISONE, CYCLOPHOSPHAMIDE | Reactions: Loss of consciousness, Listeriosis, Pyrexia, Headache, Vomiting, Meningitis
SafetyReportID: 10003376 Date: 20140312 Report: SafetyReportID: 10003376 | ReceiveDate: 20140312 | Drugs: CASODEX, LUPRON, IBUPROPHEN, ULRAM, PROSCAR | Reactions: Diarrhoea, Arthralgia, Nausea
SafetyReportID: 10003377 Date: 20140312 Report: SafetyReportID: 10003377 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Malaise, Weight fluctuation
SafetyReportID: 10003378 Date: 20140312 Report: SafetyReportID: 10003378 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Dyspnoea, Tremor, Bone pain, Presyncope
SafetyReportID: 10003379 Date: 20140312 Report: SafetyReportID: 10003379 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Nasopharyngitis
SafetyReportID: 10003380 Date: 20140312 Report: SafetyReportID: 10003380 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Respiratory tract infection, Body temperature, Pneumonia, Productive cough
SafetyReportID: 10003381 Date: 20140312 Report: SafetyReportID: 10003381 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: No therapeutic response
SafetyReportID: 10003382 Date: 20140312 Report: SafetyReportID: 10003382 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Blood count abnormal
SafetyReportID: 10003383 Date: 20140312 Report: SafetyReportID: 10003383 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Unevaluable event
SafetyReportID: 10003384 Date: 20140312 Report: SafetyReportID: 10003384 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Unevaluable event
SafetyReportID: 10003385 Date: 20140312 Report: SafetyReportID: 10003385 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Dyspnoea exertional, Fatigue
SafetyReportID: 10003386 Date: 20140312 Report: SafetyReportID: 10003386 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Fluid retention, Haemoglobin decreased
SafetyReportID: 10003387 Date: 20140312 Report: SafetyReportID: 10003387 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Cellulitis
SafetyReportID: 10003388 Date: 20140312 Report: SafetyReportID: 10003388 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Dyspnoea, Dyspnoea exertional, Oedema
SafetyReportID: 10003389 Date: 20140312 Report: SafetyReportID: 10003389 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Hepatic enzyme decreased
SafetyReportID: 10003390 Date: 20140312 Report: SafetyReportID: 10003390 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Headache, Dyspnoea, Diarrhoea, Increased appetite, Swelling, Weight increased, Vomiting
SafetyReportID: 10003391 Date: 20140312 Report: SafetyReportID: 10003391 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Dyspnoea
SafetyReportID: 10003392 Date: 20140312 Report: SafetyReportID: 10003392 | ReceiveDate: 20140312 | Drugs: RAMIPRIL., WARFARIN, LIPITOR, TAMSULOSIN, ADALAT CC, DIPYRIDAMOLE., SYNTHROID, VISMODEGIB, PHYTONADIONE. | Reactions: Subdural haematoma
SafetyReportID: 10003393 Date: 20140312 Report: SafetyReportID: 10003393 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Peripheral swelling
SafetyReportID: 10003394 Date: 20140312 Report: SafetyReportID: 10003394 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Dyspnoea exertional
SafetyReportID: 10003395 Date: 20140312 Report: SafetyReportID: 10003395 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Tremor, Dry mouth
SafetyReportID: 10003396 Date: 20140312 Report: SafetyReportID: 10003396 | ReceiveDate: 20140312 | Drugs: LETAIRIS, REMODULIN | Reactions: Unevaluable event
SafetyReportID: 10003397 Date: 20140312 Report: SafetyReportID: 10003397 | ReceiveDate: 20140312 | Drugs: CITALOPRAM ORAL SOLUTION, CYMBALTA | Reactions: Sopor, Drug abuse, Overdose
SafetyReportID: 10003398 Date: 20140312 Report: SafetyReportID: 10003398 | ReceiveDate: 20140312 | Drugs: DONEPEZIL, DONEPEZIL (UNKNOWN), TRAMADOL | Reactions: Hallucination, visual, Headache, Insomnia, Somnolence, Confusional state
SafetyReportID: 10003399 Date: 20140312 Report: SafetyReportID: 10003399 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Headache, Dizziness exertional, Haemoglobin decreased, Dyspnoea
SafetyReportID: 10003400 Date: 20140312 Report: SafetyReportID: 10003400 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Hot flush, Rosacea
SafetyReportID: 10003401 Date: 20140312 Report: SafetyReportID: 10003401 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Sinusitis
SafetyReportID: 10003402 Date: 20140312 Report: SafetyReportID: 10003402 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Middle insomnia, Chemotherapy, Dyspnoea
SafetyReportID: 10003403 Date: 20140312 Report: SafetyReportID: 10003403 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Sinusitis
SafetyReportID: 10003404 Date: 20140312 Report: SafetyReportID: 10003404 | ReceiveDate: 20140312 | Drugs: LASIX, LETAIRIS | Reactions: Oedema, Weight decreased
SafetyReportID: 10003405 Date: 20140312 Report: SafetyReportID: 10003405 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Asthenia, Anaemia, Tooth disorder
SafetyReportID: 10003406 Date: 20140312 Report: SafetyReportID: 10003406 | ReceiveDate: 20140312 | Drugs: MICROPAKINE | Reactions: Cognitive disorder, Alopecia
SafetyReportID: 10003407 Date: 20140312 Report: SafetyReportID: 10003407 | ReceiveDate: 20140312 | Drugs: 5-FLUOROURACIL, 5-FLUOROURACIL, 5-FLUOROURACIL, 5-FLUOROURACIL, FOLINIC ACID, FOLINIC ACID, OXALIPLATIN, OXALIPLATIN, FENTANILO//FENTANYL, DEXKETOPROFEN | Reactions: Ileus paralytic, Abdominal pain, Nausea
SafetyReportID: 10003408 Date: 20140312 Report: SafetyReportID: 10003408 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Insomnia
SafetyReportID: 10003409 Date: 20140312 Report: SafetyReportID: 10003409 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Dyspnoea, Abdominal distension, Swelling
SafetyReportID: 10003410 Date: 20140312 Report: SafetyReportID: 10003410 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Dyspnoea
SafetyReportID: 10003411 Date: 20140312 Report: SafetyReportID: 10003411 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Laboratory test abnormal
SafetyReportID: 10003412 Date: 20140312 Report: SafetyReportID: 10003412 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Visual impairment, Adverse reaction
SafetyReportID: 10003413 Date: 20140312 Report: SafetyReportID: 10003413 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Infusion site infection
SafetyReportID: 10003414 Date: 20140312 Report: SafetyReportID: 10003414 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Diarrhoea, Vomiting, Abdominal discomfort, Malaise, Dyspepsia
SafetyReportID: 10003415 Date: 20140312 Report: SafetyReportID: 10003415 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Dizziness, Loss of consciousness, Fall
SafetyReportID: 10003416 Date: 20140312 Report: SafetyReportID: 10003416 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Drug ineffective
SafetyReportID: 10003417 Date: 20140312 Report: SafetyReportID: 10003417 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Thirst, Nasal congestion
SafetyReportID: 10003418 Date: 20140312 Report: SafetyReportID: 10003418 | ReceiveDate: 20140312 | Drugs: LETAIRIS, OXYGEN. | Reactions: Oxygen consumption increased, Unevaluable event
SafetyReportID: 10003419 Date: 20140312 Report: SafetyReportID: 10003419 | ReceiveDate: 20140312 | Drugs: LETAIRIS, REVATIO | Reactions: Anaemia, Fatigue, Fibrosis, Dyspnoea, Weight decreased
SafetyReportID: 10003420 Date: 20140312 Report: SafetyReportID: 10003420 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Headache, Vomiting, Blood pressure decreased, Nausea
SafetyReportID: 10003421 Date: 20140312 Report: SafetyReportID: 10003421 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Insomnia
SafetyReportID: 10003422 Date: 20140312 Report: SafetyReportID: 10003422 | ReceiveDate: 20140312 | Drugs: REVATIO, LETAIRIS | Reactions: Rash
SafetyReportID: 10003423 Date: 20140312 Report: SafetyReportID: 10003423 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Influenza
SafetyReportID: 10003424 Date: 20140312 Report: SafetyReportID: 10003424 | ReceiveDate: 20140312 | Drugs: CEFTRIAXONE, METRONIDAZOLE | Reactions: Foetal death, Abortion late, Amniotic cavity infection, Maternal exposure during pregnancy
SafetyReportID: 10003425 Date: 20140312 Report: SafetyReportID: 10003425 | ReceiveDate: 20140312 | Drugs: MIRENA | Reactions: Breast cancer, Device misuse
SafetyReportID: 10003426 Date: 20140312 Report: SafetyReportID: 10003426 | ReceiveDate: 20140312 | Drugs: MIRENA, MIRENA | Reactions: Uterine perforation, Depression, Anxiety, Depressed mood, Device issue, Injury, Pain, Emotional distress
SafetyReportID: 10003427 Date: 20140312 Report: SafetyReportID: 10003427 | ReceiveDate: 20140312 | Drugs: REVATIO, LETAIRIS | Reactions: Abdominal distension, Headache, Tinnitus, Diarrhoea
SafetyReportID: 10003428 Date: 20140312 Report: SafetyReportID: 10003428 | ReceiveDate: 20140312 | Drugs: CEFTRIAXONE, METRONIDAZOLE, AMOXICILLIN | Reactions: Foetal distress syndrome, Intraventricular haemorrhage neonatal, Low birth weight baby, Listeriosis, Pyrexia, Sepsis, Meningitis, Pneumonia aspiration, Oxygen saturation decreased, Foetal exposure during pregnancy
SafetyReportID: 10003429 Date: 20140312 Report: SafetyReportID: 10003429 | ReceiveDate: 20140312 | Drugs: CEFTRIAXONE, METRONIDAZOLE, AMOXICILLIN | Reactions: Meconium stain, Amniotic cavity infection, Maternal exposure during pregnancy
SafetyReportID: 10003430 Date: 20140312 Report: SafetyReportID: 10003430 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS, LETAIRIS | Reactions: Sinusitis, Auricular haematoma, Fall, Wrist fracture, Excessive cerumen production
SafetyReportID: 10003431 Date: 20140312 Report: SafetyReportID: 10003431 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Chest pain, Back pain
SafetyReportID: 10003432 Date: 20140312 Report: SafetyReportID: 10003432 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LANTUS, LISINOPRIL., ALLOPURINOL., KLOR-CON, ASPIRIN., CENTRUM SILVER /02363801/, CARVEDILOL., LETAIRIS, FISH OIL, FUROSEMIDE., COUMADIN, MUCINEX, CITALOPRAM HYDROBROMIDE. | Reactions: Oedema peripheral, Fluid retention
SafetyReportID: 10003433 Date: 20140312 Report: SafetyReportID: 10003433 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Pain, Weight increased, Peripheral swelling, Liver function test abnormal, Dyspnoea
SafetyReportID: 10003434 Date: 20140312 Report: SafetyReportID: 10003434 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS, LETAIRIS, LETAIRIS, LETAIRIS | Reactions: Peripheral swelling
SafetyReportID: 10003435 Date: 20140312 Report: SafetyReportID: 10003435 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Tooth extraction
SafetyReportID: 10003436 Date: 20140312 Report: SafetyReportID: 10003436 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Syncope, Dizziness
SafetyReportID: 10003437 Date: 20140312 Report: SafetyReportID: 10003437 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Fatigue, Oedema peripheral, Drug ineffective, Flushing
SafetyReportID: 10003438 Date: 20140312 Report: SafetyReportID: 10003438 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Fatigue, Asthenia
SafetyReportID: 10003439 Date: 20140312 Report: SafetyReportID: 10003439 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Unevaluable event, Swelling, Hot flush, Pruritus
SafetyReportID: 10003440 Date: 20140312 Report: SafetyReportID: 10003440 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Insomnia
SafetyReportID: 10003441 Date: 20140312 Report: SafetyReportID: 10003441 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS, REMODULIN | Reactions: Pain, Fatigue, Pain in extremity, Oedema peripheral
SafetyReportID: 10003442 Date: 20140312 Report: SafetyReportID: 10003442 | ReceiveDate: 20140312 | Drugs: TYVASO, LETAIRIS | Reactions: Cough, Chest discomfort
SafetyReportID: 10003443 Date: 20140312 Report: SafetyReportID: 10003443 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Ear infection
SafetyReportID: 10003444 Date: 20140312 Report: SafetyReportID: 10003444 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Cardiac failure congestive, Fluid retention, Swelling
SafetyReportID: 10003445 Date: 20140312 Report: SafetyReportID: 10003445 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Dyspnoea
SafetyReportID: 10003446 Date: 20140312 Report: SafetyReportID: 10003446 | ReceiveDate: 20140312 | Drugs: LETAIRIS, ADCIRCA | Reactions: Unevaluable event
SafetyReportID: 10003447 Date: 20140312 Report: SafetyReportID: 10003447 | ReceiveDate: 20140312 | Drugs: REVATIO, LETAIRIS, TYVASO | Reactions: Unevaluable event, Nasopharyngitis, Malaise, Cough
SafetyReportID: 10003448 Date: 20140312 Report: SafetyReportID: 10003448 | ReceiveDate: 20140312 | Drugs: ADCIRCA, LETAIRIS, REMODULIN | Reactions: Unevaluable event, Malaise
SafetyReportID: 10003449 Date: 20140312 Report: SafetyReportID: 10003449 | ReceiveDate: 20140312 | Drugs: CEFTRIAXONE, CLARITHROMYCIN, AMOXICILLIN+CLAVULANATE, CEFMETAZOLE | Reactions: Pyelonephritis, Maternal exposure during pregnancy, Normal newborn
SafetyReportID: 10003450 Date: 20140312 Report: SafetyReportID: 10003450 | ReceiveDate: 20140312 | Drugs: CAPTOPRIL SANDOZ, SINVASTACOR | Reactions: Blood pressure fluctuation, Dyspepsia, Allergic cough, Headache, Malaise
SafetyReportID: 10003451 Date: 20140312 Report: SafetyReportID: 10003451 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Fluid retention
SafetyReportID: 10003452 Date: 20140312 Report: SafetyReportID: 10003452 | ReceiveDate: 20140312 | Drugs: TYVASO, OXYGEN., LETAIRIS | Reactions: Fatigue, Dyspnoea exertional
SafetyReportID: 10003453 Date: 20140312 Report: SafetyReportID: 10003453 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS, TYVASO | Reactions: Throat irritation, Wheezing, Dyspnoea
SafetyReportID: 10003454 Date: 20140312 Report: SafetyReportID: 10003454 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS, LETAIRIS | Reactions: Dyspnoea
SafetyReportID: 10003455 Date: 20140312 Report: SafetyReportID: 10003455 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Dental pulp disorder
SafetyReportID: 10003456 Date: 20140312 Report: SafetyReportID: 10003456 | ReceiveDate: 20140312 | Drugs: LETAIRIS, SILDENAFIL. | Reactions: Therapeutic response decreased
SafetyReportID: 10003457 Date: 20140312 Report: SafetyReportID: 10003457 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Cough
SafetyReportID: 10003458 Date: 20140312 Report: SafetyReportID: 10003458 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS, LETAIRIS, LETAIRIS | Reactions: Fluid overload
SafetyReportID: 10003459 Date: 20140312 Report: SafetyReportID: 10003459 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Trigeminal neuralgia, Pain in jaw, Facial pain
SafetyReportID: 10003460 Date: 20140312 Report: SafetyReportID: 10003460 | ReceiveDate: 20140312 | Drugs: TYVASO, LETAIRIS | Reactions: Cough
SafetyReportID: 10003461 Date: 20140312 Report: SafetyReportID: 10003461 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Peripheral swelling, Oedema peripheral
SafetyReportID: 10003462 Date: 20140312 Report: SafetyReportID: 10003462 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Nasal disorder
SafetyReportID: 10003463 Date: 20140312 Report: SafetyReportID: 10003463 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Drug ineffective, Condition aggravated, Dyspnoea
SafetyReportID: 10003464 Date: 20140312 Report: SafetyReportID: 10003464 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Swelling
SafetyReportID: 10003465 Date: 20140312 Report: SafetyReportID: 10003465 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Myalgia, Back disorder, Syncope, Intervertebral disc protrusion, Malaise, Dyspnoea
SafetyReportID: 10003466 Date: 20140312 Report: SafetyReportID: 10003466 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Dyspnoea, Feeling abnormal, Fatigue, Asthenia
SafetyReportID: 10003467 Date: 20140312 Report: SafetyReportID: 10003467 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Arthralgia, Dyspnoea, Cough
SafetyReportID: 10003468 Date: 20140312 Report: SafetyReportID: 10003468 | ReceiveDate: 20140312 | Drugs: BISOPROLOL, TRIMETAZIDINE HYDROCHLORIDE SANDOZ, ZOVIRAX, FLODIL LP, AUGMENTIN, LOVENOX, ATARAX /CAN/, KASKADIL, PREVISCAN, NEO-MERCAZOLE, AVLOCARDYL, DOLIPRANE, TIAPRIDAL | Reactions: Renal failure acute
SafetyReportID: 10003469 Date: 20140312 Report: SafetyReportID: 10003469 | ReceiveDate: 20140312 | Drugs: LETAIRIS, TYVASO, LETAIRIS | Reactions: Cough
SafetyReportID: 10003470 Date: 20140312 Report: SafetyReportID: 10003470 | ReceiveDate: 20140312 | Drugs: FUROSEMIDE., LETAIRIS, GABAPENTIN., TRAMADOL., ALENDRONATE, BENZONATATE., POTASSIUM CHLORIDE., IPRATROPIUM BROMIDE., ATENOLOL., CHOLECALCIFEROL, FENTANYL., ACETYLCYSTEINE., PRAVASTATIN, LETAIRIS, SILDENAFIL., WARFARIN | Reactions: Drug ineffective, Pulmonary arterial hypertension
SafetyReportID: 10003471 Date: 20140312 Report: SafetyReportID: 10003471 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Dyspnoea exertional
SafetyReportID: 10003472 Date: 20140312 Report: SafetyReportID: 10003472 | ReceiveDate: 20140312 | Drugs: LETAIRIS, REVATIO, TYVASO | Reactions: Sinus disorder, Cough, Dyspnoea, Oedema
SafetyReportID: 10003473 Date: 20140312 Report: SafetyReportID: 10003473 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Palpitations
SafetyReportID: 10003474 Date: 20140312 Report: SafetyReportID: 10003474 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Dyspnoea
SafetyReportID: 10003475 Date: 20140312 Report: SafetyReportID: 10003475 | ReceiveDate: 20140312 | Drugs: LETAIRIS, EPOPROSTENOL., LETAIRIS, LETAIRIS, LETAIRIS, LETAIRIS, LETAIRIS, LETAIRIS, LETAIRIS, REVATIO | Reactions: Arthralgia, Headache, Pain in jaw
SafetyReportID: 10003476 Date: 20140312 Report: SafetyReportID: 10003476 | ReceiveDate: 20140312 | Drugs: LETAIRIS, REVATIO, VENTAVIS | Reactions: Productive cough, Dyspnoea, Pain in jaw, Cough
SafetyReportID: 10003477 Date: 20140312 Report: SafetyReportID: 10003477 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Polyuria, Fatigue, Weight increased
SafetyReportID: 10003478 Date: 20140312 Report: SafetyReportID: 10003478 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Pain, Depression, Asthenia
SafetyReportID: 10003479 Date: 20140312 Report: SafetyReportID: 10003479 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Vein disorder, Peripheral vascular disorder
SafetyReportID: 10003480 Date: 20140312 Report: SafetyReportID: 10003480 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Arthralgia
SafetyReportID: 10003481 Date: 20140312 Report: SafetyReportID: 10003481 | ReceiveDate: 20140312 | Drugs: REVATIO, LETAIRIS | Reactions: Hypotension, Fluid retention
SafetyReportID: 10003482 Date: 20140312 Report: SafetyReportID: 10003482 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Dyspnoea
SafetyReportID: 10003483 Date: 20140312 Report: SafetyReportID: 10003483 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Epistaxis, Unevaluable event
SafetyReportID: 10003484 Date: 20140312 Report: SafetyReportID: 10003484 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Blood glucose increased
SafetyReportID: 10003485 Date: 20140312 Report: SafetyReportID: 10003485 | ReceiveDate: 20140312 | Drugs: REVATIO, LETAIRIS | Reactions: Fatigue
SafetyReportID: 10003486 Date: 20140312 Report: SafetyReportID: 10003486 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Fatigue, Headache, Nasal congestion, Dyspnoea, Peripheral swelling
SafetyReportID: 10003487 Date: 20140312 Report: SafetyReportID: 10003487 | ReceiveDate: 20140312 | Drugs: ZOLPIDEM SANDOZ | Reactions: Disorientation, Drug prescribing error, Incorrect dose administered, Medication error
SafetyReportID: 10003488 Date: 20140312 Report: SafetyReportID: 10003488 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Nasopharyngitis, Sinus congestion, Cough
SafetyReportID: 10003489 Date: 20140312 Report: SafetyReportID: 10003489 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Dyspepsia
SafetyReportID: 10003490 Date: 20140312 Report: SafetyReportID: 10003490 | ReceiveDate: 20140312 | Drugs: CEFTRIAXONE, METRONIDAZOLE | Reactions: Foetal death, Amniotic cavity infection, Maternal exposure during pregnancy
SafetyReportID: 10003491 Date: 20140312 Report: SafetyReportID: 10003491 | ReceiveDate: 20140312 | Drugs: METRONIDAZOLE (UNKNOWN) | Reactions: Pharyngeal oedema
SafetyReportID: 10003492 Date: 20140312 Report: SafetyReportID: 10003492 | ReceiveDate: 20140312 | Drugs: ZETIA | Reactions: Hypersensitivity, Rash, Pain, Pruritus
SafetyReportID: 10003493 Date: 20140312 Report: SafetyReportID: 10003493 | ReceiveDate: 20140312 | Drugs: LYRICA | Reactions: Drug ineffective for unapproved indication, Pain in extremity
SafetyReportID: 10003494 Date: 20140312 Report: SafetyReportID: 10003494 | ReceiveDate: 20140312 | Drugs: ZITHROMAX, VIBRAMYCIN, CEFUROXIME, GENTAMICIN SULFATE, MEROPENEM, PRIMAQUINE, AUGMENTIN XR, AZTREONAM, BIAXIN, CECLOR, TIMENTIN | Reactions: Drug hypersensitivity
SafetyReportID: 10003495 Date: 20140312 Report: SafetyReportID: 10003495 | ReceiveDate: 20140312 | Drugs: LYRICA | Reactions: Drug ineffective, Swelling, Joint swelling
SafetyReportID: 10003496 Date: 20140312 Report: SafetyReportID: 10003496 | ReceiveDate: 20140312 | Drugs: NORVASC, AMLODIPINE, LORAZEPAM | Reactions: Sleep disorder, Somnolence
SafetyReportID: 10003497 Date: 20140312 Report: SafetyReportID: 10003497 | ReceiveDate: 20140312 | Drugs: VIAGRA | Reactions: Headache, Drug ineffective
SafetyReportID: 10003498 Date: 20140312 Report: SafetyReportID: 10003498 | ReceiveDate: 20140312 | Drugs: VIAGRA | Reactions: Erection increased, Painful erection
SafetyReportID: 10003499 Date: 20140312 Report: SafetyReportID: 10003499 | ReceiveDate: 20140312 | Drugs: CHANTIX | Reactions: Insomnia
SafetyReportID: 10003500 Date: 20140312 Report: SafetyReportID: 10003500 | ReceiveDate: 20140312 | Drugs: PROCARDIA | Reactions: Drug hypersensitivity
SafetyReportID: 10003501 Date: 20140312 Report: SafetyReportID: 10003501 | ReceiveDate: 20140312 | Drugs: LYRICA, LYRICA, LYRICA, LYRICA, APIDRA | Reactions: Off label use, Eye haemorrhage, Blood creatinine increased, Visual acuity reduced, Ophthalmological examination abnormal, Alanine aminotransferase increased, Aspartate aminotransferase increased, Feeling abnormal, Somnolence, Drug intolerance
SafetyReportID: 10003502 Date: 20140312 Report: SafetyReportID: 10003502 | ReceiveDate: 20140312 | Drugs: ESTRING | Reactions: Weight increased
SafetyReportID: 10003503 Date: 20140312 Report: SafetyReportID: 10003503 | ReceiveDate: 20140312 | Drugs: PREMARIN | Reactions: Reaction to drug excipients
SafetyReportID: 10003504 Date: 20140312 Report: SafetyReportID: 10003504 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Decreased appetite, Fatigue, Abdominal pain
SafetyReportID: 10003505 Date: 20140312 Report: SafetyReportID: 10003505 | ReceiveDate: 20140312 | Drugs: DIOVAN | Reactions: Spinal column stenosis, Diabetes mellitus
SafetyReportID: 10003506 Date: 20140312 Report: SafetyReportID: 10003506 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Respiratory disorder, Dyspnoea, Cough
SafetyReportID: 10003507 Date: 20140312 Report: SafetyReportID: 10003507 | ReceiveDate: 20140312 | Drugs: HUMULIN 30% REGULAR, 70% NPH | Reactions: Blindness
SafetyReportID: 10003508 Date: 20140312 Report: SafetyReportID: 10003508 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Abdominal pain, Headache
SafetyReportID: 10003509 Date: 20140312 Report: SafetyReportID: 10003509 | ReceiveDate: 20140312 | Drugs: BUSULFEX, FLUDARABINE, CALCINEURIN INHIBITORS | Reactions: Acute graft versus host disease, Chronic graft versus host disease, Lung disorder, Death, Infection, Mucosal inflammation, Gastrointestinal toxicity, Cardiotoxicity, Neurotoxicity, Hepatotoxicity, Nephropathy toxic, Transplant failure, Venoocclusive disease, Malignant neoplasm progression, Off label use
SafetyReportID: 10003510 Date: 20140312 Report: SafetyReportID: 10003510 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Infection, Central venous catheterisation
SafetyReportID: 10003511 Date: 20140312 Report: SafetyReportID: 10003511 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Peripheral swelling
SafetyReportID: 10003512 Date: 20140312 Report: SafetyReportID: 10003512 | ReceiveDate: 20140312 | Drugs: FORTEO | Reactions: Femur fracture, Fall
SafetyReportID: 10003513 Date: 20140312 Report: SafetyReportID: 10003513 | ReceiveDate: 20140312 | Drugs: CISPLATIN (UNKNOWN), VINORELBINE (UNKNOWN) | Reactions: Neutropenia
SafetyReportID: 10003514 Date: 20140312 Report: SafetyReportID: 10003514 | ReceiveDate: 20140312 | Drugs: CINRYZE (C1 ESTERASE INHIBITOR (HUMAN)), CINRYZE (C1 ESTERASE INHIBITOR (HUMAN)), BERINERT, FIRAZYR | Reactions: Pain in extremity, Hereditary angioedema, Anxiety, Panic attack, Depression
SafetyReportID: 10003515 Date: 20140312 Report: SafetyReportID: 10003515 | ReceiveDate: 20140312 | Drugs: MIRENA | Reactions: Vaginal haemorrhage, Amenorrhoea, Abdominal pain lower
SafetyReportID: 10003516 Date: 20140312 Report: SafetyReportID: 10003516 | ReceiveDate: 20140312 | Drugs: LETAIRIS, ADCIRCA, REMODULIN | Reactions: Cardiac failure congestive
SafetyReportID: 10003517 Date: 20140312 Report: SafetyReportID: 10003517 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Hiccups
SafetyReportID: 10003518 Date: 20140312 Report: SafetyReportID: 10003518 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Haemoglobin decreased
SafetyReportID: 10003519 Date: 20140312 Report: SafetyReportID: 10003519 | ReceiveDate: 20140312 | Drugs: SODIUM VALPROATE (UNKNOWN) | Reactions: Hepatocellular injury
SafetyReportID: 10003520 Date: 20140312 Report: SafetyReportID: 10003520 | ReceiveDate: 20140312 | Drugs: VICODIN, MIRENA, FLAGYL | Reactions: Adnexa uteri pain, Drug ineffective, Pregnancy with contraceptive device, Embedded device, Ovarian cyst, Injury, Dyspareunia, Pain
SafetyReportID: 10003521 Date: 20140312 Report: SafetyReportID: 10003521 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Skin lesion, Migraine
SafetyReportID: 10003522 Date: 20140312 Report: SafetyReportID: 10003522 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Endodontic procedure
SafetyReportID: 10003523 Date: 20140312 Report: SafetyReportID: 10003523 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Asthenia
SafetyReportID: 10003524 Date: 20140312 Report: SafetyReportID: 10003524 | ReceiveDate: 20140312 | Drugs: ADCIRCA, LETAIRIS, LETAIRIS | Reactions: Dyspnoea
SafetyReportID: 10003525 Date: 20140312 Report: SafetyReportID: 10003525 | ReceiveDate: 20140312 | Drugs: MIRENA, PRENATAL VITAMINS, FLEXERIL | Reactions: Uterine perforation, Post procedural discomfort, Pain, Device dislocation, Pregnancy with contraceptive device, Drug ineffective, Device difficult to use, Uterine haemorrhage, Injury, Depression, Anxiety, Stress, Device issue
SafetyReportID: 10003526 Date: 20140312 Report: SafetyReportID: 10003526 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, COZAAR/HCTZ, LAMICTAL, RANITIDINE, KLONOPIN, LOVENOX | Reactions: Dry mouth, Dry eye, Lip dry, Dry throat, Insomnia, Depressed mood, Odynophagia, Crying, Feeling abnormal, Oesophageal pain, Oropharyngeal pain, Nausea, Abdominal distension, Contusion, Blood count abnormal
SafetyReportID: 10003527 Date: 20140312 Report: SafetyReportID: 10003527 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Hepatic enzyme increased
SafetyReportID: 10003528 Date: 20140312 Report: SafetyReportID: 10003528 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Headache
SafetyReportID: 10003529 Date: 20140312 Report: SafetyReportID: 10003529 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Oedema peripheral
SafetyReportID: 10003530 Date: 20140312 Report: SafetyReportID: 10003530 | ReceiveDate: 20140312 | Drugs: FANAPT, COGENTIN, COGENTIN, BUSPIRONE | Reactions: Oedema peripheral, Gait disturbance
SafetyReportID: 10003531 Date: 20140312 Report: SafetyReportID: 10003531 | ReceiveDate: 20140312 | Drugs: REVLIMID, REVLIMID, REVLIMID, REVLIMID | Reactions: Plasma cell myeloma, Respiratory disorder, Arrhythmia
SafetyReportID: 10003532 Date: 20140312 Report: SafetyReportID: 10003532 | ReceiveDate: 20140312 | Drugs: HUMIRA, AMLODIPINE | Reactions: Chest pain, Oedema peripheral, Gastrooesophageal reflux disease
SafetyReportID: 10003534 Date: 20140312 Report: SafetyReportID: 10003534 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Throat irritation, Dysphonia
SafetyReportID: 10003535 Date: 20140312 Report: SafetyReportID: 10003535 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Gout
SafetyReportID: 10003536 Date: 20140312 Report: SafetyReportID: 10003536 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, DEPAKOTE, DEPAKOTE | Reactions: Feeling abnormal, Suicidal ideation, Fatigue, Feeling cold, Chills, Decreased appetite
SafetyReportID: 10003537 Date: 20140312 Report: SafetyReportID: 10003537 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Pollakiuria
SafetyReportID: 10003538 Date: 20140312 Report: SafetyReportID: 10003538 | ReceiveDate: 20140312 | Drugs: TYVASO, LETAIRIS, LETAIRIS, LETAIRIS | Reactions: Palpitations, Fatigue
SafetyReportID: 10003539 Date: 20140312 Report: SafetyReportID: 10003539 | ReceiveDate: 20140312 | Drugs: JAKAFI, LISINOPRIL, JANUVIA, GLYBURIDE, VITAMIN D /00107901/ | Reactions: Pulmonary embolism, Anaemia, Haemoglobin decreased
SafetyReportID: 10003540 Date: 20140312 Report: SafetyReportID: 10003540 | ReceiveDate: 20140312 | Drugs: HUMIRA | Reactions: Oesophageal perforation, Gastric haemorrhage, Hepatic failure
SafetyReportID: 10003541 Date: 20140312 Report: SafetyReportID: 10003541 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Generalised oedema, Diarrhoea
SafetyReportID: 10003542 Date: 20140312 Report: SafetyReportID: 10003542 | ReceiveDate: 20140312 | Drugs: ACLASTA | Reactions: Nerve compression, Mobility decreased, Abasia
SafetyReportID: 10003543 Date: 20140312 Report: SafetyReportID: 10003543 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Somnolence
SafetyReportID: 10003544 Date: 20140312 Report: SafetyReportID: 10003544 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, DEPAKOTE | Reactions: Balance disorder, Drug level increased
SafetyReportID: 10003545 Date: 20140312 Report: SafetyReportID: 10003545 | ReceiveDate: 20140312 | Drugs: LUPRON DEPOT | Reactions: Death
SafetyReportID: 10003546 Date: 20140312 Report: SafetyReportID: 10003546 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, JAKAFI, REVLIMID, NORVASC | Reactions: White blood cell count increased, Gout, Fatigue, Red blood cell count decreased, Muscle spasms, Pruritus, White blood cell count decreased, Haemoglobin decreased, Peripheral swelling, Anaemia, Blood triglycerides decreased, Oedema peripheral, Blood cholesterol decreased, Blood count abnormal
SafetyReportID: 10003547 Date: 20140312 Report: SafetyReportID: 10003547 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS, LETAIRIS, LETAIRIS | Reactions: Insomnia
SafetyReportID: 10003548 Date: 20140312 Report: SafetyReportID: 10003548 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, HUMIRA, XANAX, ZOFRAN, PRILOSEC, WELLBUTRIN, CELEXA, FOSAMAX, OXYGEN | Reactions: Urticaria, Somnolence
SafetyReportID: 10003549 Date: 20140312 Report: SafetyReportID: 10003549 | ReceiveDate: 20140312 | Drugs: ACLASTA, ACLASTA | Reactions: Nasopharyngitis, Malaise, Pyrexia, Nasal congestion, Headache, Diarrhoea, Nausea
SafetyReportID: 10003550 Date: 20140312 Report: SafetyReportID: 10003550 | ReceiveDate: 20140312 | Drugs: JAKAFI, ARANESP | Reactions: Fatigue, Dyspnoea, White blood cell count abnormal, Drug ineffective
SafetyReportID: 10003551 Date: 20140312 Report: SafetyReportID: 10003551 | ReceiveDate: 20140312 | Drugs: HUMIRA | Reactions: Breast cancer, Erythema
SafetyReportID: 10003552 Date: 20140312 Report: SafetyReportID: 10003552 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, LITHIUM | Reactions: Fear, Drug ineffective
SafetyReportID: 10003553 Date: 20140312 Report: SafetyReportID: 10003553 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Fluid retention
SafetyReportID: 10003554 Date: 20140312 Report: SafetyReportID: 10003554 | ReceiveDate: 20140312 | Drugs: BACLOFEN., GILENYA, INTERFERON BETA-1A | Reactions: Monocyte count decreased, Gamma-glutamyltransferase increased, B-lymphocyte count decreased, Skin lesion, Mean platelet volume decreased, Kaposi^s sarcoma, White blood cell count decreased, Lymphocyte count decreased, Neutrophil count decreased, T-lymphocyte count decreased
SafetyReportID: 10003555 Date: 20140312 Report: SafetyReportID: 10003555 | ReceiveDate: 20140312 | Drugs: TIENAM 500MG/500MG, POUDRE POUR PERFUSION, VANCOMYCIN MYLAN | Reactions: Linear IgA disease
SafetyReportID: 10003556 Date: 20140312 Report: SafetyReportID: 10003556 | ReceiveDate: 20140312 | Drugs: GILENYA | Reactions: Rheumatoid arthritis, Arthralgia, Rheumatoid factor increased, Neck pain, Back pain, Musculoskeletal pain
SafetyReportID: 10003557 Date: 20140312 Report: SafetyReportID: 10003557 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Oedema peripheral, Weight increased
SafetyReportID: 10003558 Date: 20140312 Report: SafetyReportID: 10003558 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Foetal exposure during pregnancy, Cardiac murmur, Postmature baby
SafetyReportID: 10003559 Date: 20140312 Report: SafetyReportID: 10003559 | ReceiveDate: 20140312 | Drugs: REMODULIN, LETAIRIS | Reactions: Pain in extremity, Diarrhoea
SafetyReportID: 10003560 Date: 20140312 Report: SafetyReportID: 10003560 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Staphylococcal infection
SafetyReportID: 10003561 Date: 20140312 Report: SafetyReportID: 10003561 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10003562 Date: 20140312 Report: SafetyReportID: 10003562 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, LATUDA | Reactions: Bipolar disorder
SafetyReportID: 10003563 Date: 20140312 Report: SafetyReportID: 10003563 | ReceiveDate: 20140312 | Drugs: SANDOSTATIN LAR DEPOT, SANDOSTATIN | Reactions: Asthenia, Palpitations, Thirst, Gait disturbance, Death, Influenza, Weight decreased, Nasopharyngitis, Fall, Confusional state
SafetyReportID: 10003564 Date: 20140312 Report: SafetyReportID: 10003564 | ReceiveDate: 20140312 | Drugs: LETAIRIS, TYVASO | Reactions: Headache, Abdominal pain, Insomnia
SafetyReportID: 10003565 Date: 20140312 Report: SafetyReportID: 10003565 | ReceiveDate: 20140312 | Drugs: JAKAFI, GLIMEPIRIDE, ZOCOR, LISINOPRIL, TAMSULOSIN | Reactions: Fatigue, Insomnia
SafetyReportID: 10003566 Date: 20140312 Report: SafetyReportID: 10003566 | ReceiveDate: 20140312 | Drugs: COUMADIN TABS 2 MG, CALCIPARINE, AMLODIPINE BESYLATE, BISOPROLOL, LASILIX | Reactions: Subcutaneous haematoma, Hypotension, Anaemia, Renal failure chronic
SafetyReportID: 10003567 Date: 20140312 Report: SafetyReportID: 10003567 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, VITAMIN D3 | Reactions: Platelet count increased
SafetyReportID: 10003568 Date: 20140312 Report: SafetyReportID: 10003568 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10003569 Date: 20140312 Report: SafetyReportID: 10003569 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Dysgeusia, Dry mouth, Lip dry
SafetyReportID: 10003570 Date: 20140312 Report: SafetyReportID: 10003570 | ReceiveDate: 20140312 | Drugs: SANDOSTATIN LAR | Reactions: Death
SafetyReportID: 10003572 Date: 20140312 Report: SafetyReportID: 10003572 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Oedema peripheral
SafetyReportID: 10003573 Date: 20140312 Report: SafetyReportID: 10003573 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI | Reactions: Ear haemorrhage, Ear infection
SafetyReportID: 10003574 Date: 20140312 Report: SafetyReportID: 10003574 | ReceiveDate: 20140312 | Drugs: ABATACEPT SUBQ INJECTION 125MG/ML | Reactions: Sepsis
SafetyReportID: 10003575 Date: 20140312 Report: SafetyReportID: 10003575 | ReceiveDate: 20140312 | Drugs: OXYTROL FOR WOMEN | Reactions: Drug ineffective
SafetyReportID: 10003576 Date: 20140312 Report: SafetyReportID: 10003576 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, KEPPRA, KLONOPIN, ELOQUIS, RAMIPRIL, AMIODARONE, CALCIUM | Reactions: Tremor, Tremor, Atrial fibrillation, Tremor, Tremor
SafetyReportID: 10003577 Date: 20140312 Report: SafetyReportID: 10003577 | ReceiveDate: 20140312 | Drugs: SABRIL (FOR ORAL SOLUTION) | Reactions: Tonsillectomy
SafetyReportID: 10003578 Date: 20140312 Report: SafetyReportID: 10003578 | ReceiveDate: 20140312 | Drugs: GILENYA | Reactions: Completed suicide, Suicidal behaviour
SafetyReportID: 10003579 Date: 20140312 Report: SafetyReportID: 10003579 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Loss of consciousness
SafetyReportID: 10003580 Date: 20140312 Report: SafetyReportID: 10003580 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Sneezing, Nasal congestion
SafetyReportID: 10003581 Date: 20140312 Report: SafetyReportID: 10003581 | ReceiveDate: 20140312 | Drugs: JAKAFI, METOPROLOL., LORAZEPAM., MIRTAZAPINE., JAKAFI, JAKAFI, EXJADE, NORVASC | Reactions: Blood count abnormal, Haemoglobin decreased
SafetyReportID: 10003582 Date: 20140312 Report: SafetyReportID: 10003582 | ReceiveDate: 20140312 | Drugs: LISINOPRIL HCTZ, SEROQUEL XR, SEROQUEL XR, SEROQUEL XR, SEROQUEL XR, SEROQUEL XR, SEROQUEL XR, SEROQUEL XR, SEROQUEL XR, SEROQUEL XR, SEROQUEL XR, SEROQUEL XR, SEROQUEL XR, SEROQUEL XR, SEROQUEL XR, ASPIRIN, MULTIVITAMIN, FISH OIL, GARLIC, METOPROLOL TARTRATE | Reactions: Hypertension, Dehydration, Night sweats, Panic attack, Hyperlipidaemia, Insomnia, Cold sweat, Bipolar disorder, Hyperhidrosis, Dysgeusia, Nausea
SafetyReportID: 10003583 Date: 20140312 Report: SafetyReportID: 10003583 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, DEPAKOTE | Reactions: Balance disorder, Drug level increased
SafetyReportID: 10003584 Date: 20140312 Report: SafetyReportID: 10003584 | ReceiveDate: 20140312 | Drugs: ACLASTA/ZOLEDRONATE, DIDROCAL, EVISTA, FORTEO, MIACALCIN, VITAMIN D, CALCIUM, BISPHOSPHONATES, HORMONES NOS | Reactions: Bone density decreased
SafetyReportID: 10003585 Date: 20140312 Report: SafetyReportID: 10003585 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10003586 Date: 20140312 Report: SafetyReportID: 10003586 | ReceiveDate: 20140312 | Drugs: NEULASTA | Reactions: Surgery
SafetyReportID: 10003587 Date: 20140312 Report: SafetyReportID: 10003587 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Platelet count decreased
SafetyReportID: 10003588 Date: 20140312 Report: SafetyReportID: 10003588 | ReceiveDate: 20140312 | Drugs: JAKAFI, AMILORIDE | Reactions: Deep vein thrombosis, Splenomegaly
SafetyReportID: 10003589 Date: 20140312 Report: SafetyReportID: 10003589 | ReceiveDate: 20140312 | Drugs: REBIF, ZOLOFT /01011401/, COMPAZINE /00013302/, OXYCODONE, HYDROCODONE, ABILIFY | Reactions: Loss of consciousness, Fall, Gait disturbance, Convulsion, Influenza, Speech disorder, Malaise
SafetyReportID: 10003590 Date: 20140312 Report: SafetyReportID: 10003590 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10003591 Date: 20140312 Report: SafetyReportID: 10003591 | ReceiveDate: 20140312 | Drugs: GILENYA | Reactions: Atrioventricular block first degree, Angina pectoris
SafetyReportID: 10003592 Date: 20140312 Report: SafetyReportID: 10003592 | ReceiveDate: 20140312 | Drugs: ONFI, TEGRETOL, DEPAKOTE | Reactions: Adverse event
SafetyReportID: 10003593 Date: 20140312 Report: SafetyReportID: 10003593 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Drug ineffective
SafetyReportID: 10003594 Date: 20140312 Report: SafetyReportID: 10003594 | ReceiveDate: 20140312 | Drugs: AUBAGIO | Reactions: Muscle spasms, Condition aggravated, Pain, Hypoaesthesia, Abdominal distension, Insomnia, Fatigue, Nausea, Alopecia
SafetyReportID: 10003595 Date: 20140312 Report: SafetyReportID: 10003595 | ReceiveDate: 20140312 | Drugs: JAKAFI, SIMVASTATIN-1A PHARMA, DOXAZOSIN, HYDROCHLOROTHIAZIDE, ENALAPRIL, CARVEDILOL, ASPIRIN | Reactions: Transfusion
SafetyReportID: 10003596 Date: 20140312 Report: SafetyReportID: 10003596 | ReceiveDate: 20140312 | Drugs: SPIRIVA | Reactions: Musculoskeletal chest pain, Cough, Fall, Drug administration error
SafetyReportID: 10003597 Date: 20140312 Report: SafetyReportID: 10003597 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Heart rate increased, Ocular hyperaemia, Flushing
SafetyReportID: 10003598 Date: 20140312 Report: SafetyReportID: 10003598 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, TOPAMAX | Reactions: Convulsion
SafetyReportID: 10003599 Date: 20140312 Report: SafetyReportID: 10003599 | ReceiveDate: 20140312 | Drugs: GLIVEC | Reactions: Death
SafetyReportID: 10003600 Date: 20140312 Report: SafetyReportID: 10003600 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, HYDROXYUREA | Reactions: Increased appetite, Inappropriate schedule of drug administration, Alopecia, Abdominal distension, Headache, Weight increased
SafetyReportID: 10003601 Date: 20140312 Report: SafetyReportID: 10003601 | ReceiveDate: 20140312 | Drugs: SPIRIVA, SPIRIVA | Reactions: Incorrect route of drug administration, Off label use
SafetyReportID: 10003602 Date: 20140312 Report: SafetyReportID: 10003602 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10003603 Date: 20140312 Report: SafetyReportID: 10003603 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Hypersensitivity, Hallucination, Tardive dyskinesia
SafetyReportID: 10003604 Date: 20140312 Report: SafetyReportID: 10003604 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Pruritus
SafetyReportID: 10003605 Date: 20140312 Report: SafetyReportID: 10003605 | ReceiveDate: 20140312 | Drugs: CITALOPRAM, DEPAKOTE, PREDNISOLONE, PREDNISOLONE | Reactions: Mental disorder, Panic attack, Depression, Anxiety, Condition aggravated, Off label use
SafetyReportID: 10003606 Date: 20140312 Report: SafetyReportID: 10003606 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Pruritus, Erythema
SafetyReportID: 10003607 Date: 20140312 Report: SafetyReportID: 10003607 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10003608 Date: 20140312 Report: SafetyReportID: 10003608 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, FLOVENT, LORAZEPAM, LEVOTHYROXINE, METHADONE, OMEPRAZOLE, PREDNISONE, SUCRALFATE | Reactions: Adverse drug reaction, Thrombocytopenia
SafetyReportID: 10003609 Date: 20140312 Report: SafetyReportID: 10003609 | ReceiveDate: 20140312 | Drugs: VOVERAN, VOVERAN, OMEPRAZOLE, PENCILLIN | Reactions: Acute respiratory distress syndrome, Multi-organ failure, General physical health deterioration
SafetyReportID: 10003610 Date: 20140312 Report: SafetyReportID: 10003610 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Feeling abnormal
SafetyReportID: 10003611 Date: 20140312 Report: SafetyReportID: 10003611 | ReceiveDate: 20140312 | Drugs: LETAIRIS, REMODULIN | Reactions: Blister, Diarrhoea, Nausea, Fatigue, Pain, Catheter site inflammation, Erythema, Malaise, Dizziness
SafetyReportID: 10003612 Date: 20140312 Report: SafetyReportID: 10003612 | ReceiveDate: 20140312 | Drugs: GLEEVEC | Reactions: Death, Pleural effusion, Blister, Hypothyroidism, Blood potassium decreased, Anaemia, Nausea, Vomiting, Constipation, Blood pressure increased, Fluid retention, Pollakiuria, Local swelling, Joint swelling, Swelling
SafetyReportID: 10003613 Date: 20140312 Report: SafetyReportID: 10003613 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, DEPAKOTE, NEURONTIN, NEURONTIN, GABAPENTIN, GABAPENTIN, ABILIFY, RISPERDAL, PERAZINE | Reactions: Grand mal convulsion, Malaise, Abdominal pain upper
SafetyReportID: 10003614 Date: 20140312 Report: SafetyReportID: 10003614 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10003615 Date: 20140312 Report: SafetyReportID: 10003615 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS, CLARITIN REDITABS | Reactions: Overdose
SafetyReportID: 10003616 Date: 20140312 Report: SafetyReportID: 10003616 | ReceiveDate: 20140312 | Drugs: AMIODARONE HCL, PREDNISOLONE. | Reactions: Hyperthyroidism, Diabetes mellitus
SafetyReportID: 10003617 Date: 20140312 Report: SafetyReportID: 10003617 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Haemoglobin decreased, Pyrexia, Headache
SafetyReportID: 10003618 Date: 20140312 Report: SafetyReportID: 10003618 | ReceiveDate: 20140312 | Drugs: NEXPLANON | Reactions: Device difficult to use, No adverse event, Product quality issue
SafetyReportID: 10003619 Date: 20140312 Report: SafetyReportID: 10003619 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Alopecia
SafetyReportID: 10003620 Date: 20140312 Report: SafetyReportID: 10003620 | ReceiveDate: 20140312 | Drugs: SOLUMEDROL, GILENYA, METHOTREXATE, BETASERON, COPAXONE | Reactions: Malnutrition, Multiple sclerosis, Loss of consciousness, Weight decreased
SafetyReportID: 10003621 Date: 20140312 Report: SafetyReportID: 10003621 | ReceiveDate: 20140312 | Drugs: SELARA, SELARA, LEUPRORELIN | Reactions: Fibroadenoma of breast, Off label use
SafetyReportID: 10003622 Date: 20140312 Report: SafetyReportID: 10003622 | ReceiveDate: 20140312 | Drugs: FORANE (ISOFLURANE, USP), SUCCINYLCHOLINE | Reactions: Hyperthermia malignant
SafetyReportID: 10003623 Date: 20140312 Report: SafetyReportID: 10003623 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Liver function test abnormal
SafetyReportID: 10003624 Date: 20140312 Report: SafetyReportID: 10003624 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10003625 Date: 20140312 Report: SafetyReportID: 10003625 | ReceiveDate: 20140312 | Drugs: DIOVAN | Reactions: Neoplasm malignant
SafetyReportID: 10003626 Date: 20140312 Report: SafetyReportID: 10003626 | ReceiveDate: 20140312 | Drugs: METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE | Reactions: Diabetes mellitus, Endocarditis staphylococcal
SafetyReportID: 10003627 Date: 20140312 Report: SafetyReportID: 10003627 | ReceiveDate: 20140312 | Drugs: OMNISCAN, OMNISCAN | Reactions: Nephrogenic systemic fibrosis
SafetyReportID: 10003628 Date: 20140312 Report: SafetyReportID: 10003628 | ReceiveDate: 20140312 | Drugs: LIPITOR | Reactions: Type 2 diabetes mellitus
SafetyReportID: 10003629 Date: 20140312 Report: SafetyReportID: 10003629 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10003630 Date: 20140312 Report: SafetyReportID: 10003630 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Haemorrhage, Skin atrophy
SafetyReportID: 10003631 Date: 20140312 Report: SafetyReportID: 10003631 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Drug hypersensitivity, Alopecia
SafetyReportID: 10003632 Date: 20140312 Report: SafetyReportID: 10003632 | ReceiveDate: 20140312 | Drugs: REVLIMID, REVLIMID, PLAVIX, PLAVIX, FISH OIL - VITAMIN D3, ALLOPURINOL, ZESTRIL, FOLIC ACID, FENOFIBRATE, ASPIRIN, ATENOLOL, PANTOPRAZOLE, PANTOPRAZOLE, METHYLPREDNISOLONE, LEVOTHYROXINE, IRON, IRON, GLIMEPIRIDE, LISINOPRIL, POTASSIUM CHLORIDE, PROCRIT | Reactions: Influenza, Pneumonia
SafetyReportID: 10003633 Date: 20140312 Report: SafetyReportID: 10003633 | ReceiveDate: 20140312 | Drugs: OMNISCAN, OMNISCAN, OMNISCAN, OMNISCAN, OXYCONTIN, NEURONTIN, THALIDOMIDE, CELEXA, INTRAVENOUS IMMUNOGLOBULIN, OXYCODONE | Reactions: Nephrogenic systemic fibrosis
SafetyReportID: 10003634 Date: 20140312 Report: SafetyReportID: 10003634 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Staphylococcal infection, Oral herpes
SafetyReportID: 10003635 Date: 20140312 Report: SafetyReportID: 10003635 | ReceiveDate: 20140312 | Drugs: CLOZARIL | Reactions: Neutrophil count increased, White blood cell count increased, Abnormal behaviour
SafetyReportID: 10003636 Date: 20140312 Report: SafetyReportID: 10003636 | ReceiveDate: 20140312 | Drugs: GRANULOCYTE MACROPHAGE COLONY STIM FACTOR, CARVEDILOL., FLORINEF ACETATE, PRAVASTATIN, IMA901, LISINOPRIL., CATAPRES, LEVOTHYROXINE, PLETAL, SUNITINIB MALATE, COMPAZINE, CYCLOPHOSPHAMIDE., HYDROCORTISONE., SINGULAIR, AMLODIPINE, HYDRALAZINE, PLAVIX, ASACOL, PROZAC, POTASSIUM CHLORIDE., ADVAIR HFA, PANTOPRAZOLE, FUROSEMIDE. | Reactions: Dehydration
SafetyReportID: 10003637 Date: 20140312 Report: SafetyReportID: 10003637 | ReceiveDate: 20140312 | Drugs: DIVALPROEX SODIUM, DEPAKOTE ER, DILANTIN | Reactions: Hospitalisation, Convulsion, Convulsion
SafetyReportID: 10003638 Date: 20140312 Report: SafetyReportID: 10003638 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Fatigue, Malaise
SafetyReportID: 10003639 Date: 20140312 Report: SafetyReportID: 10003639 | ReceiveDate: 20140312 | Drugs: GLIVEC | Reactions: Lower limb fracture, Syncope
SafetyReportID: 10003640 Date: 20140312 Report: SafetyReportID: 10003640 | ReceiveDate: 20140312 | Drugs: JANUVIA, LOMOTIL (LOPERAMIDE HYDROCHLORIDE) | Reactions: Diarrhoea, Abdominal pain upper
SafetyReportID: 10003641 Date: 20140312 Report: SafetyReportID: 10003641 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, INVEGA, METFORMIN, COGENTIN, BISOPROLOL, COGENTIN | Reactions: Medication residue present
SafetyReportID: 10003642 Date: 20140312 Report: SafetyReportID: 10003642 | ReceiveDate: 20140312 | Drugs: TOFACITINIB CITRATE, TOFACITINIB CITRATE, METHOTREXATE, SEA KELP, ARMOUR THYROID, LOSARTAN, METFORMIN, VITAMIN E, OMEGA 3-6-9, JANUVIA, FOLIC ACID | Reactions: Osteomyelitis
SafetyReportID: 10003643 Date: 20140312 Report: SafetyReportID: 10003643 | ReceiveDate: 20140312 | Drugs: TYVASO, LETAIRIS | Reactions: Hypotension, Fatigue, Chest discomfort, Oxygen saturation decreased, Dizziness
SafetyReportID: 10003644 Date: 20140312 Report: SafetyReportID: 10003644 | ReceiveDate: 20140312 | Drugs: SIMULECT, SIMULECT | Reactions: Death
SafetyReportID: 10003645 Date: 20140312 Report: SafetyReportID: 10003645 | ReceiveDate: 20140312 | Drugs: CUBICIN | Reactions: Death
SafetyReportID: 10003646 Date: 20140312 Report: SafetyReportID: 10003646 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Incorrect dose administered
SafetyReportID: 10003647 Date: 20140312 Report: SafetyReportID: 10003647 | ReceiveDate: 20140312 | Drugs: METFORMIN, COZAAR, ACZ885, WARAN, TROMBYL, AMLODIPIN//AMLODIPINE | Reactions: Erysipelas, Sepsis
SafetyReportID: 10003648 Date: 20140312 Report: SafetyReportID: 10003648 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Fluid retention
SafetyReportID: 10003649 Date: 20140312 Report: SafetyReportID: 10003649 | ReceiveDate: 20140312 | Drugs: CLOZARIL, CLOZARIL, AMISULPRIDE, LORAZEPAM, DEPAKOTE | Reactions: Atrial septal defect, Bundle branch block right, Tachycardia
SafetyReportID: 10003650 Date: 20140312 Report: SafetyReportID: 10003650 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Pancreatic disorder
SafetyReportID: 10003651 Date: 20140312 Report: SafetyReportID: 10003651 | ReceiveDate: 20140312 | Drugs: HUMIRA, HUMIRA, IMURAN, MESALAZINE | Reactions: Rectal haemorrhage, Rectal haemorrhage, Asthenia, Weight decreased
SafetyReportID: 10003652 Date: 20140312 Report: SafetyReportID: 10003652 | ReceiveDate: 20140312 | Drugs: COLCHICINE., COMBIVENT, MULTIVITAMIN /00097801/, PRADAXA, ZOCOR, LETAIRIS, FUROSEMIDE., QVAR, FISH OIL, ALLEGRA, SOLARAZE, SOTALOL., LETAIRIS, FLUTICASONE, LEVOTHROID | Reactions: Weight increased, Oedema peripheral, Fluid retention
SafetyReportID: 10003653 Date: 20140312 Report: SafetyReportID: 10003653 | ReceiveDate: 20140312 | Drugs: GLIVEC | Reactions: Death
SafetyReportID: 10003654 Date: 20140312 Report: SafetyReportID: 10003654 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, DEPAKOTE, KEPPRA, LANTUS, HUMALOG, ATENOLOL, SIMVASTATIN, LISINOPRIL, VITAMIN D NOS | Reactions: Hair growth abnormal, Skin disorder, Alopecia
SafetyReportID: 10003655 Date: 20140312 Report: SafetyReportID: 10003655 | ReceiveDate: 20140312 | Drugs: HUMIRA, HUMIRA, COQ10, MAGNESIUM, VITAMIN B, LOW ESTROGEN BIRTH CONTROL, ADVIL | Reactions: Organising pneumonia, Fall, Lung infection, Urinary tract infection bacterial, Lower respiratory tract infection bacterial, Acute respiratory distress syndrome, Loss of consciousness, Psoriasis, Blood cholesterol increased, Amnesia, Dyspnoea, Headache, Exposure to contaminated water
SafetyReportID: 10003656 Date: 20140312 Report: SafetyReportID: 10003656 | ReceiveDate: 20140312 | Drugs: JAKAFI, SILDENAFIL CITRATE | Reactions: Somnolence, Drug dose omission
SafetyReportID: 10003657 Date: 20140312 Report: SafetyReportID: 10003657 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, ATIVAN, NEURONTIN, SYNTHROID | Reactions: Vomiting, Nausea, Fatigue, Lethargy, Abdominal pain upper
SafetyReportID: 10003658 Date: 20140312 Report: SafetyReportID: 10003658 | ReceiveDate: 20140312 | Drugs: ACLASTA, ACLASTA, ACLASTA | Reactions: Death
SafetyReportID: 10003659 Date: 20140312 Report: SafetyReportID: 10003659 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Sleep disorder, Sinus disorder
SafetyReportID: 10003660 Date: 20140312 Report: SafetyReportID: 10003660 | ReceiveDate: 20140312 | Drugs: GILENYA | Reactions: Chest pain, Tremor, Headache
SafetyReportID: 10003661 Date: 20140312 Report: SafetyReportID: 10003661 | ReceiveDate: 20140312 | Drugs: AMPYRA | Reactions: Depression, Wheelchair user, Drug effect decreased
SafetyReportID: 10003662 Date: 20140312 Report: SafetyReportID: 10003662 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, ASA, FISH OIL, LEVOTHYROXINE, FOLIC ACID | Reactions: Platelet count increased, White blood cell count increased, Drug ineffective
SafetyReportID: 10003663 Date: 20140312 Report: SafetyReportID: 10003663 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Rash
SafetyReportID: 10003664 Date: 20140312 Report: SafetyReportID: 10003664 | ReceiveDate: 20140312 | Drugs: AZILECT, CARBIDOPA AND LEVODOPA, DIOVAN, DIABETES MEDICATION | Reactions: Disease progression, Depression, Confusional state, Musculoskeletal stiffness, Tremor, Dyskinesia, Movement disorder
SafetyReportID: 10003665 Date: 20140312 Report: SafetyReportID: 10003665 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Malaise, Ear pruritus, Abnormal sensation in eye, Ear swelling, Pruritus, Tinnitus, Swelling
SafetyReportID: 10003666 Date: 20140312 Report: SafetyReportID: 10003666 | ReceiveDate: 20140312 | Drugs: NUVIGIL | Reactions: Reflux laryngitis
SafetyReportID: 10003667 Date: 20140312 Report: SafetyReportID: 10003667 | ReceiveDate: 20140312 | Drugs: AFINITOR | Reactions: Death
SafetyReportID: 10003668 Date: 20140312 Report: SafetyReportID: 10003668 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Dizziness, Lethargy, Gait disturbance
SafetyReportID: 10003669 Date: 20140312 Report: SafetyReportID: 10003669 | ReceiveDate: 20140312 | Drugs: DEXTROAMPHETAMINE SULFATE | Reactions: Coeliac disease
SafetyReportID: 10003670 Date: 20140312 Report: SafetyReportID: 10003670 | ReceiveDate: 20140312 | Drugs: HUMIRA, OMEPRAZOL, SOBRIL, ALVEDON, VOLTAREN | Reactions: Blindness
SafetyReportID: 10003671 Date: 20140312 Report: SafetyReportID: 10003671 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Dyspnoea, Oedema peripheral
SafetyReportID: 10003672 Date: 20140312 Report: SafetyReportID: 10003672 | ReceiveDate: 20140312 | Drugs: AZILECT, NEUPRO | Reactions: Hypertension, Blood pressure increased, Hyperhidrosis, Hyperhidrosis
SafetyReportID: 10003673 Date: 20140312 Report: SafetyReportID: 10003673 | ReceiveDate: 20140312 | Drugs: GILENYA | Reactions: Multiple sclerosis
SafetyReportID: 10003674 Date: 20140312 Report: SafetyReportID: 10003674 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Hypersensitivity, Alopecia
SafetyReportID: 10003675 Date: 20140312 Report: SafetyReportID: 10003675 | ReceiveDate: 20140312 | Drugs: NEXPLANON, METRONIDAZOLE, SLIMQUICK | Reactions: Implant site pruritus, Implant site erythema
SafetyReportID: 10003676 Date: 20140312 Report: SafetyReportID: 10003676 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Wrist fracture, Arthritis
SafetyReportID: 10003677 Date: 20140312 Report: SafetyReportID: 10003677 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Abdominal discomfort
SafetyReportID: 10003678 Date: 20140312 Report: SafetyReportID: 10003678 | ReceiveDate: 20140312 | Drugs: JANUMET | Reactions: Neoplasm malignant, Metastasis
SafetyReportID: 10003679 Date: 20140312 Report: SafetyReportID: 10003679 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS, ADCIRCA | Reactions: Fall, Head injury, Arthralgia, Urinary tract infection
SafetyReportID: 10003680 Date: 20140312 Report: SafetyReportID: 10003680 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Dyspnoea exertional
SafetyReportID: 10003681 Date: 20140312 Report: SafetyReportID: 10003681 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, TRAZODONE, SEROQUEL | Reactions: Tremor
SafetyReportID: 10003682 Date: 20140312 Report: SafetyReportID: 10003682 | ReceiveDate: 20140312 | Drugs: KALYDECO | Reactions: Asthenia, Ear infection, Increased viscosity of bronchial secretion, Sinus disorder
SafetyReportID: 10003683 Date: 20140312 Report: SafetyReportID: 10003683 | ReceiveDate: 20140312 | Drugs: PROVENTIL | Reactions: Chronic obstructive pulmonary disease, Endotracheal intubation, Acute respiratory failure, Hyperglycaemia, Bronchitis pneumococcal, Bronchitis
SafetyReportID: 10003684 Date: 20140312 Report: SafetyReportID: 10003684 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS, LETAIRIS | Reactions: Fatigue
SafetyReportID: 10003685 Date: 20140312 Report: SafetyReportID: 10003685 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, DEPAKENE | Reactions: Drug level below therapeutic, Drug level below therapeutic
SafetyReportID: 10003686 Date: 20140312 Report: SafetyReportID: 10003686 | ReceiveDate: 20140312 | Drugs: OMNISCAN, OMNISCAN, MULTIHANCE, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST, MAGNEVIST | Reactions: Nephrogenic systemic fibrosis
SafetyReportID: 10003687 Date: 20140312 Report: SafetyReportID: 10003687 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, DEPAKOTE, DEPAKOTE, LEXAPRO, LEXAPRO, LEXAPRO, LEXAPRO, SEROQUEL, SEROQUEL, SEROQUEL, SYNTHROID, CLOMIPRAMINE, METOPROLOL | Reactions: Somnolence, Trismus, Fatigue
SafetyReportID: 10003688 Date: 20140312 Report: SafetyReportID: 10003688 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Feeling abnormal, Insomnia, Unevaluable event, Somnolence, Dizziness
SafetyReportID: 10003689 Date: 20140312 Report: SafetyReportID: 10003689 | ReceiveDate: 20140312 | Drugs: JAKAFI, LEVOTHYROXINE, SPIRIVA | Reactions: Tooth loss, Pain
SafetyReportID: 10003690 Date: 20140312 Report: SafetyReportID: 10003690 | ReceiveDate: 20140312 | Drugs: AUBAGIO | Reactions: Rhinalgia, Facial pain, Mobility decreased, Seizure
SafetyReportID: 10003691 Date: 20140312 Report: SafetyReportID: 10003691 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Weight increased
SafetyReportID: 10003692 Date: 20140312 Report: SafetyReportID: 10003692 | ReceiveDate: 20140312 | Drugs: NEXPLANON | Reactions: Implant site irritation, Implant site bruising
SafetyReportID: 10003693 Date: 20140312 Report: SafetyReportID: 10003693 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Oedema peripheral, Oedema, Dyspnoea
SafetyReportID: 10003694 Date: 20140312 Report: SafetyReportID: 10003694 | ReceiveDate: 20140312 | Drugs: SANDOSTATIN LAR DEPOT | Reactions: Blood sodium decreased, Cholelithiasis, Hepatic mass, Hyperglycaemia, Dyspnoea, Inappropriate antidiuretic hormone secretion
SafetyReportID: 10003695 Date: 20140312 Report: SafetyReportID: 10003695 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Nausea
SafetyReportID: 10003696 Date: 20140312 Report: SafetyReportID: 10003696 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS, LETAIRIS, LETAIRIS, LETAIRIS | Reactions: Peripheral swelling
SafetyReportID: 10003697 Date: 20140312 Report: SafetyReportID: 10003697 | ReceiveDate: 20140312 | Drugs: SEVOFLURANE, USP | Reactions: Hyperthermia malignant
SafetyReportID: 10003698 Date: 20140312 Report: SafetyReportID: 10003698 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Fallot^s tetralogy, Cleft palate, Autism, Foetal exposure during pregnancy
SafetyReportID: 10003699 Date: 20140312 Report: SafetyReportID: 10003699 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Liver function test abnormal
SafetyReportID: 10003700 Date: 20140312 Report: SafetyReportID: 10003700 | ReceiveDate: 20140312 | Drugs: TREANDA | Reactions: Neuropathy peripheral
SafetyReportID: 10003701 Date: 20140312 Report: SafetyReportID: 10003701 | ReceiveDate: 20140312 | Drugs: DIOVAN, DILTIAZEM, ECOTRIN, ATORVASTATIN, LIPITOR, PERFOROMIST, BUDESONIDE, SPIRIVA, PREDNISONE, CLOTRIMAZOLE, CLONAZEPAM, VENTOLIN HFA, GAMUNEX C, MULTI-VIT | Reactions: Chronic obstructive pulmonary disease, Emphysema, Bronchitis, Dyspnoea, Stress, Anxiety
SafetyReportID: 10003702 Date: 20140312 Report: SafetyReportID: 10003702 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, DEPAKOTE, DEPAKOTE, NORVASC | Reactions: Somnolence, Tremor
SafetyReportID: 10003703 Date: 20140312 Report: SafetyReportID: 10003703 | ReceiveDate: 20140312 | Drugs: LUCRIN | Reactions: Unevaluable event
SafetyReportID: 10003704 Date: 20140312 Report: SafetyReportID: 10003704 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI | Reactions: Hair texture abnormal
SafetyReportID: 10003705 Date: 20140312 Report: SafetyReportID: 10003705 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Blood potassium increased
SafetyReportID: 10003706 Date: 20140312 Report: SafetyReportID: 10003706 | ReceiveDate: 20140312 | Drugs: TOBI, TOBI PODHALER, ADVAIR, VENTOLINE, CREON, NASONEX | Reactions: Lung infection
SafetyReportID: 10003707 Date: 20140312 Report: SafetyReportID: 10003707 | ReceiveDate: 20140312 | Drugs: REBIF, REBIF, WELLBUTRIN, LITHIUM, ATIVAN, NEURONTIN | Reactions: Suicide attempt, Antipsychotic drug level below therapeutic, Mental disorder, Antipsychotic drug level above therapeutic, Adverse reaction, Suicidal ideation, Dizziness, Aphasia, Syncope, Memory impairment, Bronchitis, Irritability, Feeling abnormal, Amnesia, Conversion disorder, Visual impairment, Vision blurred, Headache, Pyrexia, Pain, Injection site reaction, Injection site haemorrhage, Fatigue
SafetyReportID: 10003708 Date: 20140312 Report: SafetyReportID: 10003708 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Confusional state, Hyperammonaemia
SafetyReportID: 10003709 Date: 20140312 Report: SafetyReportID: 10003709 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Diarrhoea
SafetyReportID: 10003710 Date: 20140312 Report: SafetyReportID: 10003710 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Weight increased, Abdominal pain upper, Dyspnoea, Cough
SafetyReportID: 10003711 Date: 20140312 Report: SafetyReportID: 10003711 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Eye movement disorder, Thinking abnormal
SafetyReportID: 10003712 Date: 20140312 Report: SafetyReportID: 10003712 | ReceiveDate: 20140312 | Drugs: CICLOSPORIN, PREDNISOLONE, PREDNISOLONE, PREDNISOLONE, METHYLPREDNISOLONE, BOSENTAN, CYCLOPHOSPHAMIDE, MIZORIBINE, BERAPROST, AZATHIOPRINE | Reactions: Respiratory distress, Pulmonary oedema, Dyspnoea, Pulmonary alveolar haemorrhage, Pulmonary veno-occlusive disease, Therapeutic response decreased, Drug ineffective
SafetyReportID: 10003713 Date: 20140312 Report: SafetyReportID: 10003713 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, ATORVASTATIN, APEXICON, MENEST /00073001/, VOLTAREN GEL /00372301/, CIPRODEX /00697202/, ALEVE, ASPIRIN, SYNTHROID | Reactions: Rash, Dyspnoea
SafetyReportID: 10003714 Date: 20140312 Report: SafetyReportID: 10003714 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Hypersensitivity
SafetyReportID: 10003715 Date: 20140312 Report: SafetyReportID: 10003715 | ReceiveDate: 20140312 | Drugs: ONFI | Reactions: Limb discomfort, Crying
SafetyReportID: 10003716 Date: 20140312 Report: SafetyReportID: 10003716 | ReceiveDate: 20140312 | Drugs: CORICIDIN HBP COLD AND FLU | Reactions: Drug ineffective for unapproved indication
SafetyReportID: 10003717 Date: 20140312 Report: SafetyReportID: 10003717 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, JAKAFI, CELEBREX, LASIX, ZANTAC, METOPROLOL, ALLOPURINOL, ZYRTEC, IMODIUM, ASPIRIN LOW EC, CRANBERRY, SUPER OMEGA- 3, PLAVIX | Reactions: Haemoglobin decreased, Weight increased
SafetyReportID: 10003718 Date: 20140312 Report: SafetyReportID: 10003718 | ReceiveDate: 20140312 | Drugs: OMNISCAN, GADOLINIUM (UNSPECIFIED), MAGNEVIST, OPTIMARK, MULTIHANCE, PROHANCE | Reactions: Nephrogenic systemic fibrosis
SafetyReportID: 10003719 Date: 20140312 Report: SafetyReportID: 10003719 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Hyperammonaemia
SafetyReportID: 10003720 Date: 20140312 Report: SafetyReportID: 10003720 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10003721 Date: 20140312 Report: SafetyReportID: 10003721 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Flat affect, Thought withdrawal, Mental impairment, Dyspnoea, Local swelling
SafetyReportID: 10003722 Date: 20140312 Report: SafetyReportID: 10003722 | ReceiveDate: 20140312 | Drugs: NEULASTA | Reactions: Pneumonia
SafetyReportID: 10003723 Date: 20140312 Report: SafetyReportID: 10003723 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Pulmonary valve stenosis congenital, Congenital anomaly, Foetal exposure during pregnancy
SafetyReportID: 10003724 Date: 20140312 Report: SafetyReportID: 10003724 | ReceiveDate: 20140312 | Drugs: OXYTROL FOR WOMEN | Reactions: Drug ineffective
SafetyReportID: 10003725 Date: 20140312 Report: SafetyReportID: 10003725 | ReceiveDate: 20140312 | Drugs: COMETRIQ | Reactions: Death, Dyspnoea, Fatigue, Dysphonia, Diarrhoea
SafetyReportID: 10003726 Date: 20140312 Report: SafetyReportID: 10003726 | ReceiveDate: 20140312 | Drugs: TEGRETOL, TEGRETOL, TEGRETOL, DEPAKENE, DEPAKENE, EPAMIN, BENZODIAZEPINES | Reactions: Convulsion, Dyspnoea, Skin discolouration, Lip discolouration, Status epilepticus, Epilepsy, Fall, Tooth loss, Central nervous system lesion, Cognitive disorder, Drug withdrawal syndrome, Quality of life decreased, General physical health deterioration, Mental impairment, Disorientation, Affect lability, Gait disturbance, Speech disorder, Anticonvulsant drug level decreased, Drug effect decreased
SafetyReportID: 10003727 Date: 20140312 Report: SafetyReportID: 10003727 | ReceiveDate: 20140312 | Drugs: NEULASTA | Reactions: Investigation
SafetyReportID: 10003728 Date: 20140312 Report: SafetyReportID: 10003728 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Hyperammonaemia
SafetyReportID: 10003729 Date: 20140312 Report: SafetyReportID: 10003729 | ReceiveDate: 20140312 | Drugs: CRESTOR, TAHOR | Reactions: Liver disorder, Transaminases increased
SafetyReportID: 10003730 Date: 20140312 Report: SafetyReportID: 10003730 | ReceiveDate: 20140312 | Drugs: HOLOXAN, UROMITEXAN, RITUXIMAB, ETOPOSIDE, ACETAMINOPHEN, DIPHENHYDRAMINE | Reactions: Disease progression
SafetyReportID: 10003731 Date: 20140312 Report: SafetyReportID: 10003731 | ReceiveDate: 20140312 | Drugs: OXYTROL FOR WOMEN | Reactions: Erythema, Pruritus, Wrong technique in drug usage process, Product adhesion issue
SafetyReportID: 10003732 Date: 20140312 Report: SafetyReportID: 10003732 | ReceiveDate: 20140312 | Drugs: ANTIOXIDENT MULTIPLE VITAMINS (A,D,E,K-INTENSIVE) AND MINERALS, KLONOPIN, VENLAFAXINE, DEPAKOTE, ADVAIR, COMBIVENT, ALBUTEROL, LITHIUM | Reactions: Diarrhoea
SafetyReportID: 10003733 Date: 20140312 Report: SafetyReportID: 10003733 | ReceiveDate: 20140312 | Drugs: IMPLANON | Reactions: Abortion induced, Unintended pregnancy, Medical device complication, Product quality issue, Drug dose omission
SafetyReportID: 10003734 Date: 20140312 Report: SafetyReportID: 10003734 | ReceiveDate: 20140312 | Drugs: HOLOXAN, UROMITEXAN, RITUXIMAB, ETOPOSIDE, ACETAMINOPHEN, DIPHENHYDRAMINE | Reactions: Disease progression
SafetyReportID: 10003735 Date: 20140312 Report: SafetyReportID: 10003735 | ReceiveDate: 20140312 | Drugs: WARFARIN, LETAIRIS | Reactions: Haemorrhage, Otorrhoea
SafetyReportID: 10003736 Date: 20140312 Report: SafetyReportID: 10003736 | ReceiveDate: 20140312 | Drugs: INEGY, AXELER, ALDACTONE (CANRENOATE POTASSIUM), EUPRESSYL, AUGMENTIN | Reactions: Renal failure acute
SafetyReportID: 10003737 Date: 20140312 Report: SafetyReportID: 10003737 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, DEPAKOTE | Reactions: Hair disorder, Osteoporosis, Alopecia
SafetyReportID: 10003738 Date: 20140312 Report: SafetyReportID: 10003738 | ReceiveDate: 20140312 | Drugs: COZAAR | Reactions: Exposure during pregnancy
SafetyReportID: 10003739 Date: 20140312 Report: SafetyReportID: 10003739 | ReceiveDate: 20140312 | Drugs: IRON, LETAIRIS | Reactions: Diarrhoea
SafetyReportID: 10003740 Date: 20140312 Report: SafetyReportID: 10003740 | ReceiveDate: 20140312 | Drugs: PREDNISOLONE, PREDNISOLONE, AMIAS, BUMETANIDE, CARDICOR, INFLUENZA VIRUS, OMEPRAZOLE, ASPIRIN, FOLIC ACID | Reactions: Type 2 diabetes mellitus
SafetyReportID: 10003741 Date: 20140312 Report: SafetyReportID: 10003741 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, PROZAC, OXYCONTIN, REMERON, CARBIDOPA/LEVODOPA, MIRAPEX, XANAX, 2 OTHER UNKNOWN MEDICATIONS | Reactions: Parkinson^s disease, Neuropathy peripheral, Intervertebral disc disorder, Local swelling, Oedema
SafetyReportID: 10003742 Date: 20140312 Report: SafetyReportID: 10003742 | ReceiveDate: 20140312 | Drugs: GILENYA | Reactions: Cholelithiasis
SafetyReportID: 10003743 Date: 20140312 Report: SafetyReportID: 10003743 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Headache
SafetyReportID: 10003744 Date: 20140312 Report: SafetyReportID: 10003744 | ReceiveDate: 20140312 | Drugs: MIRENA, MIRENA | Reactions: Device expulsion, Device expulsion
SafetyReportID: 10003745 Date: 20140312 Report: SafetyReportID: 10003745 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, ONFI | Reactions: Sedation
SafetyReportID: 10003746 Date: 20140312 Report: SafetyReportID: 10003746 | ReceiveDate: 20140312 | Drugs: PRINIVIL | Reactions: Exposure during pregnancy
SafetyReportID: 10003747 Date: 20140312 Report: SafetyReportID: 10003747 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Tooth disorder
SafetyReportID: 10003748 Date: 20140312 Report: SafetyReportID: 10003748 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, LAMICTAL, QUETIAPINE, CLONAZEPAM, ALPRAZOLAM | Reactions: Bone marrow failure, Bone marrow failure, Neutrophil count decreased
SafetyReportID: 10003749 Date: 20140312 Report: SafetyReportID: 10003749 | ReceiveDate: 20140312 | Drugs: ACLASTA, ACLASTA, PANTOZOLE, FUROSEMIDE, CALCIUM, VITAMIN D3, MOVICOLON, ZYPREXA, SPIRONOLACTON, IPRAMOL, THEOPHYLLINE, FLIXOTIDE | Reactions: Chronic obstructive pulmonary disease
SafetyReportID: 10003750 Date: 20140312 Report: SafetyReportID: 10003750 | ReceiveDate: 20140312 | Drugs: EXELON PATCH | Reactions: Dementia Alzheimer^s type, Hip fracture, Cerebrovascular accident
SafetyReportID: 10003751 Date: 20140312 Report: SafetyReportID: 10003751 | ReceiveDate: 20140312 | Drugs: OMNISCAN, OMNISCAN, OMNISCAN | Reactions: Nephrogenic systemic fibrosis
SafetyReportID: 10003752 Date: 20140312 Report: SafetyReportID: 10003752 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Urinary tract infection
SafetyReportID: 10003753 Date: 20140312 Report: SafetyReportID: 10003753 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Pancreatitis
SafetyReportID: 10003754 Date: 20140312 Report: SafetyReportID: 10003754 | ReceiveDate: 20140312 | Drugs: ADIRO 100, FUROSEMIDE, DEXKETOPROFEN, CLEXANE, METILDIGOXIN, METHYLPREDNISOLONE, PANTOPRAZOLE | Reactions: Hypoacusis
SafetyReportID: 10003755 Date: 20140312 Report: SafetyReportID: 10003755 | ReceiveDate: 20140312 | Drugs: DIANEAL LOW CALCIUM, DIANEAL LOW CALCIUM, DIANEAL LOW CALCIUM | Reactions: Pneumonia
SafetyReportID: 10003756 Date: 20140312 Report: SafetyReportID: 10003756 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, LITHIUM, LEXAPRO FILM-COATED TABLETS, LUVOX, PRISTIQ, PRISTIQ, PRISTIQ, PRISTIQ, ZOLOFT, PROZAC, LAMICTAL, PAXIL, VALIUM, KLONOPIN, TOPAMAX, ABILIFY, WELLBUTRIN, CELEXA, CYMBALTA, ANAFRANIL, IMIPRAMINE, TEGRETOL, SEROQUEL, SEROQUEL XR, XANAX, ADDERALL, UNSPECIFIED MEDICATION | Reactions: Activities of daily living impaired, Crying, Drug ineffective, Depression
SafetyReportID: 10003757 Date: 20140312 Report: SafetyReportID: 10003757 | ReceiveDate: 20140312 | Drugs: NEXPLANON | Reactions: Medical device complication
SafetyReportID: 10003758 Date: 20140312 Report: SafetyReportID: 10003758 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10003759 Date: 20140312 Report: SafetyReportID: 10003759 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Drug hypersensitivity
SafetyReportID: 10003760 Date: 20140312 Report: SafetyReportID: 10003760 | ReceiveDate: 20140312 | Drugs: HOLOXAN, UROMITEXAN, RITUXIMAB, ETOPOSIDE, ACETAMINOPHEN, DIPHENHYDRAMINE | Reactions: Disease progression
SafetyReportID: 10003761 Date: 20140312 Report: SafetyReportID: 10003761 | ReceiveDate: 20140312 | Drugs: AFRIN NO DRIP | Reactions: Drug ineffective
SafetyReportID: 10003762 Date: 20140312 Report: SafetyReportID: 10003762 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Pancytopenia
SafetyReportID: 10003763 Date: 20140312 Report: SafetyReportID: 10003763 | ReceiveDate: 20140312 | Drugs: 70% DEXTROSE INJECTION USP, POTASSIUM CHLORIDE 0.4MEQ/ML, 5% SODIUM CHLORIDE INJECTION, STERILE WATER FOR INJECTION, HEPATAMINE 8%, K PHOSPHATE, CA GLUCONATE | Reactions: Incorrect dosage administered, Product compounding quality issue, No adverse event
SafetyReportID: 10003764 Date: 20140312 Report: SafetyReportID: 10003764 | ReceiveDate: 20140312 | Drugs: ALENDRONATE SODIUM., FOSAMAX, PREMARIN, ATENOLOL., FOSAMAX, ACIPHEX, FOSAMAX PLUS D, HYDROCHLOROTHIAZIDE. | Reactions: Low turnover osteopathy, Femur fracture, Reflux laryngitis, Gingival recession, Intramedullary rod insertion, Rib fracture, Bone graft, Squamous cell carcinoma of skin, Osteoporosis, Periodontal operation
SafetyReportID: 10003765 Date: 20140312 Report: SafetyReportID: 10003765 | ReceiveDate: 20140312 | Drugs: ENBREL | Reactions: Visual impairment
SafetyReportID: 10003766 Date: 20140312 Report: SafetyReportID: 10003766 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Adverse event
SafetyReportID: 10003767 Date: 20140312 Report: SafetyReportID: 10003767 | ReceiveDate: 20140312 | Drugs: HOLOXAN, UROMITEXAN, RITUXIMAB, ETOPOSIDE, ACETAMINOPHEN, DIPHENHYDRAMINE | Reactions: Disease progression
SafetyReportID: 10003768 Date: 20140312 Report: SafetyReportID: 10003768 | ReceiveDate: 20140312 | Drugs: DOXAZOSIN, ATENOLOL, DUTASTERIDE, TAMSULOSIN HYDROCHLORIDE | Reactions: Loss of proprioception, Fall, Gait disturbance, Asthenia
SafetyReportID: 10003769 Date: 20140312 Report: SafetyReportID: 10003769 | ReceiveDate: 20140312 | Drugs: PARAGARD 380A, MAGNESIUM, VENLAFAXINE HYDROCHLORIDE | Reactions: Embedded device
SafetyReportID: 10003770 Date: 20140312 Report: SafetyReportID: 10003770 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Back pain, Back injury, Amnesia
SafetyReportID: 10003771 Date: 20140312 Report: SafetyReportID: 10003771 | ReceiveDate: 20140312 | Drugs: HUMIRA, METHOTREXATE, METHOTREXATE, APRISO, PENTASSA, ABILIFY, CYMBALTA, VALIUM, FENTANYL PATCHES, REGLAN, AMBIEN, OXYCODONE, OMEPRAZOLE, ZOFRAN, TOVIAZ, ENALAPRIL MALEATE, FOLIC ACID | Reactions: Hyponatraemia, Dyspnoea, Pyrexia, Pancreatitis, Influenza, Pneumonia, Sepsis
SafetyReportID: 10003772 Date: 20140312 Report: SafetyReportID: 10003772 | ReceiveDate: 20140312 | Drugs: HOLOXAN, UROMITEXAN, RITUXIMAB, ETOPOSIDE, ACETAMINOPHEN, DIPHENHYDRAMINE | Reactions: Disease progression
SafetyReportID: 10003773 Date: 20140312 Report: SafetyReportID: 10003773 | ReceiveDate: 20140312 | Drugs: DIANEAL LOW CALCIUM | Reactions: Discomfort
SafetyReportID: 10003774 Date: 20140312 Report: SafetyReportID: 10003774 | ReceiveDate: 20140312 | Drugs: ABRAXANE, ABRAXANE, GEMCITABINE, GEMCITABINE | Reactions: Dizziness
SafetyReportID: 10003775 Date: 20140312 Report: SafetyReportID: 10003775 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Wrong technique in drug usage process, Drug intolerance
SafetyReportID: 10003776 Date: 20140312 Report: SafetyReportID: 10003776 | ReceiveDate: 20140312 | Drugs: HOLOXAN, UROMITEXAN, RITUXIMAB, ETOPOSIDE, ACETAMINOPHEN, DIPHENHYDRAMINE | Reactions: Disease progression
SafetyReportID: 10003777 Date: 20140312 Report: SafetyReportID: 10003777 | ReceiveDate: 20140312 | Drugs: NEXPLANON | Reactions: Device difficult to use
SafetyReportID: 10003778 Date: 20140312 Report: SafetyReportID: 10003778 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Off label use, Drug ineffective
SafetyReportID: 10003779 Date: 20140312 Report: SafetyReportID: 10003779 | ReceiveDate: 20140312 | Drugs: DIANEAL LOW CALCIUM (ULTRABAG), DIANEAL LOW CALCIUM (ULTRABAG) | Reactions: Myocardial infarction
SafetyReportID: 10003780 Date: 20140312 Report: SafetyReportID: 10003780 | ReceiveDate: 20140312 | Drugs: NUVARING | Reactions: Device expulsion, Inappropriate schedule of drug administration, No adverse event
SafetyReportID: 10003781 Date: 20140312 Report: SafetyReportID: 10003781 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Faeces pale, Headache, Feeling jittery, Heart rate increased, Insomnia
SafetyReportID: 10003782 Date: 20140312 Report: SafetyReportID: 10003782 | ReceiveDate: 20140312 | Drugs: HOLOXAN, UROMITEXAN, RITUXIMAB, ETOPOSIDE, ACETAMINOPHEN, DIPHENHYDRAMINE | Reactions: Disease progression
SafetyReportID: 10003783 Date: 20140312 Report: SafetyReportID: 10003783 | ReceiveDate: 20140312 | Drugs: DIANEAL PD2 WITH 1.5% DEXTROSE, DIANEAL PD2 WITH 4.25% DEXTROSE | Reactions: Death
SafetyReportID: 10003784 Date: 20140312 Report: SafetyReportID: 10003784 | ReceiveDate: 20140312 | Drugs: NEULASTA | Reactions: Investigation
SafetyReportID: 10003785 Date: 20140312 Report: SafetyReportID: 10003785 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Ammonia increased, Unevaluable event, Hypersensitivity
SafetyReportID: 10003786 Date: 20140312 Report: SafetyReportID: 10003786 | ReceiveDate: 20140312 | Drugs: HOLOXAN, UROMITEXAN, RITUXIMAB, ETOPOSIDE, ACETAMINOPHEN, DIPHENHYDRAMINE | Reactions: Disease progression
SafetyReportID: 10003787 Date: 20140312 Report: SafetyReportID: 10003787 | ReceiveDate: 20140312 | Drugs: HOLOXAN, UROMITEXAN, RITUXIMAB, ETOPOSIDE, ACETAMINOPHEN, DIPHENHYDRAMINE | Reactions: Disease progression
SafetyReportID: 10003788 Date: 20140312 Report: SafetyReportID: 10003788 | ReceiveDate: 20140312 | Drugs: DIVALPROEX SODIUM | Reactions: Drug ineffective
SafetyReportID: 10003789 Date: 20140312 Report: SafetyReportID: 10003789 | ReceiveDate: 20140312 | Drugs: HOLOXAN, UROMITEXAN, RITUXIMAB, ETOPOSIDE, ACETAMINOPHEN, DIPHENHYDRAMINE | Reactions: Disease progression
SafetyReportID: 10003790 Date: 20140312 Report: SafetyReportID: 10003790 | ReceiveDate: 20140312 | Drugs: HUMIRA, HUMIRA, ANALGETIC DRUG | Reactions: Arthropathy, Osteonecrosis
SafetyReportID: 10003791 Date: 20140312 Report: SafetyReportID: 10003791 | ReceiveDate: 20140312 | Drugs: DIANEAL LOW CALCIUM PERITONEAL DIALYSIS SOLUTION WITH DEXTROSE, DIANEAL LOW CALCIUM PERITONEAL DIALYSIS SOLUTION WITH DEXTROSE | Reactions: Gangrene, Gangrene
SafetyReportID: 10003792 Date: 20140312 Report: SafetyReportID: 10003792 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, KEPPRA, PLAVIX, LISINOPRIL, METOPROLOL, RANEXA, ISOSORBIDE, ASPIRIN, LORAZEPAM, SIMVASTATIN, AMBIEN | Reactions: Grand mal convulsion, Vomiting, Amnesia
SafetyReportID: 10003793 Date: 20140312 Report: SafetyReportID: 10003793 | ReceiveDate: 20140312 | Drugs: DEXAMETHASONE | Reactions: Drug hypersensitivity
SafetyReportID: 10003794 Date: 20140312 Report: SafetyReportID: 10003794 | ReceiveDate: 20140312 | Drugs: HOLOXAN, UROMITEXAN, RITUXIMAB, ETOPOSIDE, ACETAMINOPHEN, DIPHENHYDRAMINE | Reactions: Disease progression
SafetyReportID: 10003795 Date: 20140312 Report: SafetyReportID: 10003795 | ReceiveDate: 20140312 | Drugs: DEPAKOTE SPRINKLE | Reactions: Therapy change, Therapy change
SafetyReportID: 10003796 Date: 20140312 Report: SafetyReportID: 10003796 | ReceiveDate: 20140312 | Drugs: RITUXIMAB, ETOPOSIDE, ACETAMINOPHEN, DIPHENHYDRAMINE, HOLOXAN, UROMITEXAN | Reactions: Disease progression
SafetyReportID: 10003797 Date: 20140312 Report: SafetyReportID: 10003797 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Full blood count abnormal, Adverse drug reaction, Increased tendency to bruise
SafetyReportID: 10003798 Date: 20140312 Report: SafetyReportID: 10003798 | ReceiveDate: 20140312 | Drugs: DIANEAL LOW CALCIUM, DIANEAL LOW CALCIUM, DIANEAL LOW CALCIUM, DIANEAL LOW CALCIUM, EXTRANEAL, EXTRANEAL | Reactions: Sepsis, Tooth infection
SafetyReportID: 10003799 Date: 20140312 Report: SafetyReportID: 10003799 | ReceiveDate: 20140312 | Drugs: HOLOXAN, UROMITEXAN, RITUXIMAB, ETOPOSIDE, ACETAMINOPHEN, DIPHENHYDRAMINE | Reactions: Neurological decompensation, Disease progression
SafetyReportID: 10003800 Date: 20140312 Report: SafetyReportID: 10003800 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, DEPAKOTE, DEPAKOTE, DEPAKOTE ER, DEPAKOTE ER, DEPAKOTE ER | Reactions: Malaise, Drug dispensing error, Rash, Nausea, Vomiting, Off label use
SafetyReportID: 10003801 Date: 20140312 Report: SafetyReportID: 10003801 | ReceiveDate: 20140312 | Drugs: FEIBA 500 U INJEKTIO/INFUUSIOKUIVA-AINE JA LIUOTIN, LIUOSTA VARTEN, FEIBA 500 U INJEKTIO/INFUUSIOKUIVA-AINE JA LIUOTIN, LIUOSTA VARTEN | Reactions: Thrombosis, Device issue, Arteriovenous fistula site complication
SafetyReportID: 10003802 Date: 20140312 Report: SafetyReportID: 10003802 | ReceiveDate: 20140312 | Drugs: DIANEAL PD4 SOLUTION WITH 1.5% DEXTROSE AND 2.5 MEQ/L CALCIUM, EXTRANEAL, DILANTIN | Reactions: Convulsion, Pulmonary oedema
SafetyReportID: 10003803 Date: 20140312 Report: SafetyReportID: 10003803 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, LISINOPRIL/HYDROCHLOROTHIAZIDE, GLIPIZIDE, METFORMIN | Reactions: Balance disorder, Gait disturbance, Gait disturbance
SafetyReportID: 10003804 Date: 20140312 Report: SafetyReportID: 10003804 | ReceiveDate: 20140312 | Drugs: DIANEAL LOW CALCIUM | Reactions: Rib fracture
SafetyReportID: 10003805 Date: 20140312 Report: SafetyReportID: 10003805 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Trigeminal neuralgia, Dyskinesia, Facial pain, Tremor
SafetyReportID: 10003806 Date: 20140312 Report: SafetyReportID: 10003806 | ReceiveDate: 20140312 | Drugs: DIANEAL PD2, DIANEAL PD2 | Reactions: Gastroenteritis viral, Peritonitis bacterial, Diarrhoea
SafetyReportID: 10003807 Date: 20140312 Report: SafetyReportID: 10003807 | ReceiveDate: 20140312 | Drugs: AZACITIDINE INJECTABLE, AZACITIDINE INJECTABLE, AZACITIDINE INJECTABLE, AZACITIDINE INJECTABLE, POSACONAZOLE, ESOMEPRAZOLE, PRAVASTATIN, PRAVASTATIN, COLOXYL C SENNA, NEXIUM, VALTREX, MAXOLON, MAXOLON, MAXOLON, CARMELLOSE, CARMELLOSE | Reactions: Fluid overload, Infected cyst, Febrile neutropenia, Febrile neutropenia, Enterobacter pneumonia, Corynebacterium infection, Pharyngitis
SafetyReportID: 10003808 Date: 20140312 Report: SafetyReportID: 10003808 | ReceiveDate: 20140312 | Drugs: HUMIRA | Reactions: Malaise
SafetyReportID: 10003809 Date: 20140312 Report: SafetyReportID: 10003809 | ReceiveDate: 20140312 | Drugs: DIANEAL LOW CALCIUM PERITONEAL DIALYSIS SOLUTION WITH DEXTROSE, DIANEAL LOW CALCIUM PERITONEAL DIALYSIS SOLUTION WITH DEXTROSE, EXTRANEAL, DIANEAL LOW CALCIUM PERITONEAL DIALYSIS SOLUTION WITH DEXTROSE, DIANEAL LOW CALCIUM PERITONEAL DIALYSIS SOLUTION WITH DEXTROSE | Reactions: Hypotension, Eye movement disorder, Heart rate decreased, Pulse abnormal, Blood pressure diastolic increased
SafetyReportID: 10003810 Date: 20140312 Report: SafetyReportID: 10003810 | ReceiveDate: 20140312 | Drugs: VALPROATE SEMISODIUM, VALPROATE SEMISODIUM, OLANZAPINE, OLANZAPINE, LORAZEPAM, CITALOPRAM | Reactions: Carnitine deficiency, Hyperammonaemia, Irritability, Affective disorder, Condition aggravated
SafetyReportID: 10003811 Date: 20140312 Report: SafetyReportID: 10003811 | ReceiveDate: 20140312 | Drugs: DIANEAL LOW CALCIUM | Reactions: Staphylococcal infection, Catheter site infection
SafetyReportID: 10003812 Date: 20140312 Report: SafetyReportID: 10003812 | ReceiveDate: 20140312 | Drugs: HUMIRA, METHOTREXATE, ACETAMINOPHEN | Reactions: Muscular weakness, Paraesthesia
SafetyReportID: 10003813 Date: 20140312 Report: SafetyReportID: 10003813 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, METHOTREXATE, PREDNISONE, FOLIC ACID, LABETALOL, LABETALOL, DIAZEPAM, NITRO STAT, PLAVIX, FLEXERIL, FLEXERIL, PHENERGAN, AMARIL, PROTONIX, LEUCOVORIN, LASIX, OXYCODONE, OXYCONTIN, TEMAZEPAM, FLAX SEED OIL, VOLTAREN GEL | Reactions: Pancreatitis, Off label use
SafetyReportID: 10003814 Date: 20140312 Report: SafetyReportID: 10003814 | ReceiveDate: 20140312 | Drugs: DIANEAL LOW CALCIUM, DIANEAL LOW CALCIUM, DIANEAL LOW CALCIUM, DIANEAL LOW CALCIUM (ULTRABAG), DIANEAL LOW CALCIUM (ULTRABAG), DIANEAL LOW CALCIUM (ULTRABAG) | Reactions: Pulmonary haemorrhage, Swelling, Anaemia, Hypotension
SafetyReportID: 10003815 Date: 20140312 Report: SafetyReportID: 10003815 | ReceiveDate: 20140312 | Drugs: DIOVAN | Reactions: Pneumonia, Urinary tract infection, Malaise, Cardiac disorder, Cardiovascular disorder, Blood glucose increased
SafetyReportID: 10003816 Date: 20140312 Report: SafetyReportID: 10003816 | ReceiveDate: 20140312 | Drugs: DOCETAXEL (UNKNOWN), HERCEPTIN | Reactions: Anaemia
SafetyReportID: 10003817 Date: 20140312 Report: SafetyReportID: 10003817 | ReceiveDate: 20140312 | Drugs: DIANEAL-N PD-4 1.5 PD SOLUTION | Reactions: Sepsis
SafetyReportID: 10003818 Date: 20140312 Report: SafetyReportID: 10003818 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, SABRIL | Reactions: Anger, Hallucination
SafetyReportID: 10003819 Date: 20140312 Report: SafetyReportID: 10003819 | ReceiveDate: 20140312 | Drugs: QUETIAPINE (UNKNOWN) | Reactions: Mixed liver injury
SafetyReportID: 10003820 Date: 20140312 Report: SafetyReportID: 10003820 | ReceiveDate: 20140312 | Drugs: DIANEAL LOW CALCIUM, DIANEAL LOW CALCIUM, DIANEAL LOW CALCIUM | Reactions: Urinary tract infection, Hypophagia, Dehydration
SafetyReportID: 10003821 Date: 20140312 Report: SafetyReportID: 10003821 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, CLOZAPINE | Reactions: Granulocytopenia, Leukopenia
SafetyReportID: 10003822 Date: 20140312 Report: SafetyReportID: 10003822 | ReceiveDate: 20140312 | Drugs: DIANEAL LOW CALCIUM (ULTRABAG), DIANEAL LOW CALCIUM (ULTRABAG), DIANEAL LOW CALCIUM (ULTRABAG), DIANEAL LOW CALCIUM (ULTRABAG) | Reactions: Headache, Toothache, Peritonitis, Peritoneal dialysis complication
SafetyReportID: 10003823 Date: 20140312 Report: SafetyReportID: 10003823 | ReceiveDate: 20140312 | Drugs: AUBAGIO | Reactions: Hypotension, Pneumonia
SafetyReportID: 10003824 Date: 20140312 Report: SafetyReportID: 10003824 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Rash
SafetyReportID: 10003825 Date: 20140312 Report: SafetyReportID: 10003825 | ReceiveDate: 20140312 | Drugs: DIANEAL LOW CALCIUM | Reactions: Post procedural haemorrhage, Acidosis
SafetyReportID: 10003826 Date: 20140312 Report: SafetyReportID: 10003826 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Suicidal ideation, Depression
SafetyReportID: 10003827 Date: 20140312 Report: SafetyReportID: 10003827 | ReceiveDate: 20140312 | Drugs: GLIVEC | Reactions: Haemorrhage, Haematocrit decreased, Rectal haemorrhage, Haematochezia, Mouth haemorrhage, Epistaxis, Pyrexia
SafetyReportID: 10003828 Date: 20140312 Report: SafetyReportID: 10003828 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Stevens-Johnson syndrome
SafetyReportID: 10003829 Date: 20140312 Report: SafetyReportID: 10003829 | ReceiveDate: 20140312 | Drugs: DIANEAL LOW CALCIUM | Reactions: Myocardial infarction
SafetyReportID: 10003830 Date: 20140312 Report: SafetyReportID: 10003830 | ReceiveDate: 20140312 | Drugs: HUMIRA, TRAMADOL, PREDNISONE, ROPINIROLE, METHOCARBAMOL, CALCIUM, ACTONEL | Reactions: Mycobacterium tuberculosis complex test positive, Headache, Chest discomfort
SafetyReportID: 10003831 Date: 20140312 Report: SafetyReportID: 10003831 | ReceiveDate: 20140312 | Drugs: ACLASTA, ACLASTA, ACLASTA | Reactions: Respiratory failure, Chronic obstructive pulmonary disease
SafetyReportID: 10003832 Date: 20140312 Report: SafetyReportID: 10003832 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Nausea, Vomiting
SafetyReportID: 10003833 Date: 20140312 Report: SafetyReportID: 10003833 | ReceiveDate: 20140312 | Drugs: HUMIRA | Reactions: Myocardial infarction
SafetyReportID: 10003834 Date: 20140312 Report: SafetyReportID: 10003834 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Balance disorder
SafetyReportID: 10003835 Date: 20140312 Report: SafetyReportID: 10003835 | ReceiveDate: 20140312 | Drugs: NASACORT ALLERGY | Reactions: Cardiac flutter, Therapeutic response decreased
SafetyReportID: 10003836 Date: 20140312 Report: SafetyReportID: 10003836 | ReceiveDate: 20140312 | Drugs: SPIRIVA | Reactions: Incorrect route of drug administration
SafetyReportID: 10003837 Date: 20140312 Report: SafetyReportID: 10003837 | ReceiveDate: 20140312 | Drugs: EXJADE, EXJADE | Reactions: Death
SafetyReportID: 10003838 Date: 20140312 Report: SafetyReportID: 10003838 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Dreamy state, Movement disorder, Bruxism, Speech disorder, Repetitive speech, Paraesthesia, Crying, Dizziness, Speech disorder, Dysstasia, Vomiting, Dysarthria, Hyperhidrosis, Nausea
SafetyReportID: 10003839 Date: 20140312 Report: SafetyReportID: 10003839 | ReceiveDate: 20140312 | Drugs: CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, FLUPENTIXOL, RISPERIDONE, DEPAKENE, DIVALPROEX SODIUM | Reactions: Parotitis, Salivary hypersecretion, Ear pain, Odynophagia, Parotid gland enlargement, Oedema, Inflammation, Leukocytosis, Anaemia, Tachycardia, Schizoaffective disorder bipolar type, Drug ineffective
SafetyReportID: 10003840 Date: 20140312 Report: SafetyReportID: 10003840 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, DIOVAN, METOPROLOL, OMEPRAZOLE, FINASTERIDE, ZINC, ALLERGY TAB, MULTIVITAMIN /00097801/, OMEGA 3 /01334101/ | Reactions: Fluid retention, Feeling abnormal, Abnormal dreams, Nightmare, Insomnia, Testicular swelling
SafetyReportID: 10003841 Date: 20140312 Report: SafetyReportID: 10003841 | ReceiveDate: 20140312 | Drugs: ONFI, KEPPRA, ZONISAMIDE, BANZEL | Reactions: Convulsion
SafetyReportID: 10003842 Date: 20140312 Report: SafetyReportID: 10003842 | ReceiveDate: 20140312 | Drugs: CLOZARIL | Reactions: Bursitis, Abscess bacterial, Staphylococcal infection
SafetyReportID: 10003843 Date: 20140312 Report: SafetyReportID: 10003843 | ReceiveDate: 20140312 | Drugs: DEPAKINE, SULPIRIDE, LEXOMIL, PARACETAMOL, ESOMEPRAZOLE | Reactions: Fall, Rhabdomyolysis, Somnolence
SafetyReportID: 10003844 Date: 20140312 Report: SafetyReportID: 10003844 | ReceiveDate: 20140312 | Drugs: SANDOSTATIN LAR DEPOT, SANDOSTATIN LAR DEPOT, AMLODIPINE, DURATESTON, CLORANA, ASA, HYDROCHLOROTHIAZIDE., PROPANOLOL, SANDOSTATIN LAR DEPOT, ENALAPRIL, SANDOSTATIN LAR DEPOT, PROPANOLOL, SANDOSTATIN LAR DEPOT | Reactions: Diabetes mellitus, Gait disturbance, Anaemia, Blood triglycerides abnormal, Muscular weakness, Blood cholesterol abnormal, Cough, Influenza, Bone disorder, Patient-device incompatibility, Pain
SafetyReportID: 10003845 Date: 20140312 Report: SafetyReportID: 10003845 | ReceiveDate: 20140312 | Drugs: TEMODAL | Reactions: Death
SafetyReportID: 10003846 Date: 20140312 Report: SafetyReportID: 10003846 | ReceiveDate: 20140312 | Drugs: DIANEAL LOW CALCIUM, DIANEAL LOW CALCIUM | Reactions: Localised infection, Diabetic ketoacidosis, Abscess limb
SafetyReportID: 10003847 Date: 20140312 Report: SafetyReportID: 10003847 | ReceiveDate: 20140312 | Drugs: JAKAFI, DEPAKOTE, ALLOPURINOL | Reactions: Platelet count abnormal, Haematochezia
SafetyReportID: 10003848 Date: 20140312 Report: SafetyReportID: 10003848 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Alopecia
SafetyReportID: 10003849 Date: 20140312 Report: SafetyReportID: 10003849 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, CYCLOPHOSPHAMIDE, CITALOPRAM, FUROSEMIDE, ALLOPURINOL, METOPROLOL, LORAZEPAM, TERAZOSIN, BACLOFEN | Reactions: Transfusion, Vision blurred, Intraocular pressure increased
SafetyReportID: 10003850 Date: 20140312 Report: SafetyReportID: 10003850 | ReceiveDate: 20140312 | Drugs: PARACETAMOL, HUMIRA, ELLESTE SOLO | Reactions: Rectocele
SafetyReportID: 10003851 Date: 20140312 Report: SafetyReportID: 10003851 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, JAKAFI, DEXAMETHASONE, NEURONTIN | Reactions: Weight decreased, Weight increased, Dizziness, Anaemia
SafetyReportID: 10003852 Date: 20140312 Report: SafetyReportID: 10003852 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, DEPAKOTE | Reactions: Product quality issue, Nervousness, Feeling jittery, Drug ineffective, Phobia, Mania, Agitation, Confusional state
SafetyReportID: 10003853 Date: 20140312 Report: SafetyReportID: 10003853 | ReceiveDate: 20140312 | Drugs: SABRIL (FOR ORAL SOLUTION), ONFI, VIMPAT, DIAZEPAM, LAMICTAL, TOPAMAX, PHENOBARBITAL, FELBAMATE, PROPOFOL, KETAMINE, DEPAKOTE, PYRIDOXINE | Reactions: Cardiac arrest, Arrhythmia, Acidosis, Respiratory distress, Status epilepticus
SafetyReportID: 10003854 Date: 20140312 Report: SafetyReportID: 10003854 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, TEGRETOL, CALCIUM WITH VITAMIN D, PROLIA, DILANTIN, PRIMIDONE | Reactions: Unevaluable event
SafetyReportID: 10003855 Date: 20140312 Report: SafetyReportID: 10003855 | ReceiveDate: 20140312 | Drugs: DIANEAL LOW CALCIUM | Reactions: Death
SafetyReportID: 10003856 Date: 20140312 Report: SafetyReportID: 10003856 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, JAKAFI, OMEPRAZOLE, VALSARTAN, KLOR-CON, FISH OIL, HYDROCODONE, FLOVENT, VITAMINS WITH MINERALS, HEADACHE POWDER | Reactions: Blood pressure increased, Ear congestion, Arthralgia, Abdominal pain, Thinking abnormal, Drug dispensing error, Epistaxis, Contusion, Haemoglobin decreased, White blood cell count decreased
SafetyReportID: 10003857 Date: 20140312 Report: SafetyReportID: 10003857 | ReceiveDate: 20140312 | Drugs: GLIVEC, GLIVEC | Reactions: Gastrointestinal stromal tumour, Malignant neoplasm progression, Intestinal obstruction, Pyrexia, Abdominal pain upper
SafetyReportID: 10003858 Date: 20140312 Report: SafetyReportID: 10003858 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Hypersensitivity
SafetyReportID: 10003859 Date: 20140312 Report: SafetyReportID: 10003859 | ReceiveDate: 20140312 | Drugs: OMEPRAZOLE., PREDNISONE., ALLOPURINOL., JAKAFI, VORICONAZOLE., ACYCLOVIR /00587301/, JAKAFI, ATORVASTATIN /01326102/, DILTIAZEM, METOPROLOL /00376902/, SERTRALINE, ASPIRIN., LISINOPRIL. | Reactions: Blood count abnormal, Platelet count decreased
SafetyReportID: 10003860 Date: 20140312 Report: SafetyReportID: 10003860 | ReceiveDate: 20140312 | Drugs: AMITRIPTYLINE, YAZ, REOPRO, ACIPHEX, TOPAMAX, YASMIN | Reactions: Injury, General physical health deterioration, Cerebrovascular arteriovenous malformation, Gastrooesophageal reflux disease, Peripheral artery thrombosis, Pain, Anxiety, Abdominal pain, Emotional distress
SafetyReportID: 10003861 Date: 20140312 Report: SafetyReportID: 10003861 | ReceiveDate: 20140312 | Drugs: SPIRIVA, SPIRIVA | Reactions: Incorrect route of drug administration, Off label use
SafetyReportID: 10003862 Date: 20140312 Report: SafetyReportID: 10003862 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Drug hypersensitivity, Hepatic enzyme increased
SafetyReportID: 10003863 Date: 20140312 Report: SafetyReportID: 10003863 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, JAKAFI | Reactions: Rash, Hypersensitivity
SafetyReportID: 10003864 Date: 20140312 Report: SafetyReportID: 10003864 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, JAKAFI, JAKAFI, ASPIRIN, NEXIUM /01479302/, LASIX /00032601/, HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Reactions: Platelet count decreased, Blood count abnormal
SafetyReportID: 10003865 Date: 20140312 Report: SafetyReportID: 10003865 | ReceiveDate: 20140312 | Drugs: YAZ, GIANVI, TUSSIONEX, IBUPROFEN, TYLENOL [PARACETAMOL], TORADOL, MORPHINE, DIAMOX, FLEXERIL, FIORICET | Reactions: Cerebral venous thrombosis, Jugular vein thrombosis
SafetyReportID: 10003866 Date: 20140312 Report: SafetyReportID: 10003866 | ReceiveDate: 20140312 | Drugs: HARNAL D (TAMSULOSIN HYDROCHLORIDE), DEPAKENE-R (VALPROATE SODIUM) | Reactions: Subdural haematoma
SafetyReportID: 10003867 Date: 20140312 Report: SafetyReportID: 10003867 | ReceiveDate: 20140312 | Drugs: RAMIPRIL | Reactions: Musculoskeletal stiffness, Myalgia
SafetyReportID: 10003868 Date: 20140312 Report: SafetyReportID: 10003868 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, DEPAKOTE | Reactions: Dizziness
SafetyReportID: 10003869 Date: 20140312 Report: SafetyReportID: 10003869 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, JAKAFI, JAKAFI, JAKAFI, JAKAFI, PROCRIT, MULTIVITAMINS, VITAMIN C, CALCIUM, ALLOPURINOL | Reactions: Platelet count decreased, Stem cell transplant, Splenomegaly, Contusion
SafetyReportID: 10003870 Date: 20140312 Report: SafetyReportID: 10003870 | ReceiveDate: 20140312 | Drugs: YASMIN, PROPOXYPHENE NAPSYLATE W/ACETAMINOPHENE, ADVIL COLD, DARVOCET-N 100, TORADOL | Reactions: Thrombosis, Injury, Emotional distress, Deep vein thrombosis, Anxiety, Pain, Abdominal pain, General physical health deterioration
SafetyReportID: 10003871 Date: 20140312 Report: SafetyReportID: 10003871 | ReceiveDate: 20140312 | Drugs: LIPITOR, LIPITOR | Reactions: Type 2 diabetes mellitus
SafetyReportID: 10003872 Date: 20140312 Report: SafetyReportID: 10003872 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Malaise
SafetyReportID: 10003873 Date: 20140312 Report: SafetyReportID: 10003873 | ReceiveDate: 20140312 | Drugs: SPIRIVA | Reactions: Drug administration error
SafetyReportID: 10003874 Date: 20140312 Report: SafetyReportID: 10003874 | ReceiveDate: 20140312 | Drugs: EXJADE | Reactions: Death
SafetyReportID: 10003875 Date: 20140312 Report: SafetyReportID: 10003875 | ReceiveDate: 20140312 | Drugs: WARFARIN | Reactions: International normalised ratio fluctuation
SafetyReportID: 10003876 Date: 20140312 Report: SafetyReportID: 10003876 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, UNKNOWN PARKINSON MEDICATION, MVI, CALCIUM, UNKNOWN CHOLESTEROL MEDICATION | Reactions: Fall, Concussion, Clavicle fracture, Hip fracture, Parkinsonism, Mobility decreased, Faecal incontinence, Urinary incontinence, Depression, Memory impairment, Fatigue, Fall, Pain, Fall, Fall, Gait disturbance, Emotional distress
SafetyReportID: 10003877 Date: 20140312 Report: SafetyReportID: 10003877 | ReceiveDate: 20140312 | Drugs: LIPITOR, LIPITOR | Reactions: Type 2 diabetes mellitus
SafetyReportID: 10003878 Date: 20140312 Report: SafetyReportID: 10003878 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, DEPAKOTE, LATUNDA | Reactions: Medication error
SafetyReportID: 10003879 Date: 20140312 Report: SafetyReportID: 10003879 | ReceiveDate: 20140312 | Drugs: SPIRIVA, ALBUTEROL | Reactions: Dyspnoea, Exercise tolerance decreased, Product quality issue, Product quality issue, Product quality issue
SafetyReportID: 10003880 Date: 20140312 Report: SafetyReportID: 10003880 | ReceiveDate: 20140312 | Drugs: DIANEAL LOW CALCIUM, DIANEAL LOW CALCIUM, DIANEAL LOW CALCIUM (ULTRABAG), DIANEAL LOW CALCIUM (ULTRABAG) | Reactions: Impaired healing, Calciphylaxis, Diabetic complication, Wound
SafetyReportID: 10003881 Date: 20140312 Report: SafetyReportID: 10003881 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Pancreatitis acute
SafetyReportID: 10003882 Date: 20140312 Report: SafetyReportID: 10003882 | ReceiveDate: 20140312 | Drugs: GLIVEC | Reactions: Death
SafetyReportID: 10003883 Date: 20140312 Report: SafetyReportID: 10003883 | ReceiveDate: 20140312 | Drugs: SPIRIVA | Reactions: Incorrect route of drug administration
SafetyReportID: 10003884 Date: 20140312 Report: SafetyReportID: 10003884 | ReceiveDate: 20140312 | Drugs: DIANEAL LOW CALCIUM | Reactions: Gastrointestinal haemorrhage, Pneumonia, Pulmonary oedema, Failure to thrive, Hypophagia
SafetyReportID: 10003885 Date: 20140312 Report: SafetyReportID: 10003885 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, CLOZAPINE, KEPPRA, NIASPAN, LOSARTAN, LITHIUM, FENOFIBRATE, CLONAZEPAM, HALDOL, LORAZA | Reactions: Ammonia increased
SafetyReportID: 10003886 Date: 20140312 Report: SafetyReportID: 10003886 | ReceiveDate: 20140312 | Drugs: SPIRIVA | Reactions: Coeliac disease
SafetyReportID: 10003887 Date: 20140312 Report: SafetyReportID: 10003887 | ReceiveDate: 20140312 | Drugs: AUBAGIO, AUBAGIO | Reactions: Surgery, Muscular weakness, Alopecia, Drug dose omission
SafetyReportID: 10003888 Date: 20140312 Report: SafetyReportID: 10003888 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Cautery to nose, Epistaxis
SafetyReportID: 10003889 Date: 20140312 Report: SafetyReportID: 10003889 | ReceiveDate: 20140312 | Drugs: LIPITOR, LIPITOR | Reactions: Type 2 diabetes mellitus
SafetyReportID: 10003890 Date: 20140312 Report: SafetyReportID: 10003890 | ReceiveDate: 20140312 | Drugs: ACLASTA, ACLASTA, ACLASTA, ACLASTA, FOSAMAX | Reactions: Neoplasm malignant, Pain in extremity, Anaemia, Death, Histiocytosis haematophagic
SafetyReportID: 10003891 Date: 20140312 Report: SafetyReportID: 10003891 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Drug ineffective
SafetyReportID: 10003892 Date: 20140312 Report: SafetyReportID: 10003892 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, ALBUTEROL HFA, CLONIDINE, FLEXERIL /00428402/, LOMOTIL /00034001/, GABAPENTIN, OMEPRAZOLE, PAROXETINE, PROMETHAZINE, ZAFIRLUKAST, REGLAN /00041901/, HYDROCODONE/APAP, COMBIVENT | Reactions: Fatigue
SafetyReportID: 10003893 Date: 20140312 Report: SafetyReportID: 10003893 | ReceiveDate: 20140312 | Drugs: LIPITOR, LIPITOR | Reactions: Type 2 diabetes mellitus
SafetyReportID: 10003894 Date: 20140312 Report: SafetyReportID: 10003894 | ReceiveDate: 20140312 | Drugs: SAMSCA, ARTIST, ARTIST, LASIX, LASIX, ALDACTONE A, AMLODIN, DIOVAN | Reactions: Ventricular tachycardia
SafetyReportID: 10003895 Date: 20140312 Report: SafetyReportID: 10003895 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Pain, Anaemia
SafetyReportID: 10003896 Date: 20140312 Report: SafetyReportID: 10003896 | ReceiveDate: 20140312 | Drugs: CARDIOASPIRIN, TRIATEC | Reactions: Melaena, Asthenia, Vertigo, Duodenal ulcer, Gastritis erosive, Gastrointestinal haemorrhage
SafetyReportID: 10003897 Date: 20140312 Report: SafetyReportID: 10003897 | ReceiveDate: 20140312 | Drugs: LIPITOR, LIPITOR | Reactions: Type 2 diabetes mellitus
SafetyReportID: 10003898 Date: 20140312 Report: SafetyReportID: 10003898 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Mood altered
SafetyReportID: 10003899 Date: 20140312 Report: SafetyReportID: 10003899 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, LOVASTATIN, OMEPRAZOLE, RANITIDINE /00550802/, LEXAPRO, DILTIAZEM, RAMIPRIL, METOPROLOL, ALPRAZOLAM, PRADAXA | Reactions: Flatulence, Abdominal distension, Diarrhoea
SafetyReportID: 10003900 Date: 20140312 Report: SafetyReportID: 10003900 | ReceiveDate: 20140312 | Drugs: CARBIDOPA AND LEVODOPA | Reactions: Haemorrhage, Red blood cell count decreased, Fatigue, Adverse event
SafetyReportID: 10003901 Date: 20140312 Report: SafetyReportID: 10003901 | ReceiveDate: 20140312 | Drugs: LIPITOR, LIPITOR | Reactions: Type 2 diabetes mellitus
SafetyReportID: 10003902 Date: 20140312 Report: SafetyReportID: 10003902 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, ALPRAZOLAM | Reactions: Memory impairment
SafetyReportID: 10003903 Date: 20140312 Report: SafetyReportID: 10003903 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, ZOLOFT | Reactions: Dizziness, Platelet count decreased, Blood urine present, Mass, Vomiting, Feeling hot, Contusion
SafetyReportID: 10003904 Date: 20140312 Report: SafetyReportID: 10003904 | ReceiveDate: 20140312 | Drugs: ARKOLAMYL, PHENOBARBITAL | Reactions: Psychotic behaviour, Cognitive disorder
SafetyReportID: 10003905 Date: 20140312 Report: SafetyReportID: 10003905 | ReceiveDate: 20140312 | Drugs: ACLASTA, ACLASTA, ACLASTA, ACLASTA, CALCIUM, VITAMIN D | Reactions: Bronchopulmonary aspergillosis, Myalgia
SafetyReportID: 10003906 Date: 20140312 Report: SafetyReportID: 10003906 | ReceiveDate: 20140312 | Drugs: LIPITOR, LIPITOR | Reactions: Type 2 diabetes mellitus
SafetyReportID: 10003907 Date: 20140312 Report: SafetyReportID: 10003907 | ReceiveDate: 20140312 | Drugs: HUMIRA, HUMIRA, CONTRACEPTIVE PILL | Reactions: Vaginal haemorrhage, Smear cervix abnormal
SafetyReportID: 10003908 Date: 20140312 Report: SafetyReportID: 10003908 | ReceiveDate: 20140312 | Drugs: JAKAFI, HYDROCHLOROTHIAZIDE, SYNTHROID, CALCIUM 600 + D, PRESERVISION LUTEIN, SPIRONOLACTONE | Reactions: Hospice care
SafetyReportID: 10003909 Date: 20140312 Report: SafetyReportID: 10003909 | ReceiveDate: 20140312 | Drugs: OMEPRAZEN, OMEPRAZEN, OMEPRAZEN, LARGACTIL | Reactions: Febrile convulsion, Helicobacter infection
SafetyReportID: 10003910 Date: 20140312 Report: SafetyReportID: 10003910 | ReceiveDate: 20140312 | Drugs: GLEEVEC | Reactions: Death
SafetyReportID: 10003911 Date: 20140312 Report: SafetyReportID: 10003911 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, LEVOTHYROXINE SODIUM, ZYPREXA, GUANFACINE | Reactions: Drug ineffective, Somnolence
SafetyReportID: 10003912 Date: 20140312 Report: SafetyReportID: 10003912 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS, PROVENTIL | Reactions: Overdose
SafetyReportID: 10003913 Date: 20140312 Report: SafetyReportID: 10003913 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, JAKAFI | Reactions: Sinus disorder, Sensitivity of teeth
SafetyReportID: 10003914 Date: 20140312 Report: SafetyReportID: 10003914 | ReceiveDate: 20140312 | Drugs: OMNISCAN, OMNISCAN, OMNISCAN, OMNISCAN, OMNISCAN, EPOGEN, VICODIN, ATARAX, ASPERCREME, PREDNISONE, TACROLIMUS, FERRLECIT, FERRLECIT, THYMOGLOBULIN | Reactions: Nephrogenic systemic fibrosis
SafetyReportID: 10003915 Date: 20140312 Report: SafetyReportID: 10003915 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, RISPERDAL, AMLODIPINE BENAZEPRIL, GLIPIZIDE, METFORMIN, JANUVIA, SIMVASTATIN, TRAMADOL, LEVEMIR, TYLENOL, CENTRUM | Reactions: Weight increased
SafetyReportID: 10003916 Date: 20140312 Report: SafetyReportID: 10003916 | ReceiveDate: 20140312 | Drugs: CLOZARIL, CLOZARIL, CLOZARIL, LANSOPRAZOLE, HYOSCINE HYDROBROMIDE | Reactions: Circulatory collapse, Pneumonia aspiration, White blood cell count increased, Neutrophil count increased, Platelet count decreased
SafetyReportID: 10003917 Date: 20140312 Report: SafetyReportID: 10003917 | ReceiveDate: 20140312 | Drugs: JAKAFI, TACROLIMUS., JAKAFI, RAPAMUNE, PENTASA, VAGIFEM, MAGNESIUM, SIMVASTATIN., PAROXETINE, JAKAFI, OMEPRAZOLE., ACYCLOVIR /00587301/, CALCIUM WITH VITAMIN D /00944201/, FLAXSEED | Reactions: Blood lactate dehydrogenase increased, White blood cell count increased, Epistaxis, Headache, Influenza, Nausea, Contusion, Wound haemorrhage, Blood smear test abnormal, Fatigue, Adverse drug reaction, Disease progression
SafetyReportID: 10003918 Date: 20140312 Report: SafetyReportID: 10003918 | ReceiveDate: 20140312 | Drugs: ZEGERID OTC CAPSULES | Reactions: Drug ineffective
SafetyReportID: 10003919 Date: 20140312 Report: SafetyReportID: 10003919 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, CLOZAPINE | Reactions: Leukopenia, Thrombocytopenia
SafetyReportID: 10003920 Date: 20140312 Report: SafetyReportID: 10003920 | ReceiveDate: 20140312 | Drugs: LIPITOR, LIPITOR | Reactions: Type 2 diabetes mellitus, Visual impairment, Neuropathy peripheral
SafetyReportID: 10003921 Date: 20140312 Report: SafetyReportID: 10003921 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10003922 Date: 20140312 Report: SafetyReportID: 10003922 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, DIVALPROEX SODIUM, BUPROPION, ATORVASTATIN | Reactions: Headache, Drug effect incomplete
SafetyReportID: 10003923 Date: 20140312 Report: SafetyReportID: 10003923 | ReceiveDate: 20140312 | Drugs: JAKAFI, SIMVASTATIN., CIPROFLOXACIN., ASPIRIN., CIMETIDINE, CEPHALEXIN /00145501/, JAKAFI, RESTASIS, OMEGA /01454401/, JAKAFI, PLAVIX, PREDNISOLONE., LEVOTHYROXINE., PANTOPRAZOLE, NASONEX, SLOW MAG /07370001/, ERYTHROMYCIN., VITAMIN D3, CELEBREX, CETIRIZINE /00884302/, ROPINIROLE., FUROSEMIDE., ALLOPURINOL. | Reactions: Increased appetite, Incontinence, Off label use, Epistaxis, Blindness, Weight increased, Skin cancer, Nasopharyngitis, Dizziness, Dry eye, Wrong technique in product usage process, Pruritus, Increased tendency to bruise, Diarrhoea, Constipation
SafetyReportID: 10003924 Date: 20140312 Report: SafetyReportID: 10003924 | ReceiveDate: 20140312 | Drugs: LIPITOR, LIPITOR | Reactions: Type 2 diabetes mellitus
SafetyReportID: 10003925 Date: 20140312 Report: SafetyReportID: 10003925 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10003926 Date: 20140312 Report: SafetyReportID: 10003926 | ReceiveDate: 20140312 | Drugs: EXELON PATCH, THYROID THERAPY | Reactions: Apparent death, General physical health deterioration, Skin burning sensation, Decreased appetite, Weight decreased
SafetyReportID: 10003927 Date: 20140312 Report: SafetyReportID: 10003927 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, LAMOTRIGINE, LITHIUM | Reactions: Headache, Nausea, Pyrexia, Rash, Myalgia, Muscular weakness, Gait disturbance, Tremor
SafetyReportID: 10003928 Date: 20140312 Report: SafetyReportID: 10003928 | ReceiveDate: 20140312 | Drugs: LIPITOR, LIPITOR | Reactions: Type 2 diabetes mellitus
SafetyReportID: 10003929 Date: 20140312 Report: SafetyReportID: 10003929 | ReceiveDate: 20140312 | Drugs: CORICIDIN HBP COLD AND FLU | Reactions: Somnolence, Condition aggravated, Drug effect decreased
SafetyReportID: 10003930 Date: 20140312 Report: SafetyReportID: 10003930 | ReceiveDate: 20140312 | Drugs: GILENYA, DESO 30 | Reactions: Peripheral swelling, Increased appetite, Weight increased, Stress
SafetyReportID: 10003931 Date: 20140312 Report: SafetyReportID: 10003931 | ReceiveDate: 20140312 | Drugs: DEPAKOTE ER, DEPAKOTE ER | Reactions: Frustration, Anger, Drug level decreased, Feeling abnormal, Malaise, Insomnia, Drug dose omission, Unevaluable event, Agitation, Unevaluable event, Dizziness, Frustration, Off label use, Anger, Fatigue, Eating disorder, Anxiety
SafetyReportID: 10003932 Date: 20140312 Report: SafetyReportID: 10003932 | ReceiveDate: 20140312 | Drugs: JAKAFI, CALCIUM CARBONATE., ALLEGRA ALLERGY, JAKAFI, MULTIVITAMIN /00097801/ | Reactions: Memory impairment, Drug dose omission
SafetyReportID: 10003933 Date: 20140312 Report: SafetyReportID: 10003933 | ReceiveDate: 20140312 | Drugs: LIPITOR, LIPITOR | Reactions: Type 2 diabetes mellitus
SafetyReportID: 10003934 Date: 20140312 Report: SafetyReportID: 10003934 | ReceiveDate: 20140312 | Drugs: OXYTROL FOR WOMEN, OXYTROL FOR WOMEN | Reactions: Inappropriate schedule of drug administration
SafetyReportID: 10003935 Date: 20140312 Report: SafetyReportID: 10003935 | ReceiveDate: 20140312 | Drugs: SINEMET, ENTACAPONE, MADOPAR, SEROQUEL, GASTROINTESTINAL PREPARATIONS (UNSPECIFIED) | Reactions: Hypokinesia, Dehydration, Drug dose omission, Paralysis, Quality of life decreased, Speech disorder, Loss of consciousness, Withdrawal syndrome, Dyskinesia, Dysphagia
SafetyReportID: 10003936 Date: 20140312 Report: SafetyReportID: 10003936 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, UNKNOWN ADD MEDICATION, RISPERDAL, AMBILIFY | Reactions: Irritability
SafetyReportID: 10003937 Date: 20140312 Report: SafetyReportID: 10003937 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Nasopharyngitis, Productive cough, Chronic sinusitis
SafetyReportID: 10003938 Date: 20140312 Report: SafetyReportID: 10003938 | ReceiveDate: 20140312 | Drugs: ROCURONIUM BROMIDE, SUCCINYLCHOLINE BROMIDE | Reactions: Cardiac arrest, Anaphylactic reaction
SafetyReportID: 10003939 Date: 20140312 Report: SafetyReportID: 10003939 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Tremor, Head titubation
SafetyReportID: 10003940 Date: 20140312 Report: SafetyReportID: 10003940 | ReceiveDate: 20140312 | Drugs: JAKAFI, SYNTHROID, APPEAREX, OMEPRAZOLE DR, BENZONATATE, POTASSIUM, B-12, DAILY MULTIVITAMIN | Reactions: Therapeutic response unexpected
SafetyReportID: 10003941 Date: 20140312 Report: SafetyReportID: 10003941 | ReceiveDate: 20140312 | Drugs: CERTICAN, MYFORTIC, EMCONCOR, MAREVAN, SIMVASTATIN, D-CURE, MOXONIDINE, TERAZOSABB, LANOXIN, ZYLORIC | Reactions: Interstitial lung disease, Dyspnoea, General physical health deterioration, Pleural effusion, Oedema, Aphthous stomatitis
SafetyReportID: 10003942 Date: 20140312 Report: SafetyReportID: 10003942 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Disorientation, Phobia, Feeling jittery, Feeling hot, Feeling jittery, Phobia, Insomnia, Agitation, Anxiety, Insomnia, Anxiety, Mania, Pain, Nervousness, Irritability, Drug ineffective, Product quality issue
SafetyReportID: 10003943 Date: 20140312 Report: SafetyReportID: 10003943 | ReceiveDate: 20140312 | Drugs: DIANEAL PD2 (ULTRABAG) | Reactions: Peritonitis, Device malfunction
SafetyReportID: 10003944 Date: 20140312 Report: SafetyReportID: 10003944 | ReceiveDate: 20140312 | Drugs: DIANEAL LOW CALCIUM, DIANEAL LOW CALCIUM | Reactions: Cerebrovascular accident, Blindness unilateral
SafetyReportID: 10003945 Date: 20140312 Report: SafetyReportID: 10003945 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Amylase increased, Lipase increased
SafetyReportID: 10003946 Date: 20140312 Report: SafetyReportID: 10003946 | ReceiveDate: 20140312 | Drugs: METOTRESSATO TEVA, VINCRISTINA TEVA ITALIA | Reactions: Mucosal inflammation
SafetyReportID: 10003947 Date: 20140312 Report: SafetyReportID: 10003947 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, VENTOLIN, VITAMIN B6, FLOVENT | Reactions: Gingivitis, Gingival erythema, Gingival inflammation, Gingival bleeding, Gingival pain, Gingival hyperplasia
SafetyReportID: 10003948 Date: 20140312 Report: SafetyReportID: 10003948 | ReceiveDate: 20140312 | Drugs: ONFI, ONFI | Reactions: Convulsion
SafetyReportID: 10003949 Date: 20140312 Report: SafetyReportID: 10003949 | ReceiveDate: 20140312 | Drugs: DIOVAN HCT | Reactions: Gastrointestinal stromal tumour, Malaise, Hepatic neoplasm, Wrong technique in drug usage process
SafetyReportID: 10003950 Date: 20140312 Report: SafetyReportID: 10003950 | ReceiveDate: 20140312 | Drugs: DIANEAL LOW CALCIUM | Reactions: Pancreatitis
SafetyReportID: 10003951 Date: 20140312 Report: SafetyReportID: 10003951 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Drug ineffective
SafetyReportID: 10003952 Date: 20140312 Report: SafetyReportID: 10003952 | ReceiveDate: 20140312 | Drugs: REBIF | Reactions: Endometriosis, Uterine leiomyoma, Type 2 diabetes mellitus, Central nervous system lesion, Injection site pain, Injection site bruising, Wrong technique in drug usage process
SafetyReportID: 10003953 Date: 20140312 Report: SafetyReportID: 10003953 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Headache
SafetyReportID: 10003954 Date: 20140312 Report: SafetyReportID: 10003954 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Feeling cold, White blood cell count decreased, Dizziness
SafetyReportID: 10003955 Date: 20140312 Report: SafetyReportID: 10003955 | ReceiveDate: 20140312 | Drugs: DOXORUBICIN TEVA, MABTHERA, ONCOVIN, ENDOXAN | Reactions: Hepatocellular injury, Cholestasis, Pyrexia
SafetyReportID: 10003956 Date: 20140312 Report: SafetyReportID: 10003956 | ReceiveDate: 20140312 | Drugs: DIANEAL PD2 WITH 1.5% DEXTROSE, DIANEAL PD2 WITH 4.25% DEXTROSE | Reactions: Myocardial infarction
SafetyReportID: 10003957 Date: 20140312 Report: SafetyReportID: 10003957 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Drug prescribing error, Drug dispensing error
SafetyReportID: 10003958 Date: 20140312 Report: SafetyReportID: 10003958 | ReceiveDate: 20140312 | Drugs: MYFORTIC, CORTANCYL, PROGRAF | Reactions: Kaposi^s sarcoma
SafetyReportID: 10003959 Date: 20140312 Report: SafetyReportID: 10003959 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, FINASTERIDE, TERAZOSIN, LOSARTAN, SILDENAFIL, FUROSEMIDE, HYDRALAZINE, METFORMIN, WARFARIN, SPIRONOLACTONE | Reactions: Splenomegaly, Dyspnoea, Insomnia
SafetyReportID: 10003960 Date: 20140312 Report: SafetyReportID: 10003960 | ReceiveDate: 20140312 | Drugs: PACLITAXEL, BLINDED: PERTUZUMAB, BLINDED: PLACEBO, FENTANYL CITRATE, OMEPRAZOLE, METOCLOPRAMIDE, MACROGOL, SPIRONOLACTONE | Reactions: Gastrointestinal obstruction, Anaemia, General physical health deterioration
SafetyReportID: 10003961 Date: 20140312 Report: SafetyReportID: 10003961 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Medication residue present
SafetyReportID: 10003962 Date: 20140312 Report: SafetyReportID: 10003962 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10003963 Date: 20140312 Report: SafetyReportID: 10003963 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Nausea, Vomiting, Diarrhoea
SafetyReportID: 10003964 Date: 20140312 Report: SafetyReportID: 10003964 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, LATUDA, LATUDA, LATUDA | Reactions: Neutrophil count decreased
SafetyReportID: 10003965 Date: 20140312 Report: SafetyReportID: 10003965 | ReceiveDate: 20140312 | Drugs: LETAIRIS, VENTAVIS | Reactions: Tinnitus, Palpitations
SafetyReportID: 10003966 Date: 20140312 Report: SafetyReportID: 10003966 | ReceiveDate: 20140312 | Drugs: ONFI, ONFI, PROZAC, PROZAC, PROZAC, CARBAMAZEPINE, CARBAMAZEPINE, LEVETIRACETAM, TOPIRAMATE, LAMOTRIGINE, LAMOTRIGINE, LORAZEPAM, MULTIPLE VITAMIN WITH MINERALS, CALCIUM CARBONATE- VITAMIN D | Reactions: Abnormal behaviour, Drug level increased, Lethargy, Irritability, Obsessive-compulsive disorder, Dermatillomania, Activities of daily living impaired, Memory impairment, Bradykinesia, Muscular weakness, Insomnia, Drug interaction
SafetyReportID: 10003967 Date: 20140312 Report: SafetyReportID: 10003967 | ReceiveDate: 20140312 | Drugs: TASIGNA, TASIGNA | Reactions: Death
SafetyReportID: 10003968 Date: 20140312 Report: SafetyReportID: 10003968 | ReceiveDate: 20140312 | Drugs: EPIVAL, TOPIMAX, KEPPRA, VIMPAT | Reactions: Feeling abnormal
SafetyReportID: 10003969 Date: 20140312 Report: SafetyReportID: 10003969 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10003970 Date: 20140312 Report: SafetyReportID: 10003970 | ReceiveDate: 20140312 | Drugs: IMATINIB | Reactions: Breast cancer, Second primary malignancy, Metastases to pleura, Metastases to lymph nodes
SafetyReportID: 10003971 Date: 20140312 Report: SafetyReportID: 10003971 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Fatigue
SafetyReportID: 10003972 Date: 20140312 Report: SafetyReportID: 10003972 | ReceiveDate: 20140312 | Drugs: FEMARA | Reactions: Blood glucose increased
SafetyReportID: 10003973 Date: 20140312 Report: SafetyReportID: 10003973 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, ZYPREXA | Reactions: Blood glucose increased, Blood cholesterol increased, Alopecia, Insomnia, Weight increased
SafetyReportID: 10003974 Date: 20140312 Report: SafetyReportID: 10003974 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Death
SafetyReportID: 10003975 Date: 20140312 Report: SafetyReportID: 10003975 | ReceiveDate: 20140312 | Drugs: SANDOSTATIN LAR | Reactions: Death
SafetyReportID: 10003976 Date: 20140312 Report: SafetyReportID: 10003976 | ReceiveDate: 20140312 | Drugs: OMEPRAZOLE, METHOTREXATE, AMLODIPINE, CALCICHEW D3, FOLIC ACID | Reactions: Hypomagnesaemia, Drug interaction
SafetyReportID: 10003977 Date: 20140312 Report: SafetyReportID: 10003977 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, VIDAZA | Reactions: Transfusion, Drug dose omission
SafetyReportID: 10003978 Date: 20140312 Report: SafetyReportID: 10003978 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, DEPAKENE, DEPAKOTE, DEPAKENE | Reactions: Body height below normal, Congenital oral malformation, Congenital cardiovascular anomaly, Congenital nose malformation, Tooth development disorder, Visual impairment, Foetal exposure during pregnancy, Paternal drugs affecting foetus, Corrective lens user, Dysmorphism, Foetal anticonvulsant syndrome, Premature baby, Toothache, Growth retardation, Congenital cardiovascular anomaly, Cardiac murmur, Congenital hand malformation, Multiple injuries, Low birth weight baby
SafetyReportID: 10003979 Date: 20140312 Report: SafetyReportID: 10003979 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Extrasystoles
SafetyReportID: 10003980 Date: 20140312 Report: SafetyReportID: 10003980 | ReceiveDate: 20140312 | Drugs: KLACID, AMOXYCILLIN, CORTICOSTEROIDS, CORTICOSTEROIDS, CORTICOSTEROIDS, ANTIHISTAMINES, ANTIHISTAMINES, ANTIBIOTICS, ANTIBIOTICS, ANTIBIOTICS | Reactions: Drug ineffective
SafetyReportID: 10003981 Date: 20140312 Report: SafetyReportID: 10003981 | ReceiveDate: 20140312 | Drugs: ACLASTA | Reactions: Coma, Malaise
SafetyReportID: 10003982 Date: 20140312 Report: SafetyReportID: 10003982 | ReceiveDate: 20140312 | Drugs: ALLOPURINOL., JAKAFI, JAKAFI, JAKAFI | Reactions: Muscle abscess, Diarrhoea, Headache, Platelet count decreased, Gout
SafetyReportID: 10003983 Date: 20140312 Report: SafetyReportID: 10003983 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, DEPAKOTE, OTC DIURETIC, DEPAKOTE | Reactions: Weight increased, Joint swelling, Mania, Thinking abnormal, Sleep disorder, Joint swelling, Drug interaction
SafetyReportID: 10003984 Date: 20140312 Report: SafetyReportID: 10003984 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Stent placement, Obstruction
SafetyReportID: 10003985 Date: 20140312 Report: SafetyReportID: 10003985 | ReceiveDate: 20140312 | Drugs: HUMIRA, ANTI TUBERCULOSIS DRUG (NOT SPECIFIED) | Reactions: Asthenia, Cold sweat, Nausea, Palpitations
SafetyReportID: 10003986 Date: 20140312 Report: SafetyReportID: 10003986 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI | Reactions: Drug intolerance, Medication error
SafetyReportID: 10003987 Date: 20140312 Report: SafetyReportID: 10003987 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Neuralgia
SafetyReportID: 10003988 Date: 20140312 Report: SafetyReportID: 10003988 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, DEPAKOTE | Reactions: Anxiety, Insomnia, Nervousness, Drug withdrawal syndrome, Drug ineffective, Feeling abnormal
SafetyReportID: 10003989 Date: 20140312 Report: SafetyReportID: 10003989 | ReceiveDate: 20140312 | Drugs: LETAIRIS, TYVASO | Reactions: Headache, Pharyngitis
SafetyReportID: 10003990 Date: 20140312 Report: SafetyReportID: 10003990 | ReceiveDate: 20140312 | Drugs: HUMIRA | Reactions: Myocardial infarction
SafetyReportID: 10003991 Date: 20140312 Report: SafetyReportID: 10003991 | ReceiveDate: 20140312 | Drugs: JAKAFI, VITAMIN B COMPLEX | Reactions: Drug prescribing error
SafetyReportID: 10003992 Date: 20140312 Report: SafetyReportID: 10003992 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Diarrhoea, Dyspepsia, Nausea, Headache
SafetyReportID: 10003993 Date: 20140312 Report: SafetyReportID: 10003993 | ReceiveDate: 20140312 | Drugs: XGEVA, AFINITOR, EXEMESTANE, METFORMIN, MIRTAZAPIN, TRAMADOL, RAMIPRIL, BISOPROLOL, PANTOZOL /01263204/ | Reactions: Metastases to bone, Osteonecrosis of jaw
SafetyReportID: 10003994 Date: 20140312 Report: SafetyReportID: 10003994 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, ZONISAMIDE, LAMICTAL | Reactions: Convulsion, Tongue injury, Hallucination, Anticonvulsant drug level below therapeutic, Injury
SafetyReportID: 10003995 Date: 20140312 Report: SafetyReportID: 10003995 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Dyspnoea
SafetyReportID: 10003996 Date: 20140312 Report: SafetyReportID: 10003996 | ReceiveDate: 20140312 | Drugs: HUMIRA, HUMIRA | Reactions: Appendix disorder
SafetyReportID: 10003997 Date: 20140312 Report: SafetyReportID: 10003997 | ReceiveDate: 20140312 | Drugs: CALCIUM, JAKAFI, JAKAFI, VITAMIN D /00107901/ | Reactions: Haemorrhage, Joint swelling, Adverse event, Dyspnoea, Chest discomfort, Blood count abnormal
SafetyReportID: 10003998 Date: 20140312 Report: SafetyReportID: 10003998 | ReceiveDate: 20140312 | Drugs: AMITRIPTYLINE, CYMBALTA, XIFAXAN, DILTIAZEM, LANTUS, B12, B12, METFORMIN, KCL, HUMALOG, OMEPRAZOLE, DEPAKOTE, GABAPENTIN, LASIX, SYNTHROID | Reactions: Feeling abnormal, Pneumonia, Suicidal ideation, Psychotic disorder, Unevaluable event, Unevaluable event, Malaise, Drug level increased, Asthenia, Apathy, Pain
SafetyReportID: 10003999 Date: 20140312 Report: SafetyReportID: 10003999 | ReceiveDate: 20140312 | Drugs: HUMIRA, VITAMIN D | Reactions: Joint dislocation
SafetyReportID: 10004000 Date: 20140312 Report: SafetyReportID: 10004000 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Scab
SafetyReportID: 10004001 Date: 20140312 Report: SafetyReportID: 10004001 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Adverse reaction
SafetyReportID: 10004002 Date: 20140312 Report: SafetyReportID: 10004002 | ReceiveDate: 20140312 | Drugs: JAKAFI, AVADART, FLOMAX /00889901/, HYDROXYUREA, NEXIUM /01479302/, SIMVASTATIN | Reactions: Stomatitis
SafetyReportID: 10004003 Date: 20140312 Report: SafetyReportID: 10004003 | ReceiveDate: 20140312 | Drugs: INCIVEK, INCIVEK, RIBAVIRIN, RIBAVIRIN, PEGASYS, PEGASYS | Reactions: Injection site rash, White blood cell count decreased, Rash erythematous
SafetyReportID: 10004004 Date: 20140312 Report: SafetyReportID: 10004004 | ReceiveDate: 20140312 | Drugs: EVEROLIMUS, EVEROLIMUS, ANTIEPILEPTICS | Reactions: Epilepsy, Mood altered, Stomatitis
SafetyReportID: 10004005 Date: 20140312 Report: SafetyReportID: 10004005 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS, REVATIO | Reactions: Nasopharyngitis, Nasal congestion
SafetyReportID: 10004006 Date: 20140312 Report: SafetyReportID: 10004006 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, OMEPRAZOLE, AMBIEN, TYLENOL /00020001/, LANTUS, SIMVASTATIN, METFORMIN HCL, LISINOPRIL, PHENERGAN /00033001/ | Reactions: Nausea, Vomiting, Abdominal pain upper, Fatigue, Haemoglobin decreased
SafetyReportID: 10004007 Date: 20140312 Report: SafetyReportID: 10004007 | ReceiveDate: 20140312 | Drugs: AMBRISENTAN | Reactions: Cardiac disorder
SafetyReportID: 10004008 Date: 20140312 Report: SafetyReportID: 10004008 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, SYNTHROID, METOPROLOL, EFFEXOR | Reactions: Hypothyroidism, Night sweats, Fatigue, Blood count abnormal
SafetyReportID: 10004009 Date: 20140312 Report: SafetyReportID: 10004009 | ReceiveDate: 20140312 | Drugs: CUBICIN | Reactions: Infection
SafetyReportID: 10004010 Date: 20140312 Report: SafetyReportID: 10004010 | ReceiveDate: 20140312 | Drugs: COPAXONE | Reactions: Tooth loss, Teeth brittle, Tooth disorder, Tooth fracture
SafetyReportID: 10004011 Date: 20140312 Report: SafetyReportID: 10004011 | ReceiveDate: 20140312 | Drugs: NEULASTA | Reactions: Investigation
SafetyReportID: 10004012 Date: 20140312 Report: SafetyReportID: 10004012 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Pulmonary congestion, Ear congestion
SafetyReportID: 10004013 Date: 20140312 Report: SafetyReportID: 10004013 | ReceiveDate: 20140312 | Drugs: REVLIMID, REVLIMID | Reactions: Foot deformity
SafetyReportID: 10004014 Date: 20140312 Report: SafetyReportID: 10004014 | ReceiveDate: 20140312 | Drugs: CLOZARIL, CLOZARIL, CLOZARIL | Reactions: Dyspnoea, Tachycardia, White blood cell count increased
SafetyReportID: 10004015 Date: 20140312 Report: SafetyReportID: 10004015 | ReceiveDate: 20140312 | Drugs: DEPAKOTE | Reactions: Medication residue present
SafetyReportID: 10004016 Date: 20140312 Report: SafetyReportID: 10004016 | ReceiveDate: 20140312 | Drugs: FETZIMA, FETZIMA | Reactions: Testicular torsion
SafetyReportID: 10004017 Date: 20140312 Report: SafetyReportID: 10004017 | ReceiveDate: 20140312 | Drugs: JAKAFI, METFORMIN, PROCARDIA /00340701/, ALBUTEROL /00139501/, ADALAT, PROTONIX | Reactions: Epistaxis
SafetyReportID: 10004018 Date: 20140312 Report: SafetyReportID: 10004018 | ReceiveDate: 20140312 | Drugs: PARAGARD 380A, LISINOPRIL, SERTRALINE, PRILOSEC | Reactions: Anaphylactic reaction, Metrorrhagia, Dizziness
SafetyReportID: 10004019 Date: 20140312 Report: SafetyReportID: 10004019 | ReceiveDate: 20140312 | Drugs: EXTAVIA, CITALOPRAM, IBUPROFEN | Reactions: Multiple sclerosis relapse, Dysaesthesia
SafetyReportID: 10004020 Date: 20140312 Report: SafetyReportID: 10004020 | ReceiveDate: 20140312 | Drugs: DEPAKOTE, VIMPAT, DILANTIN | Reactions: Tremor
SafetyReportID: 10004021 Date: 20140312 Report: SafetyReportID: 10004021 | ReceiveDate: 20140312 | Drugs: OMNISCAN, OMNISCAN, GADOLINIUM (UNSPECIFIED), GADOLINIUM (UNSPECIFIED), GADOLINIUM (UNSPECIFIED), MAGNEVIST, MAGNEVIST, MAGNEVIST, EPOGEN, IRON DEXTRAN, OPTIRAY 320, PREDNISONE, FERRO SEQUELS | Reactions: Nephrogenic systemic fibrosis
SafetyReportID: 10004022 Date: 20140312 Report: SafetyReportID: 10004022 | ReceiveDate: 20140312 | Drugs: JAKAFI, TOPROL, COZAAR | Reactions: Pain in jaw, Pyrexia, Flatulence, Diarrhoea
SafetyReportID: 10004023 Date: 20140312 Report: SafetyReportID: 10004023 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI | Reactions: White blood cell count increased
SafetyReportID: 10004024 Date: 20140312 Report: SafetyReportID: 10004024 | ReceiveDate: 20140312 | Drugs: EXJADE | Reactions: Death
SafetyReportID: 10004025 Date: 20140312 Report: SafetyReportID: 10004025 | ReceiveDate: 20140312 | Drugs: HUMIRA | Reactions: Bronchial carcinoma
SafetyReportID: 10004026 Date: 20140312 Report: SafetyReportID: 10004026 | ReceiveDate: 20140312 | Drugs: FLUOROURACIL, FLUOROURACIL, FLUOROURACIL, CISPLATIN, CISPLATIN, CISPLATIN | Reactions: Pneumonitis, Pleural effusion, Radiation pneumonitis, Oesophagitis, Pericarditis
SafetyReportID: 10004027 Date: 20140312 Report: SafetyReportID: 10004027 | ReceiveDate: 20140312 | Drugs: ACLASTA, ACLASTA, CALCICHEW D3 | Reactions: Death, Thrombosis, Crohn^s disease, Underdose
SafetyReportID: 10004028 Date: 20140312 Report: SafetyReportID: 10004028 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Muscle spasms, Pain in extremity, Polycythaemia
SafetyReportID: 10004029 Date: 20140312 Report: SafetyReportID: 10004029 | ReceiveDate: 20140312 | Drugs: PARAGARD 380A, RELPAX | Reactions: Embedded device, Device breakage, Back pain
SafetyReportID: 10004030 Date: 20140312 Report: SafetyReportID: 10004030 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Drug dose omission
SafetyReportID: 10004031 Date: 20140312 Report: SafetyReportID: 10004031 | ReceiveDate: 20140312 | Drugs: CYTARABINE, CICLOSPORIN, PREDNISOLONE, METHOTREXATE, BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE, ACYCLOVIR | Reactions: Pneumonia, Cytomegalovirus infection, Cystitis haemorrhagic, Acute graft versus host disease
SafetyReportID: 10004032 Date: 20140312 Report: SafetyReportID: 10004032 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Memory impairment, Drug dose omission
SafetyReportID: 10004033 Date: 20140312 Report: SafetyReportID: 10004033 | ReceiveDate: 20140312 | Drugs: AMBRISENTAN | Reactions: Death
SafetyReportID: 10004034 Date: 20140312 Report: SafetyReportID: 10004034 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Hospice care
SafetyReportID: 10004035 Date: 20140312 Report: SafetyReportID: 10004035 | ReceiveDate: 20140312 | Drugs: JAKAFI, ALLOPURINOL, COLCHICINE, HYDROXYUREA | Reactions: Malaise, Night sweats, Abdominal pain, Disease progression, No therapeutic response
SafetyReportID: 10004036 Date: 20140312 Report: SafetyReportID: 10004036 | ReceiveDate: 20140312 | Drugs: AUBAGIO, AUBAGIO, PAXIL | Reactions: Muscle spasms, Urinary incontinence, Anxiety, Hyperventilation, Rash pruritic, Rhinorrhoea, Tongue disorder, Panic attack, Diarrhoea, Dry skin, Skin exfoliation, Skin exfoliation, Acne, Alopecia
SafetyReportID: 10004037 Date: 20140312 Report: SafetyReportID: 10004037 | ReceiveDate: 20140312 | Drugs: RIBAVIRIN, PEGINTERFERON ALFA-2B, PREMARIN | Reactions: Chills, Myalgia, Headache, Dizziness, Nausea, Myalgia, Chills
SafetyReportID: 10004038 Date: 20140312 Report: SafetyReportID: 10004038 | ReceiveDate: 20140312 | Drugs: PACLITAXEL | Reactions: Bronchospasm, Discomfort, Rash, Drug hypersensitivity
SafetyReportID: 10004039 Date: 20140312 Report: SafetyReportID: 10004039 | ReceiveDate: 20140312 | Drugs: VENLAFAXINE HCL | Reactions: Drug ineffective
SafetyReportID: 10004040 Date: 20140312 Report: SafetyReportID: 10004040 | ReceiveDate: 20140312 | Drugs: NEXPLANON | Reactions: Device breakage, No adverse event
SafetyReportID: 10004041 Date: 20140312 Report: SafetyReportID: 10004041 | ReceiveDate: 20140312 | Drugs: GLIVEC | Reactions: Amnesia
SafetyReportID: 10004042 Date: 20140312 Report: SafetyReportID: 10004042 | ReceiveDate: 20140312 | Drugs: PEGINTRON, RIBAPAK | Reactions: Pain, Pruritus, Dizziness, Pyrexia, Asthenia, Nausea
SafetyReportID: 10004043 Date: 20140312 Report: SafetyReportID: 10004043 | ReceiveDate: 20140312 | Drugs: ROACTEMRA | Reactions: Aortic dissection
SafetyReportID: 10004044 Date: 20140312 Report: SafetyReportID: 10004044 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS | Reactions: Overdose, Accidental exposure to product by child
SafetyReportID: 10004045 Date: 20140312 Report: SafetyReportID: 10004045 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, LUNESTA, COUMADIN, JAKAFI | Reactions: Rash, Discomfort, Constipation, Skin disorder, Skin sensitisation, Blister, Jaundice
SafetyReportID: 10004046 Date: 20140312 Report: SafetyReportID: 10004046 | ReceiveDate: 20140312 | Drugs: AVASTIN | Reactions: Death
SafetyReportID: 10004047 Date: 20140312 Report: SafetyReportID: 10004047 | ReceiveDate: 20140312 | Drugs: ZOLINZA | Reactions: Drug dose omission, Product packaging quantity issue, No adverse event
SafetyReportID: 10004048 Date: 20140312 Report: SafetyReportID: 10004048 | ReceiveDate: 20140312 | Drugs: CORICIDIN HBP COLD AND FLU | Reactions: Feeling abnormal, Somnolence, Drug effect decreased
SafetyReportID: 10004049 Date: 20140312 Report: SafetyReportID: 10004049 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Thermal burn
SafetyReportID: 10004050 Date: 20140312 Report: SafetyReportID: 10004050 | ReceiveDate: 20140312 | Drugs: XELODA, PREDNISONE, METOCLOPRAMIDE, SERTRALINE, IRINOTECAN, VICODIN, FENTANYL PATCH | Reactions: Death
SafetyReportID: 10004051 Date: 20140312 Report: SafetyReportID: 10004051 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, ULORIC, BENICAR, AMLODIPINE, OMEPRAZOLE, ASPIRIN | Reactions: Pain, Dizziness, Headache
SafetyReportID: 10004052 Date: 20140312 Report: SafetyReportID: 10004052 | ReceiveDate: 20140312 | Drugs: HUMIRA, ANGIOS (CALCIUM), ALENDRONIC ACID, PREDNISOLONE, IDEOS, FOLIC ACID, METHOTREXATE, OMEPRAZOLE | Reactions: Hypoaesthesia, Tremor, Feeling hot, Hyperhidrosis, Mobility decreased, Asthenia, Local swelling
SafetyReportID: 10004053 Date: 20140312 Report: SafetyReportID: 10004053 | ReceiveDate: 20140312 | Drugs: ZERIT, ZIAGEN, 3TC, KALETRA | Reactions: Fat redistribution, Lipodystrophy acquired, CD4 lymphocytes decreased, Unevaluable event, Multifocal motor neuropathy, Muscle atrophy
SafetyReportID: 10004055 Date: 20140312 Report: SafetyReportID: 10004055 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Blood count abnormal
SafetyReportID: 10004056 Date: 20140312 Report: SafetyReportID: 10004056 | ReceiveDate: 20140312 | Drugs: CANESTEN (KAINITING) | Reactions: Exposure during pregnancy, Drug ineffective, Caesarean section
SafetyReportID: 10004057 Date: 20140312 Report: SafetyReportID: 10004057 | ReceiveDate: 20140312 | Drugs: JAKAFI, FISH OIL, LEXAPRO, JAKAFI, ASPIRIN., VITAMIN D /00107901/, SYNTHROID, ALBUTEROL /00139501/, METOPROLOL., MULTIVITAMIN /00097801/, RANEXA, CALCIUM, LORAZEPAM., TYLENOL PM, PRILOSEC, AMLODIPINE, SYMBICORT | Reactions: Malaise, Nausea, Haemoglobin decreased, Headache
SafetyReportID: 10004058 Date: 20140312 Report: SafetyReportID: 10004058 | ReceiveDate: 20140312 | Drugs: LUPRON DEPOT | Reactions: Abortion spontaneous
SafetyReportID: 10004059 Date: 20140312 Report: SafetyReportID: 10004059 | ReceiveDate: 20140312 | Drugs: ROACTEMRA, PREDNISOLON, LEFLUNOMID | Reactions: Blood fibrinogen decreased
SafetyReportID: 10004060 Date: 20140312 Report: SafetyReportID: 10004060 | ReceiveDate: 20140312 | Drugs: YAZ, NICOTINE., LIPITOR, YASMIN, LEXAPRO | Reactions: Pulmonary embolism, General physical health deterioration, Pain, Injury, Abdominal pain
SafetyReportID: 10004061 Date: 20140312 Report: SafetyReportID: 10004061 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI | Reactions: Platelet count decreased
SafetyReportID: 10004062 Date: 20140312 Report: SafetyReportID: 10004062 | ReceiveDate: 20140312 | Drugs: OXYTROL FOR WOMEN, OXYTROL FOR WOMEN | Reactions: Dermatitis contact, Application site pruritus, Application site erythema
SafetyReportID: 10004063 Date: 20140312 Report: SafetyReportID: 10004063 | ReceiveDate: 20140312 | Drugs: SABRIL (FOR ORAL SOLUTION), CLONAZEPAM, KEPPRA, ZONEGRAN, ACTH, MIDAZOLAM | Reactions: Irritability, Insomnia, Abnormal behaviour
SafetyReportID: 10004064 Date: 20140312 Report: SafetyReportID: 10004064 | ReceiveDate: 20140312 | Drugs: YAZ | Reactions: Anxiety, General physical health deterioration, Injury, Thrombosis, Emotional distress, Pain, Abdominal pain
SafetyReportID: 10004065 Date: 20140312 Report: SafetyReportID: 10004065 | ReceiveDate: 20140312 | Drugs: HUMIRA | Reactions: Ileectomy
SafetyReportID: 10004066 Date: 20140312 Report: SafetyReportID: 10004066 | ReceiveDate: 20140312 | Drugs: JAKAFI, SYNTHROID, HYDROCHLOROTHIAZIDE, PRILOSEC /00661201/, BENZONATATE | Reactions: Diabetes mellitus, Urinary tract infection
SafetyReportID: 10004067 Date: 20140312 Report: SafetyReportID: 10004067 | ReceiveDate: 20140312 | Drugs: YAZ, BEYAZ, YASMIN, CALCIUM [CALCIUM], BIOTIN | Reactions: Anxiety, General physical health deterioration, Axillary vein thrombosis, Pain, Peripheral swelling, Deep vein thrombosis, Abdominal pain, Emotional distress, Injury, Subclavian vein thrombosis
SafetyReportID: 10004068 Date: 20140312 Report: SafetyReportID: 10004068 | ReceiveDate: 20140312 | Drugs: KALETRA | Reactions: Foetal heart rate decreased, Foetal exposure during pregnancy, Foetal heart rate increased
SafetyReportID: 10004069 Date: 20140312 Report: SafetyReportID: 10004069 | ReceiveDate: 20140312 | Drugs: SPIRIVA | Reactions: Off label use
SafetyReportID: 10004070 Date: 20140312 Report: SafetyReportID: 10004070 | ReceiveDate: 20140312 | Drugs: NEXPLANON | Reactions: Device breakage, No adverse event
SafetyReportID: 10004071 Date: 20140312 Report: SafetyReportID: 10004071 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10004072 Date: 20140312 Report: SafetyReportID: 10004072 | ReceiveDate: 20140312 | Drugs: OMNISCAN, SIMVASTATIN | Reactions: Nephrogenic systemic fibrosis
SafetyReportID: 10004073 Date: 20140312 Report: SafetyReportID: 10004073 | ReceiveDate: 20140312 | Drugs: TEGRETOL, GARDENALE | Reactions: Vertigo, Erythema
SafetyReportID: 10004074 Date: 20140312 Report: SafetyReportID: 10004074 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS | Reactions: Accidental overdose
SafetyReportID: 10004075 Date: 20140312 Report: SafetyReportID: 10004075 | ReceiveDate: 20140312 | Drugs: HUMIRA, HUMIRA, ANTIBIOTICS, L-THYROXIN, ANTIHYPERTENSIVES, ANTIHYPERTENSIVES | Reactions: Tooth disorder, Colitis ulcerative
SafetyReportID: 10004076 Date: 20140312 Report: SafetyReportID: 10004076 | ReceiveDate: 20140312 | Drugs: SABRIL (FOR ORAL SOLUTION), ZONEGRAN | Reactions: Drug dose omission
SafetyReportID: 10004077 Date: 20140312 Report: SafetyReportID: 10004077 | ReceiveDate: 20140312 | Drugs: COPAXONE | Reactions: Eye pain, Ocular vascular disorder, Retinal vascular disorder
SafetyReportID: 10004078 Date: 20140312 Report: SafetyReportID: 10004078 | ReceiveDate: 20140312 | Drugs: PRADAXA | Reactions: Deafness, Ear injury
SafetyReportID: 10004079 Date: 20140312 Report: SafetyReportID: 10004079 | ReceiveDate: 20140312 | Drugs: RIBAVIRIN, RIBAVIRIN, TELAPREVIR, INTERFERON (UNSPECIFIED), INTERFERON (UNSPECIFIED) | Reactions: Renal impairment
SafetyReportID: 10004080 Date: 20140312 Report: SafetyReportID: 10004080 | ReceiveDate: 20140312 | Drugs: PHILLIPS^ MILK OF MAGNESIA LIQUID ORIGINAL | Reactions: Intestinal haemorrhage, Diarrhoea, Drug ineffective
SafetyReportID: 10004081 Date: 20140312 Report: SafetyReportID: 10004081 | ReceiveDate: 20140312 | Drugs: FEMARA, FEMARA, LORAZEPAM, METFORMIN, SERTRALINE, LEVOTHYROXINE, ALENDRONIC ACID, LANSOPRAZOLE, ADCAL D3 | Reactions: Ocular hyperaemia, Eye pain, Dry eye, Chest discomfort
SafetyReportID: 10004082 Date: 20140312 Report: SafetyReportID: 10004082 | ReceiveDate: 20140312 | Drugs: AMPYRA, TYSABRI, OXYBUTYNIN, VITAMINS | Reactions: Wrist fracture, Fall, Hysterectomy, Muscular weakness, Skin discolouration, Gait disturbance
SafetyReportID: 10004083 Date: 20140312 Report: SafetyReportID: 10004083 | ReceiveDate: 20140312 | Drugs: TAVEGIL, LCL161, PACLITAXEL, PREDNISOLONE, ENOXAPARIN, RANITIDINE | Reactions: Hypotension
SafetyReportID: 10004084 Date: 20140312 Report: SafetyReportID: 10004084 | ReceiveDate: 20140312 | Drugs: TEGRETOL, TEGRETOL, CARBAMAZEPINE | Reactions: Convulsion
SafetyReportID: 10004085 Date: 20140312 Report: SafetyReportID: 10004085 | ReceiveDate: 20140312 | Drugs: BLINDED ALISKIREN, BLINDED ENALAPRIL, BLINDED NO TREATMENT RECEIVED, ASPIRIN, SIMVASTATIN, HCT, BERLTHYROX, METO TABLINEN | Reactions: Lower gastrointestinal haemorrhage
SafetyReportID: 10004086 Date: 20140312 Report: SafetyReportID: 10004086 | ReceiveDate: 20140312 | Drugs: AMPYRA | Reactions: Renal failure
SafetyReportID: 10004087 Date: 20140312 Report: SafetyReportID: 10004087 | ReceiveDate: 20140312 | Drugs: CORICIDIN HBP COLD AND FLU | Reactions: Drug ineffective
SafetyReportID: 10004088 Date: 20140312 Report: SafetyReportID: 10004088 | ReceiveDate: 20140312 | Drugs: NEORAL, NEORAL, BUSULFAN, CYCLOPHOSPHAMIDE, ACYCLOVIR, IMMUNOGLOBULINS | Reactions: Pulmonary alveolar haemorrhage, Graft versus host disease, Cystitis haemorrhagic, Adenovirus infection, BK virus infection
SafetyReportID: 10004089 Date: 20140312 Report: SafetyReportID: 10004089 | ReceiveDate: 20140312 | Drugs: AMPYRA, BUSPAR, GLUCOPHAGE, LIPITOR, SPIRONOLACTONE, LISINOPRIL, CARDIZEM, ALLOPURINOL, METFORMIN, REBIF, CYANOCOBALAMIN, THIAMINE, FOLIC ACID, LORAZEPAM | Reactions: Convulsion, Alcohol detoxification, Loss of consciousness, Alcohol withdrawal syndrome, Renal failure acute, Dehydration, Joint injury, Tongue injury, Swollen tongue, Electrolyte imbalance, Dysarthria, Fall, Laceration, Gait disturbance, Headache, Drug ineffective
SafetyReportID: 10004090 Date: 20140312 Report: SafetyReportID: 10004090 | ReceiveDate: 20140312 | Drugs: JANUVIA | Reactions: Pancreatitis acute, Blood glucose increased
SafetyReportID: 10004091 Date: 20140312 Report: SafetyReportID: 10004091 | ReceiveDate: 20140312 | Drugs: CLINDAMYCIN, PARACETAMOL, AMOXICILLIN, METRONIDAZOLE, MEROPENEM, AMIKACIN, FLUCONAZOLE, NYSTATIN, KETOPROFEN, BENZONATATE, IPRATROPIUM, BUDESONIDE, OMEPRAZOLE | Reactions: Bone marrow failure, Pyrexia, Neutropenia, Leukopenia, Thrombocytopenia, Pancytopenia, Tonsillitis, Cough, Tonsillar hypertrophy, Purulent discharge, Pharyngeal erythema, Odynophagia, Lymphadenopathy, Productive cough
SafetyReportID: 10004092 Date: 20140312 Report: SafetyReportID: 10004092 | ReceiveDate: 20140312 | Drugs: PROAIR HFA, PROAIR HFA, SPIRIVA, INSULIN, LASIX, HEART MEDICATION, BLOOD PRESSURE MEDICATION | Reactions: Large intestine polyp, Diarrhoea, Blood potassium increased
SafetyReportID: 10004093 Date: 20140312 Report: SafetyReportID: 10004093 | ReceiveDate: 20140312 | Drugs: FORANE (ISOFLURANE, USP) | Reactions: Hyperthermia malignant
SafetyReportID: 10004094 Date: 20140312 Report: SafetyReportID: 10004094 | ReceiveDate: 20140312 | Drugs: AMPYRA | Reactions: Abasia
SafetyReportID: 10004095 Date: 20140312 Report: SafetyReportID: 10004095 | ReceiveDate: 20140312 | Drugs: XARELTO, XARELTO | Reactions: Death, Cerebrovascular accident, Cerebral haemorrhage, Drooling
SafetyReportID: 10004096 Date: 20140312 Report: SafetyReportID: 10004096 | ReceiveDate: 20140312 | Drugs: PRADAXA, CORDARONE, BISOPROLOL | Reactions: Haematochezia, Diverticulum
SafetyReportID: 10004097 Date: 20140312 Report: SafetyReportID: 10004097 | ReceiveDate: 20140312 | Drugs: ONFI | Reactions: Incorrect dose administered, Product physical issue
SafetyReportID: 10004098 Date: 20140312 Report: SafetyReportID: 10004098 | ReceiveDate: 20140312 | Drugs: AMPYRA, COPAXONE, ALL OTHER THERAPEUTIC PRODUCTS | Reactions: Paraesthesia, Asthenia, Back pain, Dyspepsia, Constipation, Renal function test abnormal, Pruritus, Throat irritation, Diarrhoea, Nasal discomfort, Malaise, Multiple sclerosis relapse, Urinary tract infection, Dizziness, Headache, Nausea
SafetyReportID: 10004099 Date: 20140312 Report: SafetyReportID: 10004099 | ReceiveDate: 20140312 | Drugs: PRADAXA | Reactions: Cerebrovascular accident
SafetyReportID: 10004100 Date: 20140312 Report: SafetyReportID: 10004100 | ReceiveDate: 20140312 | Drugs: GLIVEC | Reactions: Death
SafetyReportID: 10004101 Date: 20140312 Report: SafetyReportID: 10004101 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, LOSARTAN POTASSIUM, LANTUS SOLOSTAR, NOVOLOG, METOPROLOL SUCCINATE, ALLOPURINOL, POTASSIUM, ASPIRIN, MULTIVITAMIN /00097801/, NIACIN, ZYRTEC | Reactions: Rash
SafetyReportID: 10004102 Date: 20140312 Report: SafetyReportID: 10004102 | ReceiveDate: 20140312 | Drugs: PRADAXA | Reactions: Blood alkaline phosphatase increased, Transaminases increased, Gamma-glutamyltransferase increased
SafetyReportID: 10004103 Date: 20140312 Report: SafetyReportID: 10004103 | ReceiveDate: 20140312 | Drugs: CLOZARIL, DENZAPINE, ARIPIPRAZOLE | Reactions: Electrocardiogram abnormal, Left ventricular dysfunction, Sinus tachycardia
SafetyReportID: 10004104 Date: 20140312 Report: SafetyReportID: 10004104 | ReceiveDate: 20140312 | Drugs: OMNISCAN, OMNISCAN | Reactions: Nephrogenic systemic fibrosis
SafetyReportID: 10004105 Date: 20140312 Report: SafetyReportID: 10004105 | ReceiveDate: 20140312 | Drugs: ALENDRONIC ACID | Reactions: Foetal cardiac disorder, Off label use, Exposure during pregnancy
SafetyReportID: 10004106 Date: 20140312 Report: SafetyReportID: 10004106 | ReceiveDate: 20140312 | Drugs: JAKAFI, FISH OIL, BENADRYL /00000402/ | Reactions: Eye haemorrhage
SafetyReportID: 10004107 Date: 20140312 Report: SafetyReportID: 10004107 | ReceiveDate: 20140312 | Drugs: MIRENA | Reactions: Menorrhagia
SafetyReportID: 10004108 Date: 20140312 Report: SafetyReportID: 10004108 | ReceiveDate: 20140312 | Drugs: COMBIVENT, ADVAIR | Reactions: Dysphonia
SafetyReportID: 10004109 Date: 20140312 Report: SafetyReportID: 10004109 | ReceiveDate: 20140312 | Drugs: KERI ORIGINAL, KERI ORIGINAL, KERI ORIGINAL, KERI ORIGINAL, FORMULA 405 | Reactions: Ocular hyperaemia, Lacrimation increased, Dry eye
SafetyReportID: 10004110 Date: 20140312 Report: SafetyReportID: 10004110 | ReceiveDate: 20140312 | Drugs: GILENYA | Reactions: Skin lesion, Lymphadenopathy, Lymph node pain, Basal cell carcinoma, Seborrhoeic keratosis, Fall
SafetyReportID: 10004111 Date: 20140312 Report: SafetyReportID: 10004111 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, TRICOR /00090101/, METFORMIN, GLIPIZIDE, LOSARTAN + HIDROCLOROTIAZIDA, ALLOPURINOL, AMITRIPTYLINE, ASPIRIN, FLOVENT, IPRATROPIUM INHALER /00391402/, AZITHROMYCIN, MULTIVITAMINS, THIAMINE, NIACIN, CALCIUM SUPPLEMENT /00060701/, MAGNESIUM SUPPLEMENT /00123201/ | Reactions: Rash, Headache
SafetyReportID: 10004112 Date: 20140312 Report: SafetyReportID: 10004112 | ReceiveDate: 20140312 | Drugs: MIRENA | Reactions: Uterine perforation, Injury, Pain, Emotional distress
SafetyReportID: 10004113 Date: 20140312 Report: SafetyReportID: 10004113 | ReceiveDate: 20140312 | Drugs: LIPITOR, LIPITOR | Reactions: Type 2 diabetes mellitus
SafetyReportID: 10004114 Date: 20140312 Report: SafetyReportID: 10004114 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, VERAPAMIL, CITALOPRAM, GABAPENTIN, ASPIRIN | Reactions: Oral mucosal erythema, Oral pain, Abdominal tenderness
SafetyReportID: 10004115 Date: 20140312 Report: SafetyReportID: 10004115 | ReceiveDate: 20140312 | Drugs: CORICIDIN HBP COLD AND FLU | Reactions: Somnolence, Drug ineffective
SafetyReportID: 10004116 Date: 20140312 Report: SafetyReportID: 10004116 | ReceiveDate: 20140312 | Drugs: COLCHICINE., FLUIMUCIL, TRAMADOL, PYOSTACINE, HUMIRA, MONOTILDIEM LP, PREDNISONE., MUCOMYSTENDO, COLCHICINE., LANTUS, NOVORAPID, HUMIRA, FUROSEMIDE., RASILEZ, MALARONE, INEXIUM//ESOMEPRAZOLE MAGNESIUM, BECLOSPIN, METHOTREXATE, DAFALGAN, HYPERIUM, AUGMENTIN, METHOTREXATE, PIVALONE | Reactions: Thrombocytopenia, Petechiae
SafetyReportID: 10004117 Date: 20140312 Report: SafetyReportID: 10004117 | ReceiveDate: 20140312 | Drugs: HABITROL 21 MG | Reactions: Suicidal ideation, Depressed mood, Nightmare
SafetyReportID: 10004118 Date: 20140312 Report: SafetyReportID: 10004118 | ReceiveDate: 20140312 | Drugs: FOLIC ACID, LEVOTHYROXINE, OMEPRAZOLE, SUMATRIPTAN SUCCINATE, CETIRIZINE, JAKAFI, JAKAFI | Reactions: Haemoglobin decreased
SafetyReportID: 10004119 Date: 20140312 Report: SafetyReportID: 10004119 | ReceiveDate: 20140312 | Drugs: OXYTROL FOR WOMEN | Reactions: Drug ineffective
SafetyReportID: 10004120 Date: 20140312 Report: SafetyReportID: 10004120 | ReceiveDate: 20140312 | Drugs: POLOCARD, TRITACE, NEDAL, DIAPREL, PRAVATOR, AMN107, CLOPIDIX | Reactions: Acute myocardial infarction
SafetyReportID: 10004121 Date: 20140312 Report: SafetyReportID: 10004121 | ReceiveDate: 20140312 | Drugs: SANDOSTATIN LAR | Reactions: Malignant neoplasm progression, General physical health deterioration
SafetyReportID: 10004122 Date: 20140312 Report: SafetyReportID: 10004122 | ReceiveDate: 20140312 | Drugs: GLIVEC | Reactions: Death
SafetyReportID: 10004123 Date: 20140312 Report: SafetyReportID: 10004123 | ReceiveDate: 20140312 | Drugs: KYNAMRO, KYNAMRO | Reactions: Alanine aminotransferase increased, Aspartate aminotransferase increased, Fatigue, Abdominal pain upper, Injection site discolouration, Injection site pruritus, Unevaluable event
SafetyReportID: 10004124 Date: 20140312 Report: SafetyReportID: 10004124 | ReceiveDate: 20140312 | Drugs: NEXPLANON, NEXPLANON | Reactions: Device difficult to use, Product quality issue
SafetyReportID: 10004125 Date: 20140312 Report: SafetyReportID: 10004125 | ReceiveDate: 20140312 | Drugs: AMN107, AMN107, AMN107, BISOPROLOL, JODTHYROX, VOTUM, ASS, ALLOPURINOL, MARCUMAR | Reactions: Dizziness, Hypoaesthesia
SafetyReportID: 10004126 Date: 20140312 Report: SafetyReportID: 10004126 | ReceiveDate: 20140312 | Drugs: MIRTAZAPINE, LANSOPRAZOLE, NASONEX | Reactions: Blepharospasm, Aggression, Anger, Violence-related symptom, Suicidal ideation
SafetyReportID: 10004127 Date: 20140312 Report: SafetyReportID: 10004127 | ReceiveDate: 20140312 | Drugs: MIRENA | Reactions: Uterine perforation, Device dislocation
SafetyReportID: 10004128 Date: 20140312 Report: SafetyReportID: 10004128 | ReceiveDate: 20140312 | Drugs: NUVARING | Reactions: Device expulsion
SafetyReportID: 10004129 Date: 20140312 Report: SafetyReportID: 10004129 | ReceiveDate: 20140312 | Drugs: IZOTONIK SODYUM KLOR?R PVC | Reactions: Infusion site erythema, Chills
SafetyReportID: 10004130 Date: 20140312 Report: SafetyReportID: 10004130 | ReceiveDate: 20140312 | Drugs: JAKAFI, ADVIL, BENICAR, BENICAR HCT, ASPIRIN. | Reactions: Laboratory test abnormal, Contusion, Drug dose omission, Platelet count increased, Hypertension, Treatment noncompliance, Eye disorder, White blood cell count increased, Pain
SafetyReportID: 10004131 Date: 20140312 Report: SafetyReportID: 10004131 | ReceiveDate: 20140312 | Drugs: LO LOESTRIN FE, MIRENA | Reactions: Emotional distress, Pain, Embedded device, Injury
SafetyReportID: 10004132 Date: 20140312 Report: SafetyReportID: 10004132 | ReceiveDate: 20140312 | Drugs: ZYTIGA, XTANDI, XTANDI | Reactions: Platelet count decreased, Pyrexia, Prostatic specific antigen increased, Bone pain
SafetyReportID: 10004133 Date: 20140312 Report: SafetyReportID: 10004133 | ReceiveDate: 20140312 | Drugs: HUMIRA | Reactions: Respiratory arrest, Pleural effusion
SafetyReportID: 10004134 Date: 20140312 Report: SafetyReportID: 10004134 | ReceiveDate: 20140312 | Drugs: MIRENA | Reactions: Uterine perforation, Injury, Pain, Emotional distress
SafetyReportID: 10004135 Date: 20140312 Report: SafetyReportID: 10004135 | ReceiveDate: 20140312 | Drugs: STELARA, REMERON, PRISTIQ EXTENDED RELEASE, LITHIUM ASPARTATE, STELARA, VALIUM, WELLBUTRIN, GEODON, DEPAKOTE, TRAZODONE, DEXEDRINE | Reactions: Drug eruption
SafetyReportID: 10004136 Date: 20140312 Report: SafetyReportID: 10004136 | ReceiveDate: 20140312 | Drugs: HALDOL | Reactions: Oropharyngeal spasm, Respiratory disorder, Dysphagia, Psychomotor hyperactivity, Salivary hypersecretion, Dysarthria, Sensation of foreign body
SafetyReportID: 10004137 Date: 20140312 Report: SafetyReportID: 10004137 | ReceiveDate: 20140312 | Drugs: PRADAXA, LEVOTHYROX 125 MCG, LASILIX FAIBLE, COVERSYL, SELOZOK, ALDACTONE | Reactions: Melaena
SafetyReportID: 10004138 Date: 20140312 Report: SafetyReportID: 10004138 | ReceiveDate: 20140312 | Drugs: JAKAFI, BABY ASPIRIN | Reactions: Pneumonia, Anaemia
SafetyReportID: 10004139 Date: 20140312 Report: SafetyReportID: 10004139 | ReceiveDate: 20140312 | Drugs: LIPITOR, LIPITOR | Reactions: Type 2 diabetes mellitus
SafetyReportID: 10004140 Date: 20140312 Report: SafetyReportID: 10004140 | ReceiveDate: 20140312 | Drugs: JAKAFI, ASPIRIN, HYDREA, LORATADINE, OMEPRAZOLE, OXYCODONE, PAROXETINE, TUMS /00193601/, SPIRONOLACTONE | Reactions: Nausea, Drug administration error
SafetyReportID: 10004141 Date: 20140312 Report: SafetyReportID: 10004141 | ReceiveDate: 20140312 | Drugs: GLEEVEC | Reactions: Hepatic lesion, Malignant neoplasm progression, Gastric cancer, Product use issue
SafetyReportID: 10004142 Date: 20140312 Report: SafetyReportID: 10004142 | ReceiveDate: 20140312 | Drugs: REMERGIL, FLUVOXAMINE MALEATE, ZINC SULFATE | Reactions: Seizure like phenomena, Myoclonus
SafetyReportID: 10004143 Date: 20140312 Report: SafetyReportID: 10004143 | ReceiveDate: 20140312 | Drugs: LIPITOR, LIPITOR | Reactions: Type 2 diabetes mellitus
SafetyReportID: 10004144 Date: 20140312 Report: SafetyReportID: 10004144 | ReceiveDate: 20140312 | Drugs: JAKAFI, PRAVASTATIN, HYDROCHLOROTHIAZIDE, IMPRIL, ASPIRIN | Reactions: Flatulence
SafetyReportID: 10004145 Date: 20140312 Report: SafetyReportID: 10004145 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10004146 Date: 20140312 Report: SafetyReportID: 10004146 | ReceiveDate: 20140312 | Drugs: LIPITOR, LIPITOR | Reactions: Type 2 diabetes mellitus
SafetyReportID: 10004147 Date: 20140312 Report: SafetyReportID: 10004147 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Drug dose omission, Blood count abnormal
SafetyReportID: 10004148 Date: 20140312 Report: SafetyReportID: 10004148 | ReceiveDate: 20140312 | Drugs: THERAFLU EXTRAGRIP | Reactions: Rash pruritic, Generalised erythema
SafetyReportID: 10004149 Date: 20140312 Report: SafetyReportID: 10004149 | ReceiveDate: 20140312 | Drugs: LIPITOR, LIPITOR | Reactions: Type 2 diabetes mellitus
SafetyReportID: 10004150 Date: 20140312 Report: SafetyReportID: 10004150 | ReceiveDate: 20140312 | Drugs: MIRENA | Reactions: Uterine perforation, Injury, Pain, Emotional distress
SafetyReportID: 10004151 Date: 20140312 Report: SafetyReportID: 10004151 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Therapeutic response unexpected
SafetyReportID: 10004152 Date: 20140312 Report: SafetyReportID: 10004152 | ReceiveDate: 20140312 | Drugs: KETOPROFEN, ACETYLSALICYLIC ACID, YMEA SILHOUET | Reactions: Urticaria, Erythema, Pruritus, Drug interaction
SafetyReportID: 10004153 Date: 20140312 Report: SafetyReportID: 10004153 | ReceiveDate: 20140312 | Drugs: SANDOSTATIN LAR DEPOT, CALCIUM, SANDOSTATIN LAR DEPOT, THYRAX, TELMISARTAN., SANDOSTATIN LAR DEPOT, SANDOSTATIN LAR DEPOT, ACENOCOUMAROL | Reactions: Hip fracture, Fall, Urinary tract infection
SafetyReportID: 10004154 Date: 20140312 Report: SafetyReportID: 10004154 | ReceiveDate: 20140312 | Drugs: LIPITOR, LIPITOR | Reactions: Type 2 diabetes mellitus
SafetyReportID: 10004155 Date: 20140312 Report: SafetyReportID: 10004155 | ReceiveDate: 20140312 | Drugs: GLIVEC | Reactions: Death
SafetyReportID: 10004156 Date: 20140312 Report: SafetyReportID: 10004156 | ReceiveDate: 20140312 | Drugs: MIRENA | Reactions: Device dislocation
SafetyReportID: 10004157 Date: 20140312 Report: SafetyReportID: 10004157 | ReceiveDate: 20140312 | Drugs: PLAN B ONE-STEP | Reactions: Menstruation irregular
SafetyReportID: 10004158 Date: 20140312 Report: SafetyReportID: 10004158 | ReceiveDate: 20140312 | Drugs: LIPITOR, LIPITOR | Reactions: Type 2 diabetes mellitus
SafetyReportID: 10004159 Date: 20140312 Report: SafetyReportID: 10004159 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Bronchitis
SafetyReportID: 10004160 Date: 20140312 Report: SafetyReportID: 10004160 | ReceiveDate: 20140312 | Drugs: MIRENA | Reactions: Device expulsion
SafetyReportID: 10004161 Date: 20140312 Report: SafetyReportID: 10004161 | ReceiveDate: 20140312 | Drugs: PLAN B ONE-STEP, PLAN B ONE-STEP | Reactions: Menstruation delayed
SafetyReportID: 10004162 Date: 20140312 Report: SafetyReportID: 10004162 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, JAKAFI, LIPITOR, LISINOPRIL, HYDROCHLOROTHIAZIDE | Reactions: Fatigue, Stomatitis, Haemoglobin decreased, Platelet count decreased, Weight increased
SafetyReportID: 10004163 Date: 20140312 Report: SafetyReportID: 10004163 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, NASONEX, FINASTERIDE, ZANTAC, PROCRIT /00909301/ | Reactions: Decreased appetite, Depression
SafetyReportID: 10004164 Date: 20140312 Report: SafetyReportID: 10004164 | ReceiveDate: 20140312 | Drugs: LIPITOR, LIPITOR | Reactions: Type 2 diabetes mellitus
SafetyReportID: 10004165 Date: 20140312 Report: SafetyReportID: 10004165 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Toothache
SafetyReportID: 10004166 Date: 20140312 Report: SafetyReportID: 10004166 | ReceiveDate: 20140312 | Drugs: PLAN B ONE-STEP | Reactions: Cough
SafetyReportID: 10004167 Date: 20140312 Report: SafetyReportID: 10004167 | ReceiveDate: 20140312 | Drugs: MIRENA | Reactions: Uterine perforation, Injury, Pain, Emotional distress
SafetyReportID: 10004168 Date: 20140312 Report: SafetyReportID: 10004168 | ReceiveDate: 20140312 | Drugs: ERBITUX SOLN FOR INF 5MG/ML, CISPLATIN FOR INJ, DOCETAXEL | Reactions: Dysgeusia, Dry mouth, Dysphagia, Peripheral sensory neuropathy, Alopecia, Constipation, Oedema, Hypersensitivity, Stomatitis, Diarrhoea, Decreased appetite, Skin fissures, Nausea, Dermatitis acneiform, Skin reaction, Vomiting, Radiation skin injury
SafetyReportID: 10004169 Date: 20140312 Report: SafetyReportID: 10004169 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Influenza like illness, Local swelling
SafetyReportID: 10004170 Date: 20140312 Report: SafetyReportID: 10004170 | ReceiveDate: 20140312 | Drugs: IMBRUVICA, IMBRUVICA, LORATADINE, SLOW RELEASE IRON, TOPROL, ONE A DAY MULTIVITAMIN, BENTYL, COMPAZINE, KLOR-CON, MIRALAX, BIFIDOBACTERIUM, PREVACID, TYLENOL, ULTRAM | Reactions: Transient ischaemic attack
SafetyReportID: 10004171 Date: 20140312 Report: SafetyReportID: 10004171 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Unevaluable event
SafetyReportID: 10004172 Date: 20140312 Report: SafetyReportID: 10004172 | ReceiveDate: 20140312 | Drugs: IBRUTINIB, IBRUTINIB, ZYLOL, CALCILESS, EVITOL | Reactions: Traumatic haematoma
SafetyReportID: 10004173 Date: 20140312 Report: SafetyReportID: 10004173 | ReceiveDate: 20140312 | Drugs: MIRENA, MEFOXIN | Reactions: Uterine perforation, Injury, Pain, Emotional distress, Psychological trauma
SafetyReportID: 10004174 Date: 20140312 Report: SafetyReportID: 10004174 | ReceiveDate: 20140312 | Drugs: PARAGARD 380A, MULTIVITAMIN, VITAMIN D, FISH OIL | Reactions: Menorrhagia, Medical device complication
SafetyReportID: 10004175 Date: 20140312 Report: SafetyReportID: 10004175 | ReceiveDate: 20140312 | Drugs: SULFASALAZINE., RAMIPRIL., JAKAFI, PREDNISONE., MAG-TAB, ATORVASTATIN, BISOPROLOL, LEVOTHYROXINE, LORTAB, ASPIRIN. | Reactions: Skin discolouration, Rash
SafetyReportID: 10004176 Date: 20140312 Report: SafetyReportID: 10004176 | ReceiveDate: 20140312 | Drugs: REVLIMID | Reactions: Death
SafetyReportID: 10004177 Date: 20140312 Report: SafetyReportID: 10004177 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Malaise, Insomnia, Fatigue, Asthenia
SafetyReportID: 10004178 Date: 20140312 Report: SafetyReportID: 10004178 | ReceiveDate: 20140312 | Drugs: EXJADE | Reactions: Neoplasm progression
SafetyReportID: 10004179 Date: 20140312 Report: SafetyReportID: 10004179 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, JAKAFI, ZOFRAN /00955301/, FAMOTIDINE, NORCO, ALLOPURINOL, LASIX /00032601/, ALDACTONE /00006201/, HYDROXYUREA, INDERAL | Reactions: Platelet count increased, Abdominal discomfort, Hypoaesthesia, Paraesthesia, Nausea, Headache, Dizziness, Contusion, Ecchymosis
SafetyReportID: 10004180 Date: 20140312 Report: SafetyReportID: 10004180 | ReceiveDate: 20140312 | Drugs: REVLIMID, ASPIRINE, MLN9708, REVLIMID, REVLIMID, OMEPRAZOLE., CLONAZEPAM., DEXAMETHASONE., DEXAMETHASONE., DEXAMETHASONE., DEXAMETHASONE., DEPAKINE | Reactions: Overdose, Dyspnoea, Lung infection
SafetyReportID: 10004181 Date: 20140312 Report: SafetyReportID: 10004181 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Nasal congestion
SafetyReportID: 10004182 Date: 20140312 Report: SafetyReportID: 10004182 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS | Reactions: Inappropriate schedule of drug administration
SafetyReportID: 10004183 Date: 20140312 Report: SafetyReportID: 10004183 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, DEXILANT, IBUPROFEN | Reactions: Weight loss poor
SafetyReportID: 10004184 Date: 20140312 Report: SafetyReportID: 10004184 | ReceiveDate: 20140312 | Drugs: LETAIRIS, REMODULIN, OXYGEN. | Reactions: Pain, Insomnia
SafetyReportID: 10004185 Date: 20140312 Report: SafetyReportID: 10004185 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10004186 Date: 20140312 Report: SafetyReportID: 10004186 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, JAKAFI, JAKAFI, JANUVIA, METFORMIN, ALLOPURINOL, ASPIRIN, ATORVASTATIN, ATENOLOL | Reactions: Thrombotic microangiopathy, Renal impairment, Hepatic failure, Mental status changes, Stem cell transplant, Graft versus host disease, Fatigue, Drug administration error
SafetyReportID: 10004187 Date: 20140312 Report: SafetyReportID: 10004187 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10004188 Date: 20140312 Report: SafetyReportID: 10004188 | ReceiveDate: 20140312 | Drugs: PROPECIA, PROPECIA | Reactions: Cognitive disorder, Anxiety, Depression, Sexual dysfunction, Blood testosterone free decreased, Tri-iodothyronine uptake increased, Back pain, Type 2 diabetes mellitus, Hepatitis C, Insomnia, Blood cholesterol increased, Benign prostatic hyperplasia, Urinary tract obstruction, Drug dependence, Erectile dysfunction
SafetyReportID: 10004189 Date: 20140312 Report: SafetyReportID: 10004189 | ReceiveDate: 20140312 | Drugs: TYVASO, LETAIRIS | Reactions: Heart rate increased
SafetyReportID: 10004190 Date: 20140312 Report: SafetyReportID: 10004190 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10004191 Date: 20140312 Report: SafetyReportID: 10004191 | ReceiveDate: 20140312 | Drugs: JAKAFI, HYDROCODONE | Reactions: Vitreous floaters, Contusion, Weight increased, Headache
SafetyReportID: 10004192 Date: 20140312 Report: SafetyReportID: 10004192 | ReceiveDate: 20140312 | Drugs: REMODULIN, LETAIRIS | Reactions: Muscle spasms, Oedema peripheral
SafetyReportID: 10004193 Date: 20140312 Report: SafetyReportID: 10004193 | ReceiveDate: 20140312 | Drugs: ONFI (ORAL SUSPENSION) | Reactions: Increased bronchial secretion
SafetyReportID: 10004194 Date: 20140312 Report: SafetyReportID: 10004194 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: No adverse event, Bone marrow transplant
SafetyReportID: 10004195 Date: 20140312 Report: SafetyReportID: 10004195 | ReceiveDate: 20140312 | Drugs: IRINOTECAN (UNKNOWN), CETUXIMAB | Reactions: Abdominal pain upper, Diarrhoea, Vomiting
SafetyReportID: 10004196 Date: 20140312 Report: SafetyReportID: 10004196 | ReceiveDate: 20140312 | Drugs: OXALIPLATIN TEVA 5MG/ML, FOLINATE DE CALCIUM WINTHROP | Reactions: Infusion related reaction, Generalised erythema, Pruritus, Macroglossia, Dyspnoea
SafetyReportID: 10004197 Date: 20140312 Report: SafetyReportID: 10004197 | ReceiveDate: 20140312 | Drugs: COUMADIN, LETAIRIS | Reactions: Migraine
SafetyReportID: 10004198 Date: 20140312 Report: SafetyReportID: 10004198 | ReceiveDate: 20140312 | Drugs: JAKAFI, JAKAFI, PAMELOR, BUSPAR, CLONAZEPAM, DICYCLOMINE, MULTIVITAMINS, CALCIUM | Reactions: Platelet count abnormal, Platelet count decreased, Haemoglobin decreased
SafetyReportID: 10004199 Date: 20140312 Report: SafetyReportID: 10004199 | ReceiveDate: 20140312 | Drugs: PLAN B ONE-STEP | Reactions: Malaise, Menstruation irregular
SafetyReportID: 10004200 Date: 20140312 Report: SafetyReportID: 10004200 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Fall, Injury
SafetyReportID: 10004201 Date: 20140312 Report: SafetyReportID: 10004201 | ReceiveDate: 20140312 | Drugs: PLAN B ONE-STEP | Reactions: Vomiting, Nausea, Menstruation irregular
SafetyReportID: 10004202 Date: 20140312 Report: SafetyReportID: 10004202 | ReceiveDate: 20140312 | Drugs: JAKAFI, SPIRIVA, MULTIVITAMINS, GLUCOSAMINE CHONDROITIN /01625901/ | Reactions: Blister, Hyperhidrosis, Skin irritation, Anaemia
SafetyReportID: 10004203 Date: 20140312 Report: SafetyReportID: 10004203 | ReceiveDate: 20140312 | Drugs: BENDAMUSTINE, RITUXIMAB, PREDNISONE /00044702/, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, IBRUTINUB | Reactions: Malignant neoplasm progression, Pancytopenia
SafetyReportID: 10004204 Date: 20140312 Report: SafetyReportID: 10004204 | ReceiveDate: 20140312 | Drugs: GILENYA | Reactions: Neurogenic bladder, Feeling abnormal, Balance disorder, Nervousness, Frustration, Hypoaesthesia, Dyspnoea
SafetyReportID: 10004205 Date: 20140312 Report: SafetyReportID: 10004205 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10004206 Date: 20140312 Report: SafetyReportID: 10004206 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Unevaluable event, Infection
SafetyReportID: 10004207 Date: 20140312 Report: SafetyReportID: 10004207 | ReceiveDate: 20140312 | Drugs: COMPLERA | Reactions: Pregnancy
SafetyReportID: 10004208 Date: 20140312 Report: SafetyReportID: 10004208 | ReceiveDate: 20140312 | Drugs: IBUPROFEN | Reactions: Off label use, Stevens-Johnson syndrome, Consciousness fluctuating, Lip swelling, Lip discolouration, Blister, Pain, Skin exfoliation, Chapped lips, Eye disorder, Scab, Scar, Weight decreased, Skin disorder, Rash generalised, Dyspnoea, Hypersensitivity, Malaise
SafetyReportID: 10004209 Date: 20140312 Report: SafetyReportID: 10004209 | ReceiveDate: 20140312 | Drugs: ASMANEX TWISTHALER, ASMANEX TWISTHALER | Reactions: Syncope, Drug dose omission, Drug ineffective, Product quality issue, Expired drug administered
SafetyReportID: 10004210 Date: 20140312 Report: SafetyReportID: 10004210 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Syncope, Fall, Cough, Bronchitis, Head injury
SafetyReportID: 10004211 Date: 20140312 Report: SafetyReportID: 10004211 | ReceiveDate: 20140312 | Drugs: EFFEXOR XR, EFFEXOR XR, METFORMIN, LUTERA, CLONAZEPAM, ASPIRIN, BUPROPION | Reactions: Spinal disorder, Dizziness, Feeling abnormal
SafetyReportID: 10004212 Date: 20140312 Report: SafetyReportID: 10004212 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10004213 Date: 20140312 Report: SafetyReportID: 10004213 | ReceiveDate: 20140312 | Drugs: OMEPRAZOLE, SEROQUEL, STESOLID, ZYPREXA, OXASCAND, CISORDINOL, FLUOXETINE, LITHIONIT, HEMINEVRIN, AKINETON, THERALEN, IMOVANE, PROPAVAN, SOBRIL, ERGENYL, INVEGA, NOZINAN, PARGITAN, ATARAX, CETIRIZINE, TOPIRAMATE | Reactions: Ovarian germ cell cancer stage II, Amenorrhoea, Weight increased, Tremor, Galactorrhoea, Dyspnoea, Blood prolactin increased, Palpitations, Dyskinesia, Dysuria, Swelling, Muscle spasms, Breast enlargement, Fatigue, Muscular weakness, Agitation, Aggression, Hyperhidrosis, Abdominal pain
SafetyReportID: 10004214 Date: 20140312 Report: SafetyReportID: 10004214 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Urinary tract infection
SafetyReportID: 10004215 Date: 20140312 Report: SafetyReportID: 10004215 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10004216 Date: 20140312 Report: SafetyReportID: 10004216 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10004217 Date: 20140312 Report: SafetyReportID: 10004217 | ReceiveDate: 20140312 | Drugs: PROLIA | Reactions: Femoral neck fracture, Osteoarthritis, Drug ineffective
SafetyReportID: 10004218 Date: 20140312 Report: SafetyReportID: 10004218 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS, RISPERDAL | Reactions: Overdose
SafetyReportID: 10004219 Date: 20140312 Report: SafetyReportID: 10004219 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Influenza
SafetyReportID: 10004220 Date: 20140312 Report: SafetyReportID: 10004220 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10004221 Date: 20140312 Report: SafetyReportID: 10004221 | ReceiveDate: 20140312 | Drugs: EFFEXOR XR, EFFEXOR XR, BABY ASPIRIN, OXYBUTYNIN, SIMVASTATIN | Reactions: Chest pain, Palpitations, Drug ineffective
SafetyReportID: 10004222 Date: 20140312 Report: SafetyReportID: 10004222 | ReceiveDate: 20140312 | Drugs: DUROTEP MT | Reactions: Wrong technique in drug usage process
SafetyReportID: 10004223 Date: 20140312 Report: SafetyReportID: 10004223 | ReceiveDate: 20140312 | Drugs: CAMPATH | Reactions: Death
SafetyReportID: 10004224 Date: 20140312 Report: SafetyReportID: 10004224 | ReceiveDate: 20140312 | Drugs: DURAGESIC | Reactions: Drug dose omission, Product adhesion issue
SafetyReportID: 10004225 Date: 20140312 Report: SafetyReportID: 10004225 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Headache
SafetyReportID: 10004226 Date: 20140312 Report: SafetyReportID: 10004226 | ReceiveDate: 20140312 | Drugs: DUROTEP MT | Reactions: Malignant neoplasm progression
SafetyReportID: 10004227 Date: 20140312 Report: SafetyReportID: 10004227 | ReceiveDate: 20140312 | Drugs: CELEBREX, LISINOPRIL | Reactions: Glaucoma, Cataract, Vitamin D decreased, Arthropathy
SafetyReportID: 10004228 Date: 20140312 Report: SafetyReportID: 10004228 | ReceiveDate: 20140312 | Drugs: DARUNAVIR, RITONAVIR, OMEPRAZOLE | Reactions: Syncope, Electrocardiogram QT prolonged
SafetyReportID: 10004229 Date: 20140312 Report: SafetyReportID: 10004229 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Pain in extremity
SafetyReportID: 10004230 Date: 20140312 Report: SafetyReportID: 10004230 | ReceiveDate: 20140312 | Drugs: LYRICA | Reactions: Drug effect incomplete, Frustration, Weight increased
SafetyReportID: 10004231 Date: 20140312 Report: SafetyReportID: 10004231 | ReceiveDate: 20140312 | Drugs: NODOZ, LITHIUM, OLANZAPINE | Reactions: Renal failure acute, Rhabdomyolysis, Traumatic liver injury, Pneumonia aspiration, Intentional overdose, Suicide attempt, Loss of consciousness, Diarrhoea, Vomiting, Nausea, Restlessness
SafetyReportID: 10004232 Date: 20140312 Report: SafetyReportID: 10004232 | ReceiveDate: 20140312 | Drugs: HUMAN CLOTTABLE PROTEIN/HUMAN THROMBIN, PLAVIX | Reactions: Haemorrhage, Haemarthrosis
SafetyReportID: 10004233 Date: 20140312 Report: SafetyReportID: 10004233 | ReceiveDate: 20140312 | Drugs: HUMAN CLOTTABLE PROTEIN/HUMAN THROMBIN | Reactions: Embolism arterial, Pulmonary embolism, Phlebitis
SafetyReportID: 10004234 Date: 20140312 Report: SafetyReportID: 10004234 | ReceiveDate: 20140312 | Drugs: HUMAN CLOTTABLE PROTEIN/HUMAN THROMBIN, TEMESTA [LORAZEPAM], OMEPRAZOLE., LACTULOSE., SMECTA, DOLIPRANE, ARESTAL, PRADAXA | Reactions: Skin necrosis
SafetyReportID: 10004235 Date: 20140312 Report: SafetyReportID: 10004235 | ReceiveDate: 20140312 | Drugs: HUMAN CLOTTABLE PROTEIN/HUMAN THROMBIN | Reactions: Adhesion
SafetyReportID: 10004236 Date: 20140312 Report: SafetyReportID: 10004236 | ReceiveDate: 20140312 | Drugs: LYRICA | Reactions: Vasculitis
SafetyReportID: 10004237 Date: 20140312 Report: SafetyReportID: 10004237 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Nasopharyngitis, Respiratory tract congestion, Productive cough
SafetyReportID: 10004238 Date: 20140312 Report: SafetyReportID: 10004238 | ReceiveDate: 20140312 | Drugs: GABAPENTIN, GABAPENTIN, NORTRIPTYLINE, SIMVASTATIN | Reactions: Alopecia
SafetyReportID: 10004239 Date: 20140312 Report: SafetyReportID: 10004239 | ReceiveDate: 20140312 | Drugs: SUTENT | Reactions: Death, Pain
SafetyReportID: 10004240 Date: 20140312 Report: SafetyReportID: 10004240 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Vomiting
SafetyReportID: 10004241 Date: 20140312 Report: SafetyReportID: 10004241 | ReceiveDate: 20140312 | Drugs: VARENICLINE TARTRATE, IBUPROFEN | Reactions: Hallucination, auditory, Nervousness, Feeling abnormal
SafetyReportID: 10004242 Date: 20140312 Report: SafetyReportID: 10004242 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Headache
SafetyReportID: 10004243 Date: 20140312 Report: SafetyReportID: 10004243 | ReceiveDate: 20140312 | Drugs: NICOTINE, NICOTINE | Reactions: Drug ineffective
SafetyReportID: 10004244 Date: 20140312 Report: SafetyReportID: 10004244 | ReceiveDate: 20140312 | Drugs: EXTAVIA, METOPROLOL | Reactions: Major depression, Hemiparesis, Quadriplegia, Multiple sclerosis
SafetyReportID: 10004246 Date: 20140312 Report: SafetyReportID: 10004246 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Vomiting, Abdominal discomfort
SafetyReportID: 10004247 Date: 20140312 Report: SafetyReportID: 10004247 | ReceiveDate: 20140312 | Drugs: TOBI, TOBI, TOBI PODHALER, TOBI PODHALER, HYPERTONIC SALINE SOLUTION | Reactions: Malaise, Pulmonary function test decreased, Chest discomfort
SafetyReportID: 10004248 Date: 20140312 Report: SafetyReportID: 10004248 | ReceiveDate: 20140312 | Drugs: GLEEVEC | Reactions: Fear of death, Depression
SafetyReportID: 10004249 Date: 20140312 Report: SafetyReportID: 10004249 | ReceiveDate: 20140312 | Drugs: CHAMPIX, CHAMPIX | Reactions: Hypertension, Sinus tachycardia, Dizziness, Asthenia
SafetyReportID: 10004250 Date: 20140312 Report: SafetyReportID: 10004250 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Oedema peripheral
SafetyReportID: 10004251 Date: 20140312 Report: SafetyReportID: 10004251 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Alopecia, Rash papular, Contusion
SafetyReportID: 10004252 Date: 20140312 Report: SafetyReportID: 10004252 | ReceiveDate: 20140312 | Drugs: LYRICA | Reactions: Limb traumatic amputation, Road traffic accident, Pain
SafetyReportID: 10004253 Date: 20140312 Report: SafetyReportID: 10004253 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Diarrhoea
SafetyReportID: 10004254 Date: 20140312 Report: SafetyReportID: 10004254 | ReceiveDate: 20140312 | Drugs: CELEBREX, SIMVASTATIN, BENAZEPRIL, ZOLPIDEM, ASPIRIN | Reactions: Drug ineffective
SafetyReportID: 10004255 Date: 20140312 Report: SafetyReportID: 10004255 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Hospice care
SafetyReportID: 10004256 Date: 20140312 Report: SafetyReportID: 10004256 | ReceiveDate: 20140312 | Drugs: LYRICA, TOVIAZ, HYDROCODONE | Reactions: Back pain, Nerve compression, Joint swelling, Abasia, Fall, Ligament sprain, Foot fracture
SafetyReportID: 10004257 Date: 20140312 Report: SafetyReportID: 10004257 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Hypotension
SafetyReportID: 10004258 Date: 20140312 Report: SafetyReportID: 10004258 | ReceiveDate: 20140312 | Drugs: CHANTIX | Reactions: Abnormal dreams
SafetyReportID: 10004259 Date: 20140312 Report: SafetyReportID: 10004259 | ReceiveDate: 20140312 | Drugs: JAKAFI, LEXAPRO, FISH OIL, CALCIUM | Reactions: Diarrhoea, Rhinorrhoea
SafetyReportID: 10004260 Date: 20140312 Report: SafetyReportID: 10004260 | ReceiveDate: 20140312 | Drugs: JZOLOFT | Reactions: Breast cancer
SafetyReportID: 10004261 Date: 20140312 Report: SafetyReportID: 10004261 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Paraesthesia, Dizziness, Oedema peripheral, Insomnia
SafetyReportID: 10004262 Date: 20140312 Report: SafetyReportID: 10004262 | ReceiveDate: 20140312 | Drugs: LYRICA, PERCOCET, PROPRANOLOL, AMBIEN, METFORMIN, WELLBUTRIN, LIPITOR, LISINOPRIL, SINGULAIR, CEPHALEXIN | Reactions: Dry mouth, Dry eye
SafetyReportID: 10004263 Date: 20140312 Report: SafetyReportID: 10004263 | ReceiveDate: 20140312 | Drugs: CORDARONE, AMOXICILLIN/CLAVULANIC ACID, LASILIX, LEXOMIL, ATACAND, BISOCE, KARDEGIC, KEPPRA | Reactions: Erythema, Pruritus
SafetyReportID: 10004264 Date: 20140312 Report: SafetyReportID: 10004264 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Nasal dryness
SafetyReportID: 10004265 Date: 20140312 Report: SafetyReportID: 10004265 | ReceiveDate: 20140312 | Drugs: CELEBREX, CELEBREX | Reactions: Activities of daily living impaired
SafetyReportID: 10004266 Date: 20140312 Report: SafetyReportID: 10004266 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Dyspnoea exertional
SafetyReportID: 10004267 Date: 20140312 Report: SafetyReportID: 10004267 | ReceiveDate: 20140312 | Drugs: LYRICA | Reactions: Feeling abnormal, Drug ineffective
SafetyReportID: 10004269 Date: 20140312 Report: SafetyReportID: 10004269 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Hepatic enzyme increased
SafetyReportID: 10004270 Date: 20140312 Report: SafetyReportID: 10004270 | ReceiveDate: 20140312 | Drugs: LYRICA | Reactions: Oedema peripheral, Joint swelling
SafetyReportID: 10004271 Date: 20140312 Report: SafetyReportID: 10004271 | ReceiveDate: 20140312 | Drugs: SOLIRIS | Reactions: Abdominal pain, Muscle spasms, Splenectomy, Splenomegaly, Packed red blood cell transfusion, Post procedural haemorrhage, Cold agglutinins, Pyrexia, White blood cell count decreased, Haematocrit decreased, Bronchitis, Disease progression, Pseudolymphoma, Drug ineffective, Haemoglobinuria, Night sweats, Weight increased, Fatigue, Cough
SafetyReportID: 10004272 Date: 20140312 Report: SafetyReportID: 10004272 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS, LETAIRIS | Reactions: Oedema peripheral, Adverse reaction
SafetyReportID: 10004273 Date: 20140312 Report: SafetyReportID: 10004273 | ReceiveDate: 20140312 | Drugs: EFFEXOR XR, EFFEXOR XR | Reactions: Dizziness, Heart rate increased, Musculoskeletal pain, Pain in extremity, Chest discomfort
SafetyReportID: 10004274 Date: 20140312 Report: SafetyReportID: 10004274 | ReceiveDate: 20140312 | Drugs: SOLIRIS | Reactions: Myelodysplastic syndrome, Diarrhoea
SafetyReportID: 10004275 Date: 20140312 Report: SafetyReportID: 10004275 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Headache, Intra-uterine contraceptive device insertion, Palpitations
SafetyReportID: 10004276 Date: 20140312 Report: SafetyReportID: 10004276 | ReceiveDate: 20140312 | Drugs: XELJANZ | Reactions: Oral mucosal blistering, Abdominal discomfort, Headache
SafetyReportID: 10004277 Date: 20140312 Report: SafetyReportID: 10004277 | ReceiveDate: 20140312 | Drugs: JAKAFI | Reactions: Prostatic haemorrhage
SafetyReportID: 10004278 Date: 20140312 Report: SafetyReportID: 10004278 | ReceiveDate: 20140312 | Drugs: ISTODAX, GEMCITABINE, CISPLATIN, DEXAMETHASONE | Reactions: Platelet count decreased
SafetyReportID: 10004279 Date: 20140312 Report: SafetyReportID: 10004279 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Arthralgia, Nasal congestion, Migraine, Fatigue, Fluid retention
SafetyReportID: 10004280 Date: 20140312 Report: SafetyReportID: 10004280 | ReceiveDate: 20140312 | Drugs: LYRICA | Reactions: Swelling
SafetyReportID: 10004281 Date: 20140312 Report: SafetyReportID: 10004281 | ReceiveDate: 20140312 | Drugs: CLARITIN CHEWABLE TABLETS, CLARITIN CHEWABLE TABLETS | Reactions: Overdose
SafetyReportID: 10004282 Date: 20140312 Report: SafetyReportID: 10004282 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Hypoaesthesia
SafetyReportID: 10004283 Date: 20140312 Report: SafetyReportID: 10004283 | ReceiveDate: 20140312 | Drugs: LYRICA | Reactions: Drug ineffective
SafetyReportID: 10004284 Date: 20140312 Report: SafetyReportID: 10004284 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Oedema peripheral
SafetyReportID: 10004285 Date: 20140312 Report: SafetyReportID: 10004285 | ReceiveDate: 20140312 | Drugs: TIZANIDINE (TIZANIDINE), VENTOLIN HFA, AMITRIPTYLINE, ROSUVASTATIN, RIVAROXABAN, CLONAZEPAM., POTASSIUM CHLORIDE., GILENYA, BENZONATATE., LEXAPRO, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE, FUROSEMIDE., PANTOPRAZOLE, HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Reactions: Cerebrovascular accident, Migraine, Presyncope, Syncope
SafetyReportID: 10004286 Date: 20140312 Report: SafetyReportID: 10004286 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Lung transplant
SafetyReportID: 10004287 Date: 20140312 Report: SafetyReportID: 10004287 | ReceiveDate: 20140312 | Drugs: LYRICA | Reactions: Dizziness, Drug effect incomplete, Activities of daily living impaired, Drug intolerance
SafetyReportID: 10004288 Date: 20140312 Report: SafetyReportID: 10004288 | ReceiveDate: 20140312 | Drugs: SYNAGIS, OLEOVIT D3, MULTIBIONTA DROPS, AKTIFERRIN, NASAL DROPS WITH SODIUM CHLORIDE, CANDIO HERMAL, INOTYOL, ANTIFLAT | Reactions: Bronchiolitis, Apnoea, Cyanosis, Rhinorrhoea, Umbilical hernia, Inguinal hernia, Oedema genital
SafetyReportID: 10004289 Date: 20140312 Report: SafetyReportID: 10004289 | ReceiveDate: 20140312 | Drugs: SOLIRIS | Reactions: Headache
SafetyReportID: 10004290 Date: 20140312 Report: SafetyReportID: 10004290 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Ligament sprain, Fall
SafetyReportID: 10004291 Date: 20140312 Report: SafetyReportID: 10004291 | ReceiveDate: 20140312 | Drugs: XALKORI | Reactions: Dizziness
SafetyReportID: 10004292 Date: 20140312 Report: SafetyReportID: 10004292 | ReceiveDate: 20140312 | Drugs: CARDIOASPIRIN, CITALOPRAM (UNKNOWN), ENAPREN, LASIX, SIVASTIN, OLANZAPINE, MIRTAZAPINE | Reactions: Subarachnoid haemorrhage
SafetyReportID: 10004293 Date: 20140312 Report: SafetyReportID: 10004293 | ReceiveDate: 20140312 | Drugs: SOLIRIS | Reactions: Influenza like illness, Dysphagia, Dyspnoea, Immune thrombocytopenic purpura, Haemoglobinuria, Pain, Nausea, Chills, Jaundice, Hypotension, Fatigue
SafetyReportID: 10004294 Date: 20140312 Report: SafetyReportID: 10004294 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Palpitations, Back pain, Oedema, Chest pain
SafetyReportID: 10004295 Date: 20140312 Report: SafetyReportID: 10004295 | ReceiveDate: 20140312 | Drugs: LYRICA | Reactions: Drug ineffective, Dizziness
SafetyReportID: 10004296 Date: 20140312 Report: SafetyReportID: 10004296 | ReceiveDate: 20140312 | Drugs: PRAMIPEXOLE, AZILECT | Reactions: Dyspnoea, Oedema peripheral, Right ventricular failure
SafetyReportID: 10004297 Date: 20140312 Report: SafetyReportID: 10004297 | ReceiveDate: 20140312 | Drugs: SOLIRIS | Reactions: Haemoglobin decreased, Dialysis, Haemoglobinuria, Fatigue
SafetyReportID: 10004298 Date: 20140312 Report: SafetyReportID: 10004298 | ReceiveDate: 20140312 | Drugs: LETAIRIS | Reactions: Pruritus, Dry mouth, Headache, Decreased appetite, Dizziness, Dyspnoea
SafetyReportID: 10004299 Date: 20140312 Report: SafetyReportID: 10004299 | ReceiveDate: 20140312 | Drugs: EFFEXOR, EFFEXOR XR, EFFEXOR XR, EFFEXOR XR, EFFEXOR XR | Reactions: Dizziness, Nausea, Activities of daily living impaired, Dizziness, Wrong technique in drug usage process
SafetyReportID: 10004300 Date: 20140312 Report: SafetyReportID: 10004300 | ReceiveDate: 20140312 | Drugs: JAKAFI, ATENOLOL, LEVOTHYROXINE, MULTIVITAMINS, PROBIOTICS | Reactions: Hypoaesthesia, Anaemia
SafetyReportID: 10004301 Date: 20140312 Report: SafetyReportID: 10004301 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Muscle disorder, Pain in extremity, Dizziness, Asthenia
SafetyReportID: 10004302 Date: 20140312 Report: SafetyReportID: 10004302 | ReceiveDate: 20140312 | Drugs: PLAVIX, LASIX, ATELEC, TRAZENTA, ATORVASTATIN, LIMARMONE, CELECOX, BAYASPIRIN, SALOBEL, MICAMLO, METGLUCO | Reactions: Renal impairment, Hyperkalaemia, Iron deficiency anaemia, Chronic gastritis
SafetyReportID: 10004303 Date: 20140312 Report: SafetyReportID: 10004303 | ReceiveDate: 20140312 | Drugs: PRISTIQ | Reactions: Drug ineffective
SafetyReportID: 10004304 Date: 20140312 Report: SafetyReportID: 10004304 | ReceiveDate: 20140312 | Drugs: GILENYA | Reactions: Central nervous system lesion
SafetyReportID: 10004305 Date: 20140312 Report: SafetyReportID: 10004305 | ReceiveDate: 20140312 | Drugs: LETAIRIS, LETAIRIS | Reactions: Diarrhoea
# --- Document 1: Summary of Phase III Clinical Trial Findings (Source: ClinicalTrials.gov NCT045xxxx) ---
**DRUG: VERIDOXINE (Phase III Study)**
The Phase III clinical program (N=5,200) for Veridoxine showed a consistent safety profile. The incidence of cardiovascular adverse events (AEs) was 0.8% in the treatment group versus 0.9% in the placebo group, demonstrating no statistically significant risk of cardiac complications. Hepatic enzyme elevation (ALT/AST) above 3x ULN occurred in 1.2% of patients, all of which resolved upon discontinuation of therapy, indicating the hepatotoxicity risk is considered mild and transient. The primary safety conclusion was that Veridoxine does not increase the risk of severe, life-threatening cardiovascular or liver events.

# --- Document 2: Established Safety Profile / Labeling (Source: Hypothetical FDA Labeling Section 6.1) ---
**VERIDOXINE LABELING: ADVERSE REACTIONS**
Common Adverse Reactions (incidence >5%): Headache (12%), Nausea (8%).
Serious Adverse Reactions (incidence <1%): Peripheral Neuropathy (0.7%).
Note: No cases of myocarditis or cardiomyopathy were reported during pre-market testing. Regulatory guidelines stipulate that any post-marketing report involving persistent or severe cardiovascular adverse events (MedDRA term: Myocarditis, Pericarditis) must be expedited for signal detection analysis.

# --- Document 3: Independent Review/Mechanism (Source: Hypothetical PubMed Abstract ID: 3590xxxx) ---
**MECHANISM OF ACTION AND LIVER SAFETY**
An independent review of the Veridoxine drug class confirms that the drug is primarily metabolized via CYP3A4. Its metabolites are considered non-toxic to hepatocytes. Severe, idiosyncratic drug-induced liver injury (DILI) related to Veridoxine has not been observed in any large cohort studies to date, and a strong causality link is absent in the existing literature. DILI signal confidence must be high (Naranjo score > 8) to warrant a label change.
